Endocrinology and Metabolism

Original Article

WITHDRAWN: Obesity and Bone Fragility: The Hidden Impact of Insulin Resistance on Trabecular Bone Score, Not Bone Density: Taehoon Park, Kyungwon Seo, Ki Hyun Kim, Yoonhong Kim, Bukyung Kim; Received July 14, 2025 Accepted November 26, 2025 Published online August 6, 2026; DOI: https://doi.org/10.3803/EnM.2025.2556

722 View
31 Download

PubReader ePub

Review Articles

Mineral, bone & muscle
Revisiting the Role of Vitamin D in Fracture Prevention in the Era of Mega-Trials: Sung Hye Kong; Endocrinol Metab. 2026;41(2):203-209. Published online April 29, 2026; DOI: https://doi.org/10.3803/EnM.2026.2938

2,494 View
112 Download

Abstract PDF PubReader ePub: For decades, vitamin D has been a cornerstone of preventive medicine. However, recent large-scale randomized controlled trials have failed to replicate the broad benefits previously observed in epidemiological studies, particularly with respect to fracture and fall prevention in vitamin D-replete populations. Moreover, growing evidence suggesting an increased fall risk associated with high-dose bolus administration has necessitated a re-evaluation of safety assumptions. This review synthesizes these discordant findings to propose a framework grounded in precision medicine. We explore the ‘divergent threshold’ hypothesis, whereby a serum 25-hydroxyvitamin D level of 20 to 30 ng/mL may be sufficient for skeletal health, whereas a higher threshold of 40 to 50 ng/mL appears necessary to achieve metabolic benefits, such as diabetes prevention in non-obese individuals. Ultimately, we advocate a shift away from a ‘one-size-fits-all’ paradigm toward targeted strategies that maximize efficacy while minimizing the risks associated with excess supplementation.

Mineral, bone & muscle
Anabolics in Cancer Patients: To Use or Not to Use?: A Ram Hong; Endocrinol Metab. 2026;41(2):222-230. Published online April 16, 2026; DOI: https://doi.org/10.3803/EnM.2026.3027

4,324 View
141 Download
1 Web of Science

Abstract PDF PubReader ePub: With improving cancer survival, the management of osteoporosis in cancer survivors has become increasingly important. Cancer treatment-induced bone loss and aging place many survivors at high risk of fragility fractures. Anabolic agents, including parathyroid hormone (PTH) receptor agonists and the anti-sclerostin antibody romosozumab, effectively stimulate bone formation and reduce fracture risk in the general population. However, their use in cancer patients remains limited because of safety concerns and insufficient clinical evidence. Preclinical studies suggested a potential risk of osteosarcoma with PTH analogues and possible effects on tumor growth or bone metastasis through modulation of the bone microenvironment, although long-term human studies have not demonstrated an increased malignancy risk. In clinical practice, PTH analogues are generally avoided in patients with active malignancy, bone metastases, hypercalcemia, or a history of osteosarcoma. In selected cancer survivors with a sufficiently long diseasefree interval, their cautious use may be considered depending on recurrence risk. Romosozumab may represent another potential option, although supporting evidence remains limited. Overall, the use of anabolic therapy in cancer patients should be individualized, carefully balancing fracture risk against potential oncologic safety concerns.

Mineral, bone & muscle
Beyond Weight Loss: Skeletal Considerations in Obesity Treatment: Myung Jin Kim, Yun Kyung Cho; Endocrinol Metab. 2026;41(2):210-221. Published online April 8, 2026; DOI: https://doi.org/10.3803/EnM.2026.2986

6,896 View
190 Download
1 Web of Science
1 Crossref

Abstract PDF PubReader ePub

The rapid evolution of obesity therapeutics, led by glucagon-like peptide-1 receptor agonists (GLP-1RAs) and metabolic surgery, has achieved unprecedented weight loss. However, the skeletal consequences of such substantial weight reduction are of increasing clinical concern. This review explores the relationship between obesity, weight-loss modalities, and bone health. While obesity was historically viewed as bone-protective due to mechanical loading, recent evidence highlights qualitative bone deterioration and sitespecific fracture risks. Intentional weight loss through caloric restriction or bariatric surgery consistently accelerates bone turnover and reduces bone mineral density (BMD), with surgical interventions showing the most significant impact. Emerging data on GLP-1RAs suggest modest BMD declines, largely proportional to weight loss and likely driven by mechanical unloading. Conversely, preclinical studies indicate that GLP-1 signaling may exert direct osteoanabolic and anti-resorptive effects. To preserve skeletal integrity, obesity management must shift toward a holistic body composition framework. Integrating structured resistance exercise, optimizing nutrition (calcium, vitamin D, and protein), and implementing skeletal monitoring in high-risk individuals are essential. Future obesity care should prioritize the maintenance of bone quality and lean mass alongside fat reduction to ensure long-term skeletal resilience and prevent fragility fractures.

Citations

Citations to this article as recorded by

Association Between Lifestyle Factors and the Prevalence of Non-Communicable Diseases in Saudi Adults Across Different Age Groups: A Cross-Sectional Study
Somia A. Nassar
Diseases.2026; 14(5): 163. CrossRef

Revisiting the Role of Vitamin D in Fracture Prevention in the Era of Mega-Trials: Sung Hye Kong; Received January 23, 2026 Accepted February 3, 2026 Published online March 4, 2026; DOI: https://doi.org/10.3803/EnM.2029.2938 [Epub ahead of print]

2,653 View
52 Download

Abstract PDF PubReader ePub: For decades, vitamin D has been a cornerstone of preventive medicine. However, recent large-scale randomized controlled trials have failed to replicate the broad benefits previously observed in epidemiological studies, particularly with respect to fracture and fall prevention in vitamin D-replete populations. Moreover, growing evidence suggesting an increased fall risk associated with highdose bolus administration has necessitated a re-evaluation of safety assumptions. This review synthesizes these discordant findings to propose a framework grounded in precision medicine. We explore the ‘divergent threshold’ hypothesis, whereby a serum 25-hydroxyvitamin D level of 20 to 30 ng/mL may be sufficient for skeletal health, whereas a higher threshold of 40 to 50 ng/mL appears necessary to achieve metabolic benefits, such as diabetes prevention in non-obese individuals. Ultimately, we advocate a shift away from a ‘one-size-fits-all’ paradigm toward targeted strategies that maximize efficacy while minimizing the risks associated with excess supplementation.

Mineral, bone & muscle
Complete Blood Count Parameters and Bone Health: Clinical and Experimental Evidence: Jeonghoon Ha, Mayo Ono, Hui Zhu, Caroline Cencer, Xiyu Ge, Joy Y. Wu; Endocrinol Metab. 2025;40(6):811-820. Published online December 3, 2025; DOI: https://doi.org/10.3803/EnM.2025.2695

3,590 View
104 Download
5 Web of Science
5 Crossref

Abstract PDF PubReader ePub

Osteoporotic fractures pose a significant burden in aging populations, yet current assessment strategies may overlook systemic factors influencing bone health. Emerging evidence suggests that complete blood count (CBC) parameters, including red blood cell indices, white blood cell (WBC) counts and subtypes, and platelet counts, are associated with skeletal fragility and fracture risk. Anemia has been consistently linked to reduced bone mineral density and increased fracture susceptibility, potentially due to impaired oxygen delivery and osteoblast dysfunction. Elevated red cell distribution width may reflect oxidative stress and has been associated with bone loss. Inflammatory markers such as high WBC count and neutrophil-to-lymphocyte ratio are implicated in enhanced osteoclast activity, while platelet abnormalities may influence bone remodeling and fracture healing. These associations suggest that CBC-derived markers could serve as accessible and cost-effective indicators to support osteoporosis evaluation. However, important limitations remain, including undefined clinical thresholds, limited longitudinal evidence, and uncertain causality. Further research is needed to clarify underlying mechanisms and determine whether correcting hematological abnormalities can improve skeletal outcomes. A cautious, evidence-based approach is warranted to define the role of CBC parameters in the clinical assessment of bone health.

Citations

Citations to this article as recorded by

Complete Blood Count Parameters and Bone Health: Clinical and Experimental Evidence (Endocrinol Metab 2025;40:811-20, Jeonghoon Ha et al.)
Federica Tramontana, Richard Quinton
Endocrinology and Metabolism.2026; 41(2): 333. CrossRef
Complete Blood Count Parameters and Bone Health: Clinical and Experimental Evidence (Endocrinol Metab 2025;40:811-20, Jeonghoon Ha et al.)
Jeonghoon Ha, Joy Y. Wu
Endocrinology and Metabolism.2026; 41(2): 335. CrossRef
Different Analytical Modes on Automatic Hematology Analyzers for Testing Quality Control Materials and Commutability Assessment
Bingshuang Ren, Ya Cheng, Hongping Ba, Weijia Cheng, Xuwei Zhou, Hui Zhen, Shimin Wu, Jie Gong
International Journal of Laboratory Hematology.2026;[Epub] CrossRef
Sarcopenia and inflammatory markers in early-stage breast cancer: a retrospective case-control study of NLR, MLR, RDW-CV, and HRR in middle-aged and elderly women
Yu Liu, Xinyu Zhai, Zhongyu Wang, Wei Jia
Frontiers in Surgery.2026;[Epub] CrossRef
Clinically constrained Bayesian network analysis of immune–metabolic factors associated with bone mineral density in a real-world orthopedic cohort
Chong Zhao, Yuemei Hu, Zhenqi Zhu, Weiwei Xia, Haiying Liu
Frontiers in Surgery.2026;[Epub] CrossRef

Original Article

Mineral, bone & muscle
Lack of Association between Vitamin D Insufficiency and Cardiovascular or Fracture Risk: A UK Biobank Study: Yongin Cho, Jong Hyun Jhee, Jong Ho Jhee, Hye-Sun Park; Endocrinol Metab. 2026;41(2):308-318. Published online October 15, 2025; DOI: https://doi.org/10.3803/EnM.2025.2482

3,720 View
91 Download
1 Web of Science
1 Crossref

Abstract PDF Supplementary Material PubReader ePub

Background
Vitamin D deficiency has been linked to increased risks of fractures and cardiovascular (CV) events, but the clinical relevance of the ‘insufficiency’ range remains unclear. We investigated CV and fracture risks across vitamin D levels, with a focus on the insufficiency range.
Methods
Using UK Biobank data, we analyzed 375,044 participants aged 40 to 69 years. Vitamin D status was categorized as deficient (<50 nmol/L), insufficient (≥50 to <75 nmol/L), or sufficient (≥75 nmol/L). Outcomes included three-point major adverse cardiovascular events (3P-MACE; myocardial infarction, stroke, and CV mortality) and major osteoporotic fractures, assessed via hospital records, registries, and death certificates.
Results
The vitamin D-deficient group had an increased risk of CV events (adjusted hazard ratio [aHR], 1.17; 95% confidence interval [CI], 1.11 to 1.24) and fractures (aHR, 1.09; 95% CI, 1.01 to 1.18) compared to the vitamin D-sufficient group. Within the deficient group, the severely deficient group (<30 nmol/L) exhibited a markedly higher risk (aHR, 1.29; 95% CI, 1.21 to 1.37 for 3PMACE; and aHR, 1.20; 95% CI, 1.10 to 1.32 for fractures). In contrast, the vitamin D-insufficient group (50 to 75 nmol/L) showed no significant increase in the risk of either outcome, with no clear benefit or harm observed. Spline curve analysis revealed a negative correlation between vitamin D levels and risk, which was observed only within the deficient range and not within the insufficient range.
Conclusion
Vitamin D deficiency is strongly associated with increased CV disease and fracture risks, whereas the insufficiency range shows no significant risk or benefit, raising questions about its clinical relevance.

Citations

Citations to this article as recorded by

Beyond a Universal Threshold: Reconsidering the Clinical Meaning of Vitamin D Insufficiency
Kyoung Jin Kim
Endocrinology and Metabolism.2026; 41(2): 231. CrossRef

Review Article

Mineral, bone & muscle
Incorporating Artificial Intelligence into Fracture Risk Assessment: Using Clinical Imaging to Predict the Unpredictable: Sung Hye Kong; Endocrinol Metab. 2025;40(4):499-507. Published online August 4, 2025; DOI: https://doi.org/10.3803/EnM.2025.2518

7,251 View
129 Download
9 Web of Science
11 Crossref

Abstract PDF PubReader ePub

Artificial intelligence (AI) is increasingly being explored as a complementary tool to traditional fracture risk assessment methods. Conventional approaches, such as bone mineral density measurement and established clinical risk calculators, provide populationlevel stratification but often fail to capture the structural nuances of bone fragility. Recent advances in AI—particularly deep learning techniques applied to imaging—enable opportunistic screening and individualized risk estimation using routinely acquired radiographs and computed tomography (CT) data. These models demonstrate improved discrimination for osteoporotic fracture detection and risk prediction, supporting applications such as time-to-event modeling and short-term prognosis. CT- and radiograph-based models have shown superiority over conventional metrics in diverse cohorts, while innovations like multitask learning and survival plots contribute to enhanced interpretability and patient-centered communication. Nevertheless, challenges related to model generalizability, data bias, and automation bias persist. Successful clinical integration will require rigorous external validation, transparent reporting, and seamless embedding into electronic medical systems. This review summarizes recent advances in AI-driven fracture assessment, critically evaluates their clinical promise, and outlines a roadmap for translation into real-world practice.

Citations

Citations to this article as recorded by

Quantitative CT Analysis for Predicting Hip Fragility Fracture Risk in Postmenopausal Women: A Value Assessment
昭春杜
Advances in Clinical Medicine.2026; 16(01): 2897. CrossRef
Advancements in ex vivo bone biomechanics: multimodal technologies and their integration with artificial intelligence
Safa Unal, Mustafa Unal
Methods.2026; 249: 48. CrossRef
Artificial Intelligence for Fracture Risk Prediction: A Bibliometric Analysis of Research Hotspots and Evolutionary Trends
Bo Wang, Yin Lian, Lina Gao
Applied Artificial Intelligence Research.2026;[Epub] CrossRef
Comment on “Assessing deep learning model performance in osteoporosis screening with lumbar spine radiographs”
Dhananjay Kumar Mishra, Koyel Roy, Tarun Madan Kanade
Journal of Bone and Mineral Metabolism.2026;[Epub] CrossRef
Role of bone turnover markers in prediction of fracture healing: a contemporary evidence-based perspective
Hamza Ali, Adarsh Kumar Singh, Anurag Baghel, Shafaque Asif
International Journal of Research in Orthopaedics.2026; 12(3): 848. CrossRef
Consensus statement on the application of artificial intelligence in osteoporosis screening and management: perspectives from the Asia-Pacific region
Chun-Feng Huang, Wen-Hui Fang, Kun-Hui Chen, Sung-Yen Lin, Cheng-Jung Ho, Jawl-Shan Hwang, Ta-Wei Tai, Yuan-Fu Liu, Chien-An Shih, Jung-Fu Chen, Shih-Te Tu, Ding-Cheng Chan, Rong-Sen Yang, Shau-Huai Fu, Hsuan-Yu Chen, Keh-Sung Tsai, Tien-Tsai Cheng, Fang-
Osteoporosis International.2026; 37(5): 1039. CrossRef
Hybrid movement strategies in orthopedic oncology: Mechanistic integration of musculoskeletal and tumor–host interactions
Dongdong Wang, Yahui Li
Seminars in Oncology.2026; 53(5): 152516. CrossRef
Artificial Intelligence for Osteoporosis Diagnosis, Risk Prediction and Therapy: Current Advances, Clinical Challenges, and Future Perspectives
Zhaochen Zhang, Yuxi He, Zhanhao Mo, Peng Zhang, Zhenya Tian, Lanfeng Huang
Clinical Interventions in Aging.2026; Volume 21: 1. CrossRef
The future of DXA: How AI is transforming bone health diagnostics
Mahsa Shakeri, Seyyed Mohammad Hosseini, Nikolas Knowles, Forough Jamil, Mohammad Haghparast, Leili Darvish
Journal of Microscopy.2026;[Epub] CrossRef
Bidirectional Domain Shift Failure in Radiograph Fracture Classification Across Out-of-Distribution Pediatric and Mixed-Age Multi-Region Data
Rahim Patwary, Milan Toma
Applied Sciences.2026; 16(14): 6853. CrossRef
Diagnostic Value of Opportunistic CT-Based Bone Density Assessment in Patients with and Without Sacral Insufficiency Fractures
Julian Ramin Andresen, Guido Schröder, Thomas Haider, Hans-Christof Schober, Reimer Andresen
Diagnostics.2025; 15(22): 2926. CrossRef

Original Articles

Mineral, bone & muscle
Osteoporosis Management after the Occurrence of Medication-Related Osteonecrosis of the Jaw: A 13-Year Experience at a Tertiary Center: Chun Ho Wong, Kimberly Hang Tsoi, Jingya Jane Pu, Nancy Su Jiang, Stacey Sheung Yi Chan, Connie Hong Nin Loong, Xincheng Zou, Carol Ho Yi Fong, Eunice Ka Hong Leung, Alan Chun Hong Lee, Chi Ho Lee, Kathryn Choon Beng Tan, Yu Cho Woo, Yu-xiong Su, David Tak Wai Lui; Endocrinol Metab. 2025;40(6):974-990. Published online June 13, 2025; DOI: https://doi.org/10.3803/EnM.2024.2262

9,378 View
326 Download
5 Web of Science
5 Crossref

Abstract PDF PubReader ePub

Background
We investigated osteoporosis management strategies and clinical outcomes following the occurrence of medicationrelated osteonecrosis of the jaw (MRONJ).
Methods
We retrospectively studied individuals diagnosed with MRONJ during osteoporosis treatment who were managed in the Osteoporosis Center or the Oral Maxillofacial Surgery & Dental Unit at Queen Mary Hospital in Hong Kong between 2010 and 2022. We examined subsequent osteoporosis management plans, fracture events, and bone mineral density (BMD).
Results
Thirty-six individuals were included (mean age, 78.5 years; 94.4% women). The estimated prevalence of MRONJ was 0.26%. All patients had been exposed to bisphosphonates, and seven had also received denosumab before MRONJ. Following MRONJ, only 14 individuals continued anti-osteoporosis treatment, a decision influenced by a higher fracture probability at MRONJ onset. The most common regimen was a teriparatide-raloxifene sequence (n=8): three patients achieved stable BMD, four achieved improving BMD, and one exhibited a mixed response. The patient with a mixed BMD response had also been treated with denosumab. Six patients sustained incident fractures after MRONJ, and these patients had lower BMD T-scores than their counterparts. Two patients experienced MRONJ recurrence, which was associated with the resumption of bisphosphonate or denosumab therapy after MRONJ. These patients had higher BMD T-scores than those who did not experience MRONJ recurrence.
Conclusion
MRONJ is challenging because high fracture risk necessitates discontinuation of antiresorptive agents. Teriparatide followed by raloxifene may be a reasonable regimen. Individualised decisions in osteoporosis management after MRONJ are required to balance fracture risk reduction with minimising MRONJ recurrence.

Citations

Citations to this article as recorded by

Denosumab Therapy Beyond 10 Years: Subsequent Treatment and Densitometric Outcomes
Xi Xiong, Chun Ho Wong, Kimberly H. Tsoi, Connie H.N. Loong, Carol H.Y. Fong, Alan C.H. Lee, Chi Ho Lee, Kathryn C.B. Tan, Yu Cho Woo, Manju Chandran, David T.W. Lui
Endocrine Practice.2026; 32(6): 861. CrossRef
Double-edged-sword effect of bisphosphonates on the osteogenic differentiation of human periodontal ligament stem cells
Mengyu Li, Jiajia Wang, Hanjin Ruan, Zhouyang Wang, Shaoyi Wang, Yue He, Zhiyuan Zhang
Frontiers in Pharmacology.2026;[Epub] CrossRef
Combination and sequential therapy for postmenopausal osteoporosis: recent advances and clinical practice
Jiazhen Liu, Yuqing Hu, Zhen Yao, Hongyu Wang
Beni-Suef University Journal of Basic and Applied Sciences.2026;[Epub] CrossRef
Medication-Related Osteonecrosis of the Jaw: An Evidence-Based 2025 Position Statement from a Korean Multidisciplinary Task Force
Jin-Woo Kim, Sung-Hye Kong, Jae-Young Kim, Mi Kyung Kwak, Jun-Young Kim, Ji-Hyeon Oh, Hyung-Youl Park, BeomTaek Kim, Young-Kyun Lee, Jeong Joon Han, Moon-Young Kim, Yong Jun Choi, Yong-Dae Kwon, Kwang-Sup Song, Beom-Jun Kim, Sun-Jong Kim, Seung-Hoon Baek,
Endocrinology and Metabolism.2025; 40(6): 787. CrossRef
Medication-related osteonecrosis of the jaw: an evidence-based 2025 position statement from a Korean multidisciplinary task force
Jin-Woo Kim, Sung-Hye Kong, Jae-Young Kim, Mi Kyung Kwak, Jun-Young Kim, Ji-Hyeon Oh, Hyung-Youl Park, BeomTaek Kim, Young-Kyun Lee, Jeong Joon Han, Moon-Young Kim, Yong Jun Choi, Yong-Dae Kwon, Kwang-Sup Song, Beom-Jun Kim, Sun-Jong Kim, Seung-Hoon Baek,
Journal of the Korean Association of Oral and Maxillofacial Surgeons.2025; 51(6): 333. CrossRef

Mineral, bone & muscle
Effects of Sequential Anti-Resorptive Agents on Bone Mineral Density Following Denosumab Withdrawal: A Multicenter Real-World Study in Korea (MAXCARE Study): Jeonghoon Ha, Kyong Yeun Jung, Kyoung Jin Kim, Seong Hee Ahn, Hyo-Jeong Kim, Yoon-Sok Chung, on Behalf of MAXCARE Research Group; Endocrinol Metab. 2025;40(5):748-758. Published online February 11, 2025; DOI: https://doi.org/10.3803/EnM.2024.2227

9,184 View
469 Download
3 Web of Science
6 Crossref

Abstract PDF PubReader ePub

Background
Denosumab is a potent anti-resorptive agent widely used for osteoporosis. However, its discontinuation results in a ‘rebound phenomenon’ of rapid bone loss, necessitating transition to alternative anti-resorptive therapies. Despite this, there is limited evidence to guide the selection of the most effective agent, particularly among bisphosphonates. This study aimed to evaluate the efficacy of different anti-resorptive therapies following denosumab discontinuation in a real-world clinical setting.
Methods
This retrospective study included 360 patients (low-dose alendronate/calcitriol combination [MXM, n=118], alendronate [ALD, n=53], risedronate [RIS, n=20], ibandronate [IBN, n=30], zoledronic acid [ZOL, n=106], selective estrogen receptor modulator [SERM, n=33]) who received at least 12 months of post-denosumab anti-resorptive therapy. Bone mineral density (BMD) changes from baseline and fracture patterns were assessed over the treatment period.
Results
Baseline characteristics, including age and body mass index, were comparable across groups, with an average of 4.2 denosumab administrations per patient. The SERM group experienced the greatest BMD decline across all sites. Significant BMD reductions in the lumbar spine and femoral neck and in the femoral neck alone were observed in the IBN and RIS groups, respectively. While BMD decline was also observed in the MXM, ALD, and ZOL groups, these changes were not statistically significant.
Conclusion
MXM, ALD, and ZOL mitigated BMD loss following denosumab discontinuation. Conversely, RIS, IBN, and SERM did not adequately prevent BMD decline. These findings underscore the importance of selecting the most appropriate sequential antiresorptive therapy in clinical practice to minimize BMD loss and reduce the risk of adverse outcomes.

Citations

Citations to this article as recorded by

当院におけるデノスマブ使用継続による中期的な骨密度変化の検討
暖基中野, 克樹江﨑, 雄太土居, 慶一小澤
Orthopedics & Traumatology.2026; 75(1): 147. CrossRef
Stratégies pour l’arrêt du dénosumab dans l’ostéoporose post-ménopausique
Yannick Degboé, Guillaume Couture
Revue du Rhumatisme.2026;[Epub] CrossRef
Alendronate for 6 or 12 mo following denosumab discontinuation in women with postmenopausal osteoporosis: a prospective observational study
Polyzois Makras, Athanasios D Anastasilakis, Andrea Palermo, Anda Mihaela Naciu, Stergios A Polyzos, Danai Georgakopoulou, Athanasios Papatheodorou, Matthaios Savvidis, Socrates Papapoulos, Maria P Yavropoulou
Journal of Bone and Mineral Research.2026;[Epub] CrossRef
Potent bisphosphonate therapy for preventing fractures after denosumab discontinuation in osteoporosis
Asim Shah, Suleman Khan, Syeda Vilay Zehra Rizvi, Kanza Farhan, Misbah Uddin, Syeda Umme Abiha Rizvi, Sabika Fatima, Ang Raj Karan, Aizaz Anwar Khalid, Ahmad Ali, Somaiya Ahmed
Medicine.2026; 105(36): e50542. CrossRef
Denosumab—efficacy, safety, persistence and sequential strategies—a systematic review
Natasha Amran Laursen, Anne Sophie Sølling, Torben Harsløf, Bente L. Langdahl
Osteoporosis International.2026;[Epub] CrossRef
Pharmacological Management of Osteoporosis in Geriatric Populations: A Comprehensive Literature Review
E. N. Dudinskaya, N. V. Brailova, O. N. Tkacheva
Russian Journal of Geriatric Medicine.2025; (2): 115. CrossRef

Review Articles

Mineral, Bone & Muscle
Long-Term Efficacy and Safety of Denosumab: Insights beyond 10 Years of Use: Jeonghoon Ha, Youn-Ju Lee, Jinyoung Kim, Chaiho Jeong, Yejee Lim, Jeongmin Lee, Ki-Hyun Baek, on Behalf of the Catholic Medical Center Bone Research Group; Endocrinol Metab. 2025;40(1):47-56. Published online January 13, 2025; DOI: https://doi.org/10.3803/EnM.2024.2125

62,397 View
1,380 Download
14 Web of Science
17 Crossref

Abstract PDF PubReader ePub

Osteoporosis management in post-menopausal women focuses on fracture prevention, with denosumab as a key therapeutic option. Despite its proven efficacy in reducing fracture risk and increasing bone mineral density (BMD) over 10 years, its long-term impact remains uncertain. We evaluated the literature on its efficacy and safety beyond the initial decade. Clinical trials and real-world studies confirm denosumab’s sustained efficacy, especially in lumbar spine BMD, with hip BMD stabilizing. Concerns about adverse events (AEs) like hypocalcemia and osteonecrosis of the jaw necessitate vigilant monitoring. Risks of atypical femoral fractures and malignancies also require attention, despite unclear links to treatment duration. Clinical guidelines for denosumab beyond 10 years are limited, emphasizing the need for careful monitoring. In certain scenarios, such as advanced chronic kidney disease, prolonged denosumab may be required to balance AE risks with fracture prevention benefits. Denosumab shows potential for long-term efficacy in augmenting BMD; however, monitoring for AEs is crucial to guide clinical decision-making effectively.

Citations

Citations to this article as recorded by

Enhancing osteoporosis treatment: emerging roles of engineered exosomes in bone regeneration and repair
Hongtao Li, Hongyu Pan, Minshan Feng
Journal of Translational Medicine.2026;[Epub] CrossRef
Denosumab Therapy Beyond 10 Years: Subsequent Treatment and Densitometric Outcomes
Xi Xiong, Chun Ho Wong, Kimberly H. Tsoi, Connie H.N. Loong, Carol H.Y. Fong, Alan C.H. Lee, Chi Ho Lee, Kathryn C.B. Tan, Yu Cho Woo, Manju Chandran, David T.W. Lui
Endocrine Practice.2026; 32(6): 861. CrossRef
Managing Bone Fragility in Older Adults with Diabetes: Pathophysiology, Assessment, and Therapeutic Considerations
Gulistan Bahat, Tugba Erdogan, Savas Ozturk, Ozlem Soyluk Selcukbiricik, Serdar Ozkok, Dilek Gogas Yavuz, Mehmet Akif Karan, Jean-Yves Reginster
Drugs & Aging.2026; 43(4): 341. CrossRef
Comment on “Bone fragility and atypical femoral fractures in SLE: role of disease activity, infection, and treatment”
Manish Juneja, Harshawardhan Ramteke, Rakhshanda Khan
Journal of Bone and Mineral Metabolism.2026;[Epub] CrossRef
Synergistic Efficacy of Calcitriol Combined with Denosumab versus Calcitriol Alone in Postmenopausal Osteoporosis: A Retrospective Cohort Study
Xueyuan Li, Ming Hu, Yi Shen
International Journal of Women's Health.2026; Volume 18: 1. CrossRef
Diagnosis and treatment of osteoporosis: 2026 recommendations of the Polish Society for Rheumatology
Piotr Leszczyński, Cezary Iwaszkiewicz, Zbigniew Michał Żuber, Brygida Kwiatkowska, Bogdan Piotr Batko, Katarzyna Krystyna Pawlak-Buś
Rheumatology.2026;[Epub] CrossRef
Challenges in Sequential Antiresorptive Therapy After Long-Term Denosumab Discontinuation: A Case Report and Narrative Review of the Literature
Maria-Evangelia Koloutsou, Melina Despina Pieper, Maria Mateniadou, Angeliki Papapanagiotou, Athanasios D. Anastasilakis, Polyzois Makras, Maria P. Yavropoulou
Journal of Clinical Medicine.2026; 15(14): 5443. CrossRef
Three-year longitudinal assessment of denosumab’s efficacy and safety in postmenopausal osteoporosis: a 36-month real-world cohort study
Rong-Lin Xia, Chen Li, Li Wang, Ai-Jun Chao, Wei Wei
Frontiers in Medicine.2026;[Epub] CrossRef
Clinical implications of denosumab discontinuation for spine surgeons
Charu Jain, Matthew T. Drake, David Essig, Sohrab Virk, Paul A. Anderson
The Spine Journal.2026;[Epub] CrossRef
Chronic kidney disease: from mineral dysregulation to bone and cardiovascular disease
Melpomeni Moustaki, Stavroula A. Paschou, Eleni Palioura, Evanthia Kassi, Symeon Tournis, Andromachi Vryonidou
Journal of Endocrinological Investigation.2026;[Epub] CrossRef
Primary hyperparathyroidism presenting as atraumatic bilateral hip fractures: a case report
Kevin McCarroll, Aisling Carroll, Finlay Brennan, Daire Gargan, Donal Fitzpatrick, Rosaleen Lannon
Journal of Medical Case Reports.2026;[Epub] CrossRef
Management of Osteoporosis and Low Bone Mass in Kidney Disease
Matthew Mulroy, Angela Primbas, Isidro B. Salusky, Jane Weinreb, Albert Shieh
Clinical Journal of the American Society of Nephrology.2026;[Epub] CrossRef
Pharmaceutical market for bone resorption inhibitors in Uzbekistan: structure, trends, and pricing aspects
Z. K. Yusupova, D. T. Saipova
FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology.2026;[Epub] CrossRef
Good flatmates: immature neutrophils protect bone integrity
Matthias Gunzer
Blood.2025; 146(11): 1259. CrossRef
Rheumatoid Arthritis and Osteoporosis as Prototypes of Immunosenescence in Osteoimmunology: Molecular Pathways of Inflammaging and Targeted Therapies
Ernesto Aitella, Gianluca Azzellino, Ciro Romano, Lia Ginaldi, Massimo De Martinis
International Journal of Molecular Sciences.2025; 26(19): 9268. CrossRef
Significant Response to Denosumab Yet with Severe Rebound Hypercalcemia in a 9-Year-Old Boy with Aneurysmal Bone Cyst: A Case Report
Laurence Allain, Sarah Elbaz, Sayanthen Sathyakumar, William Le Gallou, Christina Coleman, Hallie Coltin, Dardye Eugène, Abha Gupta, Sebastiano A. G. Lava, Samuele Renzi
Children.2025; 12(11): 1524. CrossRef
Biosimilar denosumab CT-P41 in the treatment of osteoporosis
Karel Urbánek
Clinical Osteology.2025; 30(2): 96. CrossRef

Mineral, Bone & Muscle
Effects of Endocrine-Disrupting Chemicals on Bone Health: So Young Park, Sung Hye Kong, Kyoung Jin Kim, Seong Hee Ahn, Namki Hong, Jeonghoon Ha, Sihoon Lee, Han Seok Choi, Ki-Hyun Baek, Jung-Eun Kim, Sang Wan Kim, on Behalf of Metabolic Bone Disease Study Group of Korean Endocrine Society; Endocrinol Metab. 2024;39(4):539-551. Published online July 17, 2024; DOI: https://doi.org/10.3803/EnM.2024.1963

14,407 View
507 Download
27 Web of Science
25 Crossref

Abstract PDF PubReader ePub

This comprehensive review critically examines the detrimental impacts of endocrine-disrupting chemicals (EDCs) on bone health, with a specific focus on substances such as bisphenol A (BPA), per- and polyfluoroalkyl substances (PFASs), phthalates, and dioxins. These EDCs, by interfering with the endocrine system’s normal functioning, pose a significant risk to bone metabolism, potentially leading to a heightened susceptibility to bone-related disorders and diseases. Notably, BPA has been shown to inhibit the differentiation of osteoblasts and promote the apoptosis of osteoblasts, which results in altered bone turnover status. PFASs, known for their environmental persistence and ability to bioaccumulate in the human body, have been linked to an increased osteoporosis risk. Similarly, phthalates, which are widely used in the production of plastics, have been associated with adverse bone health outcomes, showing an inverse relationship between phthalate exposure and bone mineral density. Dioxins present a more complex picture, with research findings suggesting both potential benefits and adverse effects on bone structure and density, depending on factors such as the timing and level of exposure. This review underscores the urgent need for further research to better understand the specific pathways through which EDCs affect bone health and to develop targeted strategies for mitigating their potentially harmful impacts.

Citations

Citations to this article as recorded by

Bile acids insufficiency links perfluorooctane sulfonate-induced oxidative stress-mediated fatty liver with osteoarthritis
Jialing Yu, Sihan Huang, Jianbin Zhang, Zijian Su, Yiming Chang, Keke Liu, Lu Yang, Huiying Guo, Jinshao Ye, Xujing Liang, Xiaojia Chen, An Hong, Yibo Zhang
Journal of Hazardous Materials.2026; 501: 140750. CrossRef
Unraveling the Mechanisms of Osteoporosis Triggered by Methylparaben and Monomethyl Phthalate through Integrated Mendelian Randomization, In Silico Simulations, and Experimental Validation
Hailong Liu, Xin Xu, Longzhuo Du, Wencan Zhang, Yongyuan Guo, Fujian Zhang, Houyi Sun, Haipeng Si, Peilai Liu
Environmental Science & Technology.2026; 60(1): 228. CrossRef
One-step synthesis of porous chlorine-modified graphitic carbon nitrides for efficient photocatalytic degradation of bisphenol A: DFT insights and mechanistic pathways under visible light
Yun-Cheng Mei, Tesfaye Abebe Geleta, Ashkan Miri, Prashanth Venkatesan, Yu-Chiang Chao, Yutong Chen, Pei-Hsin Chou, Ren Qian Tee, Yang-hsin Shih
Journal of Environmental Chemical Engineering.2026; 14(1): 121018. CrossRef
Effects of Endocrine Disruptors on the Molecular Regulation of Bone Metabolism: Wnt/β-Catenin Signaling Pathway
Deren KAYA, Rabia ŞEMSİ
FUTURE BIOCHEMISTRY AND BIOSCIENCE.2026; : 1. CrossRef
Methyl-4-hydroxybenzoate induces osteoporosis via the AKT1/LC3B/Beclin1 autophagy signaling pathway: Integrating network toxicology and experimental validation
Furui Fu, Wenhao Wang, Yunqi Li, Senjie Shi, Jin Huang, Tianpeng Liu, Yi Shen, Mengting Yuan, Chuanglong Xu, Hongyu Wang, Haitao Zhang, Xiang Gao, Dezhi Tang
Ecotoxicology and Environmental Safety.2026; 312: 119913. CrossRef
Endocrine Society of India’s National White Paper on Endocrine Disrupting Chemicals – A Call for Action
Gagan Priya, Narendra Kotwal, Sri V. Madhu, Shinjan Patra, Kaushik Pandit, Beatrice Anne, Mohan T. Shenoy, Jayshree Swain, Sambit Das, Lakshmi N. Kopalle, Lakshmi Nagendra, Saptarshi Bhattacharya, Shehla S. Shaikh, Sunetra Mondal, Ganesh K. Bhat, Ameya Jo
Indian Journal of Endocrinology and Metabolism.2026; 30(1): 4. CrossRef
Ultrasound-assisted synthesis of Ag/TiO2 nanocomposite for the degradation of bisphenol a under solar irradiation
Chahida Oussalah, Lamia Brahmi, Abdelhalim Balouli, Farida Kaouah
Reaction Kinetics, Mechanisms and Catalysis.2026; 139(3): 2487. CrossRef
The effects of acetamiprid exposure on osteoporosis: inducing imbalanced bone remodeling by disrupting the equilibrium of adipogenic/osteoblast/osteoclast differentiation
Yanan Song, Yucheng Yan, Feng Liu, Yunyun Du, Yichao Li, Yiman Li, Haoxuan Gao, Bing Wu, Yundi Hu, Xiaoyu Li, Huifang Yang, Ji Zhao
Journal of Hazardous Materials.2026; 510: 142097. CrossRef
The association of nitrate exposure with bone mineral density in adolescents aged 12 to 19: A cross-sectional study
Shuo Duan, Shuaishuai Wang, Zhiyang Liu, Shuaiwei Li, Yisi Wang, Minglei Zhang
Medicine.2026; 105(16): e48351. CrossRef
PFOA effects on osteoblast differentiation: Involvement of oxidative stress and endocannabinoid receptors
Fiorenza Sella, Christian Giommi, Damiano Carbonari, Marta Lombó, Oliana Carnevali
General and Comparative Endocrinology.2026; 380: 114932. CrossRef
Micronutrients as Mitigators of Endocrine Disrupting Chemical Health Effects: A Scoping Review and Framework for Epidemiologic Studies
Heather M. Guetterman, Jessie P. Buckley, Kasandra Sanidad, Emily Jamo, Rita S. Strakovsky
Current Environmental Health Reports.2026;[Epub] CrossRef
Airborne contaminant exposure and bone development: a systematic review and meta-analysis
Madeline K M Vera-Colón, Ruth M Meletz, Celina N Phillipson, Nicole R L Sparks
Toxicological Sciences.2026;[Epub] CrossRef
Exploring the relationship between microplastic exposure and bone health
Apostolos I Gogakos, Stergios A Polyzos, Dimitrios A Anastasilakis, Athanasios D Anastasilakis
Endocrine Connections.2026;[Epub] CrossRef
Curcumin Attenuates Bisphenol F-Induced Osteoporosis and Osteogenic Dysfunction via PI3K/AKT Pathway Activation
Yue Su, Hao Li, Keyi Zhang, Na Liang, Xiongfei Hu, Gang Luo, Xiuhong Yang, Qiang Wang, Lin Xiao
Nutrients.2026; 18(14): 2335. CrossRef
Cadmium Exposure and Osteoporosis: A Spatially Contextualized Adverse Outcome Pathway Integrating Epidemiology, Toxicogenomics and Transcriptomics
Ye Tong, Baicheng Wan, Gaofeng Zeng, Shaohui Zong
Biological Trace Element Research.2026; 204(10): 8143. CrossRef
Metal biomarkers and bone mineral density in women undergoing DXA: Associations with cadmium and selenium balance in a hospital-based study
Iman Al-Saleh, Reem Al-Rouqi, Ruba Alsaeed, Yara Aljerayed, Hissah Alnuwaysir, Ahmed Sherif Mahmoud, Abdullah Alkhenizan, Ghada Hussein, Ahmad Almuhaideb
International Journal of Hygiene and Environmental Health.2026; 278: 114904. CrossRef
Environmental Contaminants and Osteoporosis-Related Outcomes: A Systematic Review and Meta-Analysis
Francesco Leonforte, Vito Nicosia, Gianluca Testa, Marco Sapienza, Fabrizio Mattu, Alessia Caldaci, Tommaso Filippini, Vito Pavone, Antonio Mistretta
Toxics.2026; 14(9): 790. CrossRef
Elucidating the mechanism of phthalates induced osteoporosis through network toxicology and molecular docking
Xiao Zhang, Xi Zhu, Wenbo Gu, Xusheng Li, Tenyao Niu, Pengcheng Mao, Haifeng Yuan
Ecotoxicology and Environmental Safety.2025; 291: 117820. CrossRef
Exposure to polycyclic aromatic hydrocarbons and bone mineral density in children and adolescents: results from the 2011–2016 National Health and Nutrition Examination Survey
Peng Zhang, Shuailei Li, Hao Zeng, Yongqiang Sun
Frontiers in Public Health.2025;[Epub] CrossRef
Harmful beauty – Temporal profile of urinary phthalate metabolites in tattooed volunteers from Slovakia
Branislav Kolena, Natália Prochácková, Henrieta Hlisníková, Miroslava Nagyová, Ida Petrovičová
Toxicology Letters.2025; 410: 96. CrossRef
Integrated PBPK modelling for PFOA exposure and risk assessment
Achilleas Karakoltzidis, Spyros P. Karakitsios, Catherine Gabriel, Dimosthenis Α. Sarigiannis
Environmental Research.2025; 282: 121947. CrossRef
Associations of urinary organophosphate ester metabolites with bone mineral density in U.S. children and adolescents aged 8–19 years: a cross-sectional study based on NHANES 2011–2018
Hongliang Jin, Xinyun Zhou, Xinyue Wang, Yan Zhang
European Journal of Pediatrics.2025;[Epub] CrossRef
Non-linear associations between exposure to a mixture of per- and polyfluoroalkyl substances and thyroid hormone levels in Korean adults
Seung Min Chung, Ji-Hyeon Cha, Young-Heun Jung, Ju-Hyun Kim, Jun Sung Moon, Kyu Chang Won
Environment International.2025; 201: 109585. CrossRef
Citizen Science in Action: Preliminary Observations on Bat Box Use in the Perth and Peel Regions, Western Australia
Kelly Sheldrick, Kelly Duckworth
Journal of The Royal Society of Western Australia.2025;[Epub] CrossRef
Comment on “Standardized gynecologic consultation and bone surveillance in patients with breast cancer receiving hormone therapy”2
Rachana Mehta, Ranjana Sah
Supportive Care in Cancer.2025;[Epub] CrossRef

Mineral, Bone & Muscle
Osteocalcin: Beyond Bones: Jakub Krzysztof Nowicki, Elżbieta Jakubowska-Pietkiewicz; Endocrinol Metab. 2024;39(3):399-406. Published online May 28, 2024; DOI: https://doi.org/10.3803/EnM.2023.1895

36,121 View
565 Download
37 Web of Science
44 Crossref

Abstract PDF PubReader ePub

Apart from basic roles such as supporting the body, protecting internal organs, and storing calcium, the skeletal system also performs hormonal functions. In recent years, several reports have been published on proteins secreted by bones and their impact on the homeostasis of the entire body. These proteins include fibroblast growth factor 23, sclerostin, lipocalin 2, and osteocalcin. Osteocalcin, the most abundant non-collagenous protein in bone tissue, is routinely measured as a clinical marker for diagnosing bone metabolism disorders. Its molecule undergoes numerous transformations, with decarboxylation being the critical process. Decarboxylation occurs in the acidic environment typical of bone resorption, facilitating the release of the molecule into the bloodstream and enabling its hormonal action. Decarboxylated osteocalcin promotes insulin secretion and stimulates the proliferation of pancreatic islet β-cells. It also plays a role in reducing the accumulation of visceral fat and decreasing fat storage in the liver. Furthermore, decarboxylated osteocalcin levels are inversely correlated with fasting serum glucose levels, total body fat, visceral fat area, and body mass index. Apart from its role in energy metabolism, osteocalcin affects testosterone production and the synthesis of glucagon-like peptide-1. It is also actively involved in muscle-bone crosstalk and influences cognitive function.

Citations

Citations to this article as recorded by

The relationship between circulating osteocalcin and muscle mass measurements in humans: A systematic review and meta-analysis
Quan Zhang, Yuzhen Xie, Tanner Jenkins, James Carson
Sports Medicine and Health Science.2026; 8(5): 509. CrossRef
Prognostic biomarkers for overall survival in patients undergoing surgery for bone metastases: a pan-cancer study
Elisa Belluzzi, Assunta Pozzuoli, Pietro Belloni, Maria Grazia Rodà, Andrea Angelini, Pietro Ruggieri
Frontiers in Medicine.2026;[Epub] CrossRef
Targeting muscle-bone crosstalk with hormone-like peptides: Systems approach reveals RGHGP-mediated suppression of LAMB1-MAPK osteoclastogenesis
Yu-jie Xi, Rui Cai, Shao-wei Hu, Bo Zhang, He Xu, Hong-yan Zhao, Hong-jun Yang, Fei-fei Guo
Phytomedicine.2026; 153: 157926. CrossRef
Association Between Gestational Diabetes Mellitus and Maternal Bone Metabolism: A Cross-Sectional Study
Waheed Ullah Hafiz, Muhammad Asif, Mobina Manzoor, Irma Umar, Waqas Ahmad, Fahad Asim, Muhammad Naveed Mushtaq, Amna Ayub, Muhammad Affan, Zia Mohyuddin Khan
Pakistan BioMedical Journal.2026; : 20. CrossRef
Bidirectional interaction between the skeletal and nervous systems: a review
Alina M. Khodorovskaya, Olga E. Agranovich, Margarita V. Savina, Yuriy E. Garkavenko, Evgenii V. Melchenko, Svetlana I. Trofimova, Ekaterina V. Petrova, Anna D. Dreval, Daniil B. Vcherashniy
Pediatric Traumatology, Orthopaedics and Reconstructive Surgery.2026; 14(1): 102. CrossRef
Vitamin K as an Endocrine Modulator: Mechanistic Links to Glucose Metabolism and Beyond
Wojciech Matuszewski, Mikołaj Madeksza, Michał Szklarz, Aleksandra Rutkiewicz, Joanna Rutkowska, Joanna Maria Harazny
Nutrients.2026; 18(8): 1183. CrossRef
Bone phenotype in familial partial lipodystrophy type 2: Insulin resistance and sclerostin
Hippolyte Dupuis, Arnaud Jannin, Lucille Van Es, Romain Vankemmel, Olivier Ernst, Pascal Pigny, Georges Lion, Benjamin Chevalier, Bernard Cortet, Stéphanie Espiard, Marie-Christine Vantyghem
Diabetes & Metabolism.2026; 52(3): 101762. CrossRef
Role of bone turnover markers in prediction of fracture healing: a contemporary evidence-based perspective
Hamza Ali, Adarsh Kumar Singh, Anurag Baghel, Shafaque Asif
International Journal of Research in Orthopaedics.2026; 12(3): 848. CrossRef
Association of Bone Metabolism Markers with Glycemic Parameters in Type 2 Diabetes Mellitus: Insights from a Cross-sectional Study on Serum Osteocalcin, Vitamin D, and Parathyroid Hormone
Mohammad N Khan, Anisha Tanwar, Mandayal Jamatia
Indian Journal of Medical Biochemistry.2026; 30(2): 172. CrossRef
Physical exercise therapy as an anti-aging strategy for osteosarcopenia: a narrative review
Ting ting Liu, Pengwei Zhang, Wan tao Dong, Yan long Gong, Zhi jie Fang, Ning Li, Xin Ma
Frontiers in Aging.2026;[Epub] CrossRef
Sclerostin as a modern marker of bone-mineral disorders associated with chronic kidney disease in patients with chronic kidney disease stage V and diabetes mellitus
T. L. Malska, L. P. Martynyuk
The Journal of V N Karazin Kharkiv National University series "Medicine".2026; : 174. CrossRef
Biomaterials at the interface of bone-derived factors and inter-organ communication: Current evidence and future perspectives
Luli Ji, Fuwei Zhu, Xiaogang Wang, Jing Wang, Changsheng Liu
Bioactive Materials.2026; 66: 530. CrossRef
Metainflammation, Mitochondrial Dysfunction, and Organokine Crosstalk: A Central Axis Linking Metabolic Syndrome to Cardiovascular Diseases
Ana Flávia Pontes Sodré, Lucca Gonsales Rodrigues, Kátia P. Sloan, Lance A. Sloan, Masaru Tanaka, Rui Curi, Larissa Naomi Takeda, Ricardo de Alvares Goulart, Ana Luiza Decanini Miranda de Souza, Claudia Rucco Penteado Detregiachi, Antonelly Cassio Alves C
International Journal of Molecular Sciences.2026; 27(15): 6554. CrossRef
RNA cytosine modifications regulates musculoskeletal disorders
Haitao Wang, Peirui Ke, Xing Zhao, Shuying Shen
Molecular Biology Reports.2026;[Epub] CrossRef
Assessing scale and predictive diversity in models for single-cell transcriptomics based on Geneformer
Junfan Chen, Fabian Schmidt, Ricardo Henao, Michael Domaratzki
PLOS Computational Biology.2026; 22(7): e1013701. CrossRef
Molecular mechanisms, therapeutic strategies, and inter-organ fibrosis crosstalk of Gla proteins in cardiovascular disease
Shuai Zhao, Siena Bush, Ivan O. Rosas, Svetlana Reilly, Xander H. T. Wehrens
Communications Biology.2026;[Epub] CrossRef
GLP-1 receptor agonists and tendon healing: a systematic review and meta-analysis
Mohammed Y. Khayyat, Yasir M. Khayyat
Archives of Medical Science.2026;[Epub] CrossRef
Comparative Analysis Of Combined Oral Contraceptives And Non-Steroidal Anti-Inflammatory Drugs (NSAIDS) In Treating Dysmenorrhea: A Multi-Center Study
Meiyi Ren
Pakistan Journal of Pharmaceutical Sciences.2026;[Epub] CrossRef
Interorgan Crosstalk in MASLD: A Narrative Review
Amedeo Lonardo, Ralf Weiskirchen
Biomedicines.2026; 14(9): 1949. CrossRef
Tibial bone compression promotes recovery after brain injury through osteocyte PIEZO1
Zhiqing Cai, Zhimin Zhang, Yuxin Wang, Shencai Liu, Jiarong Leng, Yun Chu, Jihang Liu, Yingying Fang, Bochong Chen, Wenquan Liang, Hong Wang, Lu Zhang, Weiguo Zou, Fan Yang, Qiancheng Song, Di Lu, Xiaochun Bai
Nature Neuroscience.2026;[Epub] CrossRef
Association between Serum Osteocalcin and Cardiometabolic Risk Factors in Latent Autoimmune Diabetes in Adults: Insights from Glutamic Acid Decarboxylase Subgroup Analysis
Xiuli Fu, Zihui Xu, Jinlin Xu, Qin Tan, Zhongjing Wang
Endocrine, Metabolic & Immune Disorders - Drug Targets.2026;[Epub] CrossRef
Associations Between Serum Osteocalcin and Metabolic, Nutritional, and Hormonal Status in Male Patients with Chronic Kidney Disease: A Cross-Sectional Study
Magdalena Markowska, Arkadiusz Lubas, Aleksandra Rymarz, Stanisław Niemczyk, Katarzyna Romejko
Biomedicines.2026; 14(10): 2309. CrossRef
Osteocalcin: A bone protein with multiple endocrine functions
William Determe, Sabina Chaudhary Hauge, Justine Demeuse, Philippe Massonnet, Elodie Grifnée, Loreen Huyghebaert, Thomas Dubrowski, Matthieu Schoumacher, Stéphanie Peeters, Caroline Le Goff, Pieter Evenepoel, Ditte Hansen, Etienne Cavalier
Clinica Chimica Acta.2025; 567: 120067. CrossRef
Liver function linked to bone health: A bibliometric of the liver-bone axis
Wei-Jin Zhang, Xun-Pei Xu, Xin-Hua Song, Zhan-Rong Zhang, Xuan-Rui Zhang, Biao Yang, Zheng-Bo Tao, Zheng Zhang, Xu-Hui Zhou
World Journal of Hepatology.2025;[Epub] CrossRef
GluOC Induced SLC7A11 and SLC38A1 to Activate Redox Processes and Resist Ferroptosis in TNBC
Jiaojiao Xu, Xue Bai, Keting Dong, Qian Du, Ping Ma, Ziqian Zhang, Jianhong Yang
Cancers.2025; 17(5): 739. CrossRef
Bioactive Zn ingredients endow Ti-Zn composites with exceptional mechanical and osteogenic properties as biomedical implants
Li Ma, Yue Li, Chang-shun Wang, Zi-hao Chen, Si-yu Zhao, Bo Cheng, Cheng-lin Li
Biomaterials Advances.2025; 174: 214308. CrossRef
Primary Hyperparathyroidism: An Analysis Amid the Co-Occurrence of Type 2 Diabetes Mellitus
Ana-Maria Gheorghe, Mihaela Stanciu, Claudiu Nistor, Ioana Codruta Lebada, Mara Carsote
Life.2025; 15(4): 677. CrossRef
Association between the appendicular skeletal muscle mass-to-visceral fat area ratio and bone mineral density and osteoporosis: A cross-sectional study
Jiao Liu, Fujue Ji, Haesung Lee, Jong-Hee Kim
Experimental Gerontology.2025; 206: 112772. CrossRef
A six-month weight loss intervention is associated with significant changes in serum biomarkers related to inflammation, bone and cartilage metabolism in obese patients with psoriatic arthritis and matched controls
Linda Torres, Charlotte A. Jonsson, Björn Eliasson, Helena Forsblad-d’Elia, Anton J. Landgren, Annelie Bilberg, Inger Gjertsson, Ingrid Larsson, Eva Klingberg
BMC Rheumatology.2025;[Epub] CrossRef
Body Kines and Organ Crosstalks: A Mini Review
Nabil Elnaggar, Mohamed Elnaggar
International Journal of Diabetes and Endocrinology.2025; 10(2): 45. CrossRef
Injectable and Assembled Calcium Sulfate/Magnesium Silicate 3D Scaffold Promotes Bone Repair by In Situ Osteoinduction
Wei Zhu, Tianhao Zhao, Han Wang, Guangli Liu, Yixin Bian, Qi Wang, Wei Xia, Siyi Cai, Xisheng Weng
Bioengineering.2025; 12(6): 599. CrossRef
Biomolecular Basis of Life
Janusz Wiesław Błaszczyk
Metabolites.2025; 15(6): 404. CrossRef
Comparison of the effects of zoledronic acid versus denosumab on bone metabolism, inflammatory response, and immunoglobulins in breast cancer patients with bone metastases
Xian Zhang, Jinfeng Tong, Zhi Wang, Hailong Yang, Pei Shi
Journal of Medical Biochemistry.2025; 44(4): 731. CrossRef
The gut–bone axis in osteoporosis: a multifaceted interaction with implications for bone health
Chunli Gu, Hong Du, Ningying Li, Yunlong Zhou, Sha Li, Yuchen Sun, Yiyang Han, Xuan Xu, Xianrong Li
Frontiers in Endocrinology.2025;[Epub] CrossRef
Understanding Insulin Actions Beyond Glycemic Control: A Narrative Review
Rayan Riachi, Elie Khalife, Andrzej Kędzia, Elżbieta Niechciał
Journal of Clinical Medicine.2025; 14(14): 5039. CrossRef
Relationship between bone turnover markers and diabetic kidney disease in patients with type 2 diabetes
Xueyan Men, Peipei Yue, Weiwei Hao, Lei Zhang, En Chen, Jing Liu
Frontiers in Endocrinology.2025;[Epub] CrossRef
The association between the ZJU index and bone mineral density (BMD) among patients with type 2 diabetes mellitus
Yuan Zhang, Yali Jing
Metabolism Open.2025; 28: 100413. CrossRef
Organokine-Mediated Crosstalk: A Systems Biology Perspective on the Pathogenesis of MASLD—A Narrative Review
Sandra Maria Barbalho, Lucas Fornari Laurindo, Vitor Engracia Valenti, Nahum Méndez-Sánchez, Mariana M. Ramírez-Mejía, Ricardo de Alvares Goulart
International Journal of Molecular Sciences.2025; 26(23): 11547. CrossRef
In vitro Evaluation of Osteogenic Potential of Foxtail Millet (Setaria italica linn.) Extract on MG-63 Cell Line
Radhikaba Pruthvirajsinh Zala, Vaibhav Sunil Ladke, Chandrashekhar Ganpat Raut, Prachi Vijay Prasad, Manasi Vinod Chavan, Shital Rahul Rasane
Biomedical and Biotechnology Research Journal.2025; 9(4): 353. CrossRef
Osteocalcin and metabolic dysfunction in young women with obesity
Carolina Piterschi, Lorina Vudu
Moldovan Journal of Health Sciences.2025; 12(3): 86. CrossRef
Muscle–bone biochemical crosstalk in osteosarcopenia: focusing on mechanisms and potential therapeutic strategies
Qinzuo Dong, Danyang Li, Ke Zhang, Hua Shi, Ming Cai, Yangdi Li, Rong Zhao, Dongdong Qin
Journal of Endocrinology.2025;[Epub] CrossRef
Glucagon-like peptide-1 receptor agonists: Exploring the mechanisms from glycemic control to treatment of multisystemic diseases
Mo-Wei Kong, Yang Yu, Ying Wan, Yu Gao, Chun-Xiang Zhang
World Journal of Gastroenterology.2024; 30(36): 4036. CrossRef
GPR37 and its neuroprotective mechanisms: bridging osteocalcin signaling and brain function
Xuepeng Bian, Yangping Wang, Weijie Zhang, Changlin Ye, Jingjing Li
Frontiers in Cell and Developmental Biology.2024;[Epub] CrossRef
The Role of Bone-Derived Osteocalcin in Testicular Steroidogenesis: Contributing Factor to Male Fertility
Izatus Shima Taib, Putri Ayu Jayusman
Diseases.2024; 12(12): 335. CrossRef

Mineral, Bone & Muscle
Roles of Parathyroid Hormone and Fibroblast Growth Factor 23 in Advanced Chronic Kidney Disease: Yosuke Nakagawa, Hirotaka Komaba; Endocrinol Metab. 2024;39(3):407-415. Published online May 16, 2024; DOI: https://doi.org/10.3803/EnM.2024.1978

21,543 View
448 Download
20 Web of Science
24 Crossref

Abstract PDF PubReader ePub

Parathyroid hormone (PTH) and fibroblast growth factor 23 (FGF23) each play a central role in the pathogenesis of chronic kidney disease (CKD)-mineral and bone disorder. Levels of both hormones increase progressively in advanced CKD and can lead to damage in multiple organs. Secondary hyperparathyroidism (SHPT), characterized by parathyroid hyperplasia with increased PTH secretion, is associated with fractures and mortality. Emerging evidence suggests that these associations may be partially explained by PTH-induced browning of adipose tissue and increased energy expenditure. Observational studies suggest a survival benefit of PTHlowering therapy, and a recent study comparing parathyroidectomy and calcimimetics further suggests the importance of intensive PTH control. The mechanisms underlying the regulation of FGF23 secretion by osteocytes in response to phosphate load have been unclear, but recent experimental studies have identified glycerol-3-phosphate, a byproduct of glycolysis released by the kidney, as a key regulator of FGF23 production. Elevated FGF23 levels have been shown to be associated with mortality, and experimental data suggest off-target adverse effects of FGF23. However, the causal role of FGF23 in adverse outcomes in CKD patients remains to be established. Further studies are needed to determine whether intensive SHPT control improves clinical outcomes and whether treatment targeting FGF23 can improve patient outcomes.

Citations

Citations to this article as recorded by

Fibroblast growth factor 23 (FGF23): From synthesis to cleavage
Shusen Yuan, Qi Wang, Chao Meng, Hongjie Ji, Baowei Li
Molecular and Cellular Endocrinology.2027; 623: 112909. CrossRef
Heterogeneous regulation of fibroblast growth factor 23 in acute kidney injury, chronic kidney disease, and polycystic kidney disease: mechanisms, diagnostic utility, and clinical implications
Xiaohua Hu, Bo Yang, Haimin Chen, Min Min, Nanmei Liu, Cheng Xue
Frontiers in Molecular Biosciences.2026;[Epub] CrossRef
Endocrine disorders linked to chronic kidney disease: Mechanisms and clinical implications
Marcio J Concepción-Zavaleta, Jenyfer M Fuentes-Mendoza, Elida P López-Ramírez, Jesús A Martínez-García, Luis A Concepción-Urteaga, José Paz-Ibarra
World Journal of Nephrology.2026;[Epub] CrossRef
Diabetes progression and its association with fracture risk in type 2 diabetes
Bongsung Kim, Kyu-Na Lee, Kyungdo Han, Mee Kyoung Kim
Osteoporosis International.2026;[Epub] CrossRef
Pre-Parathyroidectomy PTH as an Integrated Biomarker of Glandular Remodeling and Skeletal Turnover in Secondary Hyperparathyroidism
Min-Tser Liao, Chia-Chao Wu, Yi-Chou Hou, Kuo-Wang Tsai, Li-Jane Shih, Kuo-Cheng Lu, Chien-Lin Lu
International Journal of Molecular Sciences.2026; 27(11): 5094. CrossRef
Allopurinol has no effect on calcitriol or other CKD-MBD biomarkers: a randomized double-blind study
Tiago E Costa, Julia C Lauar, Mariana L R Innecchi, Luiza Karla R P Araujo, Venceslau A Coelho, Luciene M dos Reis, Rosa M A Moysés, Rosilene M Elias
Journal of the Endocrine Society.2026;[Epub] CrossRef
Combination therapy with nutritional vitamin D and calcimimetics in secondary hyperparathyroidism: a mechanism-based approach to restoring PTH regulation
Chien-Lin Lu, Yi-Chou Hou, Chia-Chao Wu, Te-Chao Fang, Cai-Mei Zheng, Kuo-Cheng Lu
Frontiers in Nutrition.2026;[Epub] CrossRef
Fracture prevention in osteoporosis and nephrolithiasis: maintaining the balance of mineral metabolism
O.I. Nishkumai, O.B. Iaremenko, V.E. Kondratiuk, Mike K.S. Chan, M.B. Dzhus, I.V. Rudenko, A.B. Bezrodnyi
TRAUMA.2026; 27(3): 233. CrossRef
Safety, tolerability, pharmacokinetics, and pharmacodynamics of oral JMKX003002 in Chinese healthy participants: a randomized, double-blind, placebo-controlled, single- and multiple-ascending dose, and food-effect phase I clinical trial
Guoying Cao, Xiaomeng Mao, Xiaojie Wu, Nanyang Li, Haijing Yang, Jingjing Wang, Jicheng Yu, Jingqiu Hu, Lingli Zhang, Jingyun Chen, Jing Zhang
Annals of Medicine.2026;[Epub] CrossRef
Association Between Serum Parathyroid Hormone Levels and Femoral Bone Mineral Density in Patients with Chronic Kidney Disease Stage 3
Laura Montaño-Azor, Petra Cantón Guerrero, María Ángeles Jiménez Sánchez, María José Jiménez Moral, Raquel María García-Sáez, María Encarnación Rodríguez-Ortiz, Mariano Rodríguez, Victoria Pendón-Ruiz de Mier, Esperanza Romero-Rodríguez
Journal of Clinical Medicine.2026; 15(14): 5519. CrossRef
Role of fibroblast growth factor-23 in renal disease activity and bone density involvement in patients with lupus nephritis
Nashwa M Azoz, Ammar A Ammar, Howaida A Nafady, Rabea A Gadelkareem, Essam M Abdel Aziz, Randa A Elzohne
World Journal of Nephrology.2026;[Epub] CrossRef
Headache across the spectrum of kidney disease: epidemiology, clinical patterns, pathophysiological mechanisms, and management-a narrative review
Amin Roshdy Soliman, Rabab Mahmoud Ahmed, Ahmed Fayed
The Egyptian Journal of Internal Medicine.2026;[Epub] CrossRef
Bone turnover markers associated with cognitive dysfunction in patients undergoing hemodialysis: a cross-sectional study
Kazuhiko Kato, Akio Nakashima, Chiharu Aizawa, Arisa Kobayashi, Shunichiro Shinagawa, Ichiro Ohkido, Mitsuyoshi Urashima, Takashi Yokoo
JBMR Plus.2026;[Epub] CrossRef
Gene expression and hormonal signaling in osteoporosis: from molecular mechanisms to clinical breakthroughs
Gurinderdeep Singh, Ronald Darwin, Krishna Chandra Panda, Shaikh Amir Afzal, Shashwat Katiyar, Ram C. Dhakar, Sangeetha Mani
Journal of Biomaterials Science, Polymer Edition.2025; 36(10): 1466. CrossRef
Correlation linking fibroblast growth factor 23 in circulation (FGF-23) and serum aldosterone levels in different stages of chronic kidney disease
Amira Hassan Elsaid Dohuim, Medhat Abd El Megeid Ghazy, Nahla Abdel Aziz Nosair, Amr Khalifa Hussien
The Egyptian Journal of Internal Medicine.2025;[Epub] CrossRef
Effects of Blood Flow Restriction Training and Possible Applications in Chronic Kidney Disease: A Narrative Review
Shen Liu, Zhuo Wang, Jia-fu Tang, Yong-long Yang, Wei-xiu Ji, Da-qi Xu
Current Physical Medicine and Rehabilitation Reports.2025;[Epub] CrossRef
Correlation Between Fibroblast Growth Factor 23 and Biochemical Parameters in Hemodialysis Patients With End-Stage Renal Disease
Barat Yusubov, Mirkhalig Javadov, Khanbaba Huseynov, Muradali Bakhshiyev
Cureus.2025;[Epub] CrossRef
Serum FGF-23 and Vitamin D Deficiency as Predictors of Metabolic Syndrome in Chronic Kidney Disease

Pakistan Journal of Medicine and Dentistry.2025; : 334. CrossRef
Efficacy of Different Doses of Sodium in the Dialysis Fluid on the Levels of Calcium, Phosphorus and Parathyroid Hormone in Patients Undergoing Chronic Hemodialysis
Asieh Aref, Ladan Mirzaei, Ali Ghorbani, Samaneh Tirom, Elham Farhadi
Nephro-Urology Monthly.2025;[Epub] CrossRef
Skeletal Health in Youth with Type 2 Diabetes
Hanine AlArab, Anna Zenno, Melinda Pierce
Current Osteoporosis Reports.2025;[Epub] CrossRef
Capture the superior anti-osteoporotic innovative multi-component complex from Ligustri Lucidi Fructus based on Component Recombination strategy
Jun Jiang, Baixiu Zhao, Yuwen Ma, Yichen Zeng, Yusong Zeng, Jin Fang, Wenjiao Kang, Tong Chen
Phytomedicine.2025; 146: 157116. CrossRef
Serum Calcium as a Determinant of Fibroblast Growth Factor 23 Levels in Patients With Primary Hyperparathyroidism and Graves’ Disease
Hiroyuki Yamashita, Yusuke Mori, Yasuo Imanishi, Hisakazu Shindo, Daisuke Tatsushima, Seigo Tachibana, Takashi Fukuda, Hiroshi Takahashi, Yuji Nagayama, Shinya Satoh
Cureus.2025;[Epub] CrossRef
Immune mechanisms in chronic kidney disease-mineral and bone disorder: current insights and therapeutic implications
Bin Xu, Rui Ma, Yuqiang Wu, Chi Liu, Xiangrong Song
Frontiers in Medicine.2025;[Epub] CrossRef
Treatment outcomes and determinants of combined hemodialysis-hemoperfusion therapy in chronic glomerulonephritis
Xiaotong Yuan
American Journal of Translational Research.2025; 17(11): 8612. CrossRef

Original Article

Mineral, Bone & Muscle
End-to-End Semi-Supervised Opportunistic Osteoporosis Screening Using Computed Tomography: Jieun Oh, Boah Kim, Gyutaek Oh, Yul Hwangbo, Jong Chul Ye; Endocrinol Metab. 2024;39(3):500-510. Published online May 9, 2024; DOI: https://doi.org/10.3803/EnM.2023.1860

8,531 View
114 Download
9 Web of Science
10 Crossref

Abstract PDF Supplementary Material PubReader ePub

Background
Osteoporosis is the most common metabolic bone disease and can cause fragility fractures. Despite this, screening utilization rates for osteoporosis remain low among populations at risk. Automated bone mineral density (BMD) estimation using computed tomography (CT) can help bridge this gap and serve as an alternative screening method to dual-energy X-ray absorptiometry (DXA).
Methods
The feasibility of an opportunistic and population agnostic screening method for osteoporosis using abdominal CT scans without bone densitometry phantom-based calibration was investigated in this retrospective study. A total of 268 abdominal CT-DXA pairs and 99 abdominal CT studies without DXA scores were obtained from an oncology specialty clinic in the Republic of Korea. The center axial CT slices from the L1, L2, L3, and L4 lumbar vertebrae were annotated with the CT slice level and spine segmentation labels for each subject. Deep learning models were trained to localize the center axial slice from the CT scan of the torso, segment the vertebral bone, and estimate BMD for the top four lumbar vertebrae.
Results
Automated vertebra-level DXA measurements showed a mean absolute error (MAE) of 0.079, Pearson’s r of 0.852 (P<0.001), and R² of 0.714. Subject-level predictions on the held-out test set had a MAE of 0.066, Pearson’s r of 0.907 (P<0.001), and R² of 0.781.
Conclusion
CT scans collected during routine examinations without bone densitometry calibration can be used to generate DXA BMD predictions.

Citations

Citations to this article as recorded by

Artificial Intelligence in Rheumatology: From Algorithms to Clinical Impact in Osteoporosis and Chronic Inflammatory Rheumatic Diseases
Marie Doussiere, Ahlem Aboud, Gilles Dequen, Vincent Goëb
Journal of Clinical Medicine.2026; 15(2): 491. CrossRef
The Diagnostic Value of Image-Based Machine Learning for Osteoporosis: Systematic Review and Meta-Analysis
Rui Zhao, Haolin Yang, Yangbo Li, Xiaoyun Li, Zhijie Yang, Yanping Lin, Jiachun Huang, Lei Wan, Hongxing Huang
Journal of Medical Internet Research.2026; 28: e75965. CrossRef
Artificial intelligence in osteoporosis assessment using CT imaging: a scoping review
Hanwen Cheng, Yajun Zhang, Meng Meng, Simin Liu, Yang Yang, Yuyang Ran, Yuhui Kou
Frontiers in Medicine.2026;[Epub] CrossRef
Artificial Intelligence for Osteoporosis Diagnosis, Risk Prediction and Therapy: Current Advances, Clinical Challenges, and Future Perspectives
Zhaochen Zhang, Yuxi He, Zhanhao Mo, Peng Zhang, Zhenya Tian, Lanfeng Huang
Clinical Interventions in Aging.2026; Volume 21: 1. CrossRef
Phantomless estimation of bone mineral density on computed tomography: a scoping review
Aleena Waqar, Alberto Bazzocchi, Maria Pilar Aparisi Gómez
RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.2025; 197(11): 1262. CrossRef
Diagnostic accuracy of axial and sagittal CT measurements for osteoporosis: A multi-vertebra evaluation
Sevde Nur Emir, Ahmet Kürşat Soydan, Safiye Sanem Dereli Bulut
Journal of Clinical Densitometry.2025; 28(4): 101596. CrossRef
Artificial intelligence in spine surgery
Cheng Zhang, Shanshan Liu, Jialin Shi, Xingyu Zhou, Peter Passias, Nanfang Xu, Weishi Li
Spine Research.2025; 1(1): 13. CrossRef
Deep Learning–Assisted Automated Diagnosis of Osteoporosis Based on Computed Tomography Scans: Systematic Review and Meta-Analysis
Aobo Wang, Ziqian Ma, Tianyi Wang, Ruiyuan Chen, Yu Xi, Qichao Wu, Shuo Yuan, Ning Fan, Peng Du, Lei Zang
Journal of Medical Internet Research.2025; 27: e77155. CrossRef
Changes of bone, adipose, and muscle-related body compositions in gastric cancers after gastrectomy using deep learning based automatic segmentation
Mengying Xu, Dan Liu, Mengze Zhang, Song Liu, Zhengyang Zhou
BMC Gastroenterology.2025;[Epub] CrossRef
Unaccounted Variations Can Surreptitiously Spoil the Validity of “Good” Biostatistical Models
Abhaya Indrayan
Journal of the Epidemiology Foundation of India.2024; 2(4): 205. CrossRef

Review Articles

Mineral, Bone & Muscle
Bone Loss after Solid Organ Transplantation: A Review of Organ-Specific Considerations: Kyoung Jin Kim, Jeonghoon Ha, Sang Wan Kim, Jung-Eun Kim, Sihoon Lee, Han Seok Choi, Namki Hong, Sung Hye Kong, Seong Hee Ahn, So Young Park, Ki-Hyun Baek, on Behalf of Metabolic Bone Disease Study Group of Korean Endocrine Society; Endocrinol Metab. 2024;39(2):267-282. Published online April 25, 2024; DOI: https://doi.org/10.3803/EnM.2024.1939

18,721 View
544 Download
23 Web of Science
27 Crossref

Abstract PDF PubReader ePub

This review article investigates solid organ transplantation-induced osteoporosis, a critical yet often overlooked issue, emphasizing its significance in post-transplant care. The initial sections provide a comprehensive understanding of the prevalence and multifactorial pathogenesis of transplantation osteoporosis, including factors such as deteriorating post-transplantation health, hormonal changes, and the impact of immunosuppressive medications. Furthermore, the review is dedicated to organ-specific considerations in transplantation osteoporosis, with separate analyses for kidney, liver, heart, and lung transplantations. Each section elucidates the unique challenges and management strategies pertinent to transplantation osteoporosis in relation to each organ type, highlighting the necessity of an organ-specific approach to fully understand the diverse manifestations and implications of transplantation osteoporosis. This review underscores the importance of this topic in transplant medicine, aiming to enhance awareness and knowledge among clinicians and researchers. By comprehensively examining transplantation osteoporosis, this study contributes to the development of improved management and care strategies, ultimately leading to improved patient outcomes in this vulnerable group. This detailed review serves as an essential resource for those involved in the complex multidisciplinary care of transplant recipients.

Citations

Citations to this article as recorded by

Considerations for Endpoints in Lung Transplant Clinical Trials: An ISHLT Consensus Statement
John R. Greenland, Michael Perch, Kieran Halloran, Deborah J. Levine, Eric D. Morrell, Anna Reed, Ciara M. Shaver, Jonathan P. Singer, Stuart C. Sweet, Robin Vos, Shambhu Aryal, Nicholas Avdimiretz, Fay Burrows, Daniel Calabrese, Fiorella Calabrese, Silvi
The Journal of Heart and Lung Transplantation.2026; 45(2): e104. CrossRef
The immunobiology and therapeutic potential of regulatory T cells in autoimmune diseases and allergic diseases
Wen-Wen Xie, Jian-Bin Huang, Yi-Chi Zhou, Jing-Yi Yuan, Jia-Xue Feng, Xiao-Hang Shi, Li Tian, Xian-Hai Zeng, Shu-Qi Qiu, Mei-Zhen Zhao, Bao-Hui Cheng, Hao-Tao Zeng
Frontiers in Immunology.2026;[Epub] CrossRef
Osteoporosis After Menopause and After Drug Therapy: The Molecular Mechanism of Bone Loss and Its Treatment
Kelly I-Rong Lee, Jie-Hong Chen, Kuo-Hu Chen
International Journal of Molecular Sciences.2026; 27(2): 641. CrossRef
Bone Health in Young Lung Transplant Recipients: A Retrospective Study
Aviva Lerman, Osnat Shtraichman, Yaron Rudman, Mordechai R. Kramer, Idit Dotan, Gloria Tsvetov, Talia Diker Cohen
Respiration.2026; 105(7): 763. CrossRef
Endocrine disorders linked to chronic kidney disease: Mechanisms and clinical implications
Marcio J Concepción-Zavaleta, Jenyfer M Fuentes-Mendoza, Elida P López-Ramírez, Jesús A Martínez-García, Luis A Concepción-Urteaga, José Paz-Ibarra
World Journal of Nephrology.2026;[Epub] CrossRef
The liver-bone axis: an emerging player in disease pathogenesis and therapeutic intervention
Shenqi Han, Yi Wei, Guanxing Yu, Wenlong Jia, Wei Liao, Yi He, Kun Cheng, Jianping Zhao, Shuai Xiang, Wanguang Zhang, Xiaoping Chen, Bixiang Zhang, Zhao Huang
Science China Life Sciences.2026; 69(7): 2264. CrossRef
A Deep Dive Into Endocrine and Reproductive Health in Patients With Cystic Fibrosis: Before and Beyond Solid Organ Transplantations
Maheswaran Dhanasekaran, Basma Ataallah, Jawairia Shakil, Bhargavi Patham
Endocrine Practice.2026; 32(9): 1409. CrossRef
The Association Between Post‐Kidney Transplant Persistent Hyperparathyroidism and Fracture Risk: A Longitudinal Cohort Study
Rachel Stemme, Yi Liu, Jingyao Hong, Yiting Li, Joy Zhou Done, Jennine Weller, Anatoliy V. Rudin, Daniel C. Brennan, Lilah F. Morris‐Wiseman, Dorry L. Segev, Mara A. McAdams‐DeMarco, Aarti Mathur
Clinical Transplantation.2026;[Epub] CrossRef
Impact of solid organ transplant on postoperative outcomes following lumbar spine fusion surgery: A propensity-matched retrospective cohort analysis
Vu Bui, Kevin Yoon, Theodore Quan, Christopher P. Bellaire, Jonathan P. Japa, Mark Ehioghae, Addisu Mesfin
North American Spine Society Journal (NASSJ).2026; 27: 100901. CrossRef
Bone fragility in a post-intestinal transplant patient with mesenteric heterotopic ossification
Husam Hamshary, Dania S Bacha, Leila Z Khan
JBMR Plus.2026;[Epub] CrossRef
Bone Mineral Density Loss After Kidney Transplantation: Metabolic Determinants, Diagnostic Approaches, and Preventive Strategies
Clemens Untersulzner, Markus Pirklbauer, Pieter Evenepoel, Heinz Zoller, Andreas Kronbichler
Kidney International Reports.2026; 11(9): 106685. CrossRef
Management of bone health in adult solid organ transplant recipients: a multidisciplinary care pathway
Hussein Saadi, M. Cecilia Lansang, Samer El-Kaissi, Leila Khan, Mona Gossmann, Marie M. Budev, Abby Abelson, Karla Arce, Christina C. Lindenmeyer
Clinical Transplantation and Research.2026; 40(2): 193. CrossRef
Isolated trochlea and triquetrum fractures in an immunocompromised adolescent after a ground-level fall
Daniel Lynch, Varun Naga, Ty Davis, Saumya Kapoor, John F Lovejoy
BMJ Case Reports.2026; 19(7): e268846. CrossRef
Vertebral trabecular attenuation serial changes on chest CT after autologous hematopoietic stem cell transplantation
Zeynep Atçeken, Sezer Kula, Taner Tan, Umur Topcu, Çetin Atasoy, Yüksel Peker
Skeletal Radiology.2026; 55(11): 2823. CrossRef
Bone health after lung transplantation: a case report
Vanessa Lee, Paula Bermel, James Foster
Journal of Rehabilitation Medicine.2026; 58: jrm46110. CrossRef
Seguimiento compartido del paciente trasplantado renal en España: documento de consenso para la coordinación entre centros trasplantadores y centros no trasplantadores
Dolores Redondo-Pachón, Carina Rodriguez-Luque, Mónica Pérez-Mir, Inmaculada Poveda, Ainhoa Inza, Carlos Jiménez, Alex Gutiérrez, Thais López, Natalia Polanco, Pilar Fraile-Gómez, Carola Arcal, Edoardo Melilli, Sara Outón, Guadalupe Tabernero, Daniela Val
Nefrología.2026; : 501631. CrossRef
Experimental and Clinical Transplantation.2026;[Epub] CrossRef
Pharmacological Interventions for Osteoporosis in Kidney Transplant Recipients: A Systematic Review and Meta-analysis
Aschariya Wipattanakitcharoen, Tanun Ngamvichchukorn, Sirinatta Prachathai, Kullaya Takkavatakarn, Kearkiat Praditpornsilpa, Paweena Susantitaphong
Kidney Medicine.2026; : 101537. CrossRef
Liver transplantation-related osteoporosis and fragility fractures: pathogenic pathways, risk stratification and novel targeted therapy advances
Meiqi Wang, Qi Wang
Frontiers in Immunology.2026;[Epub] CrossRef
Romosozumab as Treatment for Severe Osteoporosis in Heart and Lung Transplant Recipients
Lisa M. Raven, Jacqueline R. Center, Christopher A. Muir
Endocrines.2025; 6(1): 2. CrossRef
Side Effects of Immunosuppressant Drugs After Liver Transplant
Filippo Gabrielli, Elisa Bernasconi, Arianna Toscano, Alessandra Avossa, Alessia Cavicchioli, Pietro Andreone, Stefano Gitto
Pharmaceuticals.2025; 18(3): 342. CrossRef
Exploiting regulatory T cells (Tregs): Cutting-edge therapy for autoimmune diseases
Marwa Hassan, Mohamed Elzallat, Dina Mostafa Mohammed, Mahmoud Balata, Walaa H. El-Maadawy
International Immunopharmacology.2025; 155: 114624. CrossRef
Results of the implementation of a multidisciplinary care protocol for preventing fragility fractures following liver transplantation
A. Monegal, J. L. Carrasco, P. Peris, B. Frade-Sosa, A. Azuaga, H. Florez, A. Dura, N. Guañabens, J. Colmenero
Osteoporosis International.2025; 36(7): 1213. CrossRef
Treatment of osteoporosis in the solid organ transplant recipient: an organ-based approach
Soumya Kurnool, Nandi Shah, Preethika Ekanayake
Therapeutic Advances in Endocrinology and Metabolism.2025;[Epub] CrossRef
Global and regional prevalence of osteoporosis in kidney transplant recipients: a systematic review and meta-analysis
Mobin Ghazaiean, Tahoora Mousavi, Mahmood Moosazadeh
Clinical and Experimental Medicine.2025;[Epub] CrossRef
Endocrine effects of long-term calcineurin inhibitor use in solid organ transplant recipients
Talia Diker Cohen, Idit Dotan, Bronya Calvarysky, Eyal Robenshtok
European Journal of Endocrinology.2025; 193(3): R1. CrossRef
Bone disease in kidney transplant: don’t forget about osteomalacia: a case report and literature review
Francesco Aguanno, Alessia Passaseo, Simona Barbuto, Daniele Vetrano, Guido Zavatta, Guido Marzocchi, Sandro Giannini, Giorgia Comai, Gaetano La Manna, Giuseppe Cianciolo
International Urology and Nephrology.2025; 58(4): 1381. CrossRef

Mineral, Bone & Muscle
Acromegaly and Bone: An Update: Andrea Giustina; Endocrinol Metab. 2023;38(6):655-666. Published online December 22, 2023; DOI: https://doi.org/10.3803/EnM.2023.601

18,766 View
408 Download
37 Web of Science
39 Crossref

Abstract PDF PubReader ePub

Since our discovery in 2006 that acromegaly is associated with an increased risk of vertebral fractures, many authors have confirmed this finding in both cross-sectional and prospective studies. Due to the high epidemiological and clinical impact of this newly discovered comorbidity of acromegaly, this topic has progressively become more important and prominent over the years, and the pertinent literature has been enriched by new findings on the pathophysiology and treatment. The aim of this narrative review was to discuss these novel findings, integrating them with the seminal observations, in order to give the reader an updated view of how the field of acromegaly and bone is developing, from strong clinical observations to a mechanistic understanding and possible prevention and treatment.

Citations

Citations to this article as recorded by

Integrative Machine Learning Approach for Predicting Resistance to First-generation Receptor Ligands in Acromegaly
Wei Lin, Songchang Shi, Yuanyuan Zheng, Edward Laws, Timothy R Smith, Le Min
The Journal of Clinical Endocrinology & Metabolism.2026; 111(2): 484. CrossRef
Association between vertebral fracture risk and bone mineral density in patients with acromegaly
Shuaiming Chen, Min Liu, Huiwen Tan, Lin Ji, Yerong Yu, Shu Jiang, Bowen Cai, Wei Wang, Songping Zheng, Xin Zan, Huan Xu, Jing Li, Jianwei Li
Pituitary.2026;[Epub] CrossRef
The Journey of Acromegaly Towards Treatment: A Single-Center Study
Varvara Chalmantzi, Sophia Vlachou, Maria Eleni Chondrogianni, Maria Panagaki, Ariadni Spyroglou, Marina Tsoli, Eva Kassi, Gregory Kaltsas, Krystallenia I. Alexandraki
Journal of Personalized Medicine.2026; 16(2): 85. CrossRef
Cancer Risk in Patients with Acromegaly: Insights from a Single Center in Ankara
Murat Cinel, Ozgur Demir, Rovsan Hasenov, Sule Canlar, Caglar Keskin, Asena Gökçay Canpolat, Mustafa Sahin, Sevim Güllü, Demet Corapcioglu
Journal of Clinical Medicine.2026; 15(4): 1573. CrossRef
Glucocorticoid-Induced Osteoporosis: Pathogenesis, the Impact of Different Administration Routes on Bone Mineral Density, and Fracture Risk and Treatment Options—A Narrative Review
Monika Kapszewicz, Marta Michalska-Kasiczak, Ewa Sewerynek
Journal of Clinical Medicine.2026; 15(7): 2488. CrossRef
Increased prevalence of morphometric vertebral fractures in patients with hypercalcitoninemia due to medullary thyroid carcinoma
Luigi di Filippo, Vincenzo Franzese, Giuseppina Incampo, Anna Maria Formenti, Lucrezia Albanese, Mauro Doga, Debora Onorati, Riccardo Maggiore, Riccardo Rosati, Francesca Perticone, Raffaele Giubbini, Andrea Giustina
Bone.2026; 208: 117872. CrossRef
Consensus on acromegaly complications: an update
Andrea Giustina, Luigi di Filippo, Maria Fleseriu, Rosario Pivonello, Stephan Petersenn, John Wass, Susan L. Samson, Alberto M. Pereira, Raúl M. Luque, Betina Biagetti, Maria Chiara Zatelli, Ken K Y Ho, Cesar L. Boguszewski, Aart Jan van der Lely, Mark Gu
Pituitary.2026;[Epub] CrossRef
Lipodystrophy look-alikes: navigating diagnostic overlap with endocrine diseases
Giovanni Ceccarini, Donatella Gilio, Silvia Magno, Lavinia Palladino, Ferruccio Santini
European Journal of Endocrinology.2026; 194(5): R1. CrossRef
Neuroendocrine and neural control of bone mass in health and disease
Mone Zaidi, Se-Min Kim, Vitaly Ryu, Daria Lizneva, Terry F. Davies, Clifford J. Rosen, Tony Yuen, Andrea Giustina
Journal of Clinical Investigation.2026;[Epub] CrossRef
Recent progress in the understanding of psychological complications of acromegaly: toward a longitudinal clinical phenotype
Gabriella Martino, Orlando Silvestro, Francesco Ferraù, Salvatore Cannavò
Pituitary.2026;[Epub] CrossRef
Calcaneal quantitative ultrasound parameters strongly correlate with DXA measurements in patients with acromegaly
Claudia Campana, Andrea Casabella, Anna Arecco, Maurizio Cutolo, Serena Tonelli, Elvis Hysa, Lara Vera, Francesca Bertaina, Jessica Amarù, Diego Ferone, Sabrina Paolino, Federico Gatto
Pituitary.2026;[Epub] CrossRef
Osteometabolic complications in patients with secreting pituitary adenomas: Is there an impact of gender?
Luigi di Filippo, Matteo Acanfora, Simona Bolamperti, Umberto Terenzi, Maristella Bonomo, Andrea Giustina
Pituitary.2026;[Epub] CrossRef
Assessment of nurses’ knowledge and awareness of acromegaly in a high-volume tertiary center: a cross-sectional study
Birgul Genc, Sefika Burcak Polat, Aysegul Koc, Reyhan Ersoy
Pituitary.2026;[Epub] CrossRef
Vitamin D and hip protectors in osteosarcopenia: a combined hip fracture preventing approach
Alessandro Giustina, Andrea Giustina
Reviews in Endocrine and Metabolic Disorders.2025; 26(1): 1. CrossRef
Long-Term Prognosis and Systemic Impact of Acromegaly: Analyses Utilizing Korean National Health Insurance Data
Sangmo Hong, Kyungdo Han, Cheol-Young Park
Endocrinology and Metabolism.2025; 40(1): 1. CrossRef
Frailty and pituitary surgery: a systematic review
Mendel Castle-Kirszbaum, Ann McCormack, Christopher Ovenden, Jeremy Kam, James King, Yi Yuen Wang, Tony Goldschlager
Pituitary.2025;[Epub] CrossRef
Artificial intelligence in acromegaly: Why, when and how
Alessandro Giustina, Andrea Giustina
Pituitary.2025;[Epub] CrossRef
Muscle dysfunction is associated with poor quality of life in long-term controlled patients with acromegaly
Luciana Martel-Duguech, Helena Bascuñana, Jordi Cuartero, Susan M. Webb, Elena Valassi
Pituitary.2025;[Epub] CrossRef
Evaluation of bone density and microstructure by DXA, TBS and HR-pQCT: an assessment of cortical porosity and its association with vertebral fractures in patients with acromegaly
PG Ornellas, EMF Gama, LMC Mendonça, C Villela-Nogueira, FP Paranhos-Neto, L Kasuki, MR Gadelha, MLF Farias, M Madeira
Journal of Endocrinological Investigation.2025; 48(9): 2087. CrossRef
Growth Hormone and Bone: Preclinical and Clinical Perspectives
Kevin C.J. Yuen
Endocrine Practice.2025; 31(9): 1197. CrossRef
Development and application of HDA-ABi-GRU-based on the interpersonal problems scale of personality disorders in acromegaly patients
Shashi Kiran Tagilapalli, Lei Shi, Zhentian Wu, Canhui Tian, Yanmei Tie, Dongsheng He, Haijun Wang, Wenli Chen
Neurocomputing.2025; 653: 131138. CrossRef
Collaboration Between Endocrinologists and Dentists in the Care of Patients with Acromegaly—A Narrative Review
Beata Wiśniewska, Kosma Piekarski, Sandra Spychała, Ewelina Golusińska-Kardach, Maria Stelmachowska-Banaś, Marzena Wyganowska
Journal of Clinical Medicine.2025; 14(15): 5511. CrossRef
Skeletal Health in Pituitary and Neuroendocrine Diseases: Prevention and Treatments of Bone Fragility
Flavia Costanza, Antonella Giampietro, Laura De Marinis, Antonio Bianchi, Sabrina Chiloiro, Alfredo Pontecorvi
Targets.2025; 3(3): 26. CrossRef
Consensus on acromegaly therapeutic outcomes: an update
Shlomo Melmed, Luigi di Filippo, Maria Fleseriu, Moisés Mercado, Niki Karavitaki, Mark Gurnell, Roberto Salvatori, Stylianos Tsagarakis, Marco Losa, Pietro Maffei, Alberto M. Pereira, Eliza B. Geer, Laurence Katznelson, Aart Jan van der Lely, Jens Bollers
Nature Reviews Endocrinology.2025; 21(11): 718. CrossRef
ACROMEGALY – ETIOLOGY, SYMPTOMS, TREATMENT. LITERATURE REVIEW
Michał Ochwat, Katarzyna Dąbek, Aleksandra Kajtel, Anna Skowronek, Martyna Piekarska-Magiera, Adam Sielicki, Maria Ochwat, Tomasz Skowronek, Michał Oborski, Zofia Sudoł
International Journal of Innovative Technologies in Social Science.2025;[Epub] CrossRef
Acromegaly treatment and bone: a bidirectional relationship
Sabrina Chiloiro, Chiara Palumbo, Antonella Giampietro, Laura De Marinis, Antonio Bianchi, Andrea Giustina, Alfredo Pontecorvi
Pituitary.2025;[Epub] CrossRef
Dental Implantology in Acromegaly: Pathophysiological Challenges, Biomaterial Interactions, and Future Directions—A Narrative Review
Beata Wiśniewska, Sandra Spychała, Kosma Piekarski, Ewelina Golusińska-Kardach, Maria Stelmachowska-Banaś, Marzena Wyganowska
Journal of Functional Biomaterials.2025; 16(11): 411. CrossRef
New insights into the vitamin D/PTH axis in endocrine-driven metabolic bone diseases
Luigi di Filippo, John P. Bilezikian, Ernesto Canalis, Umberto Terenzi, Andrea Giustina
Endocrine.2024; 85(3): 1007. CrossRef
Bone health and skeletal fragility in second- and third-line medical therapies for acromegaly: preliminary results from a pilot single center experience
Sabrina Chiloiro, Antonella Giampietro, Amato Infante, Pier Paolo Mattogno, Liverana Lauretti, Alessandro Olivi, Laura De Marinis, Alfredo Pontecorvi, Francesco Doglietto, Antonio Bianchi
Pituitary.2024; 27(3): 303. CrossRef
Standards of care for medical management of acromegaly in pituitary tumor centers of excellence (PTCOE)
Andrea Giustina, M. M. Uygur, S. Frara, A. Barkan, N. R. Biermasz, P. Chanson, P. Freda, M. Gadelha, L. Haberbosch, U. B. Kaiser, S. Lamberts, E. Laws, L. B. Nachtigall, V. Popovic, M. Reincke, A. J. van der Lely, J. A. H. Wass, S. Melmed, F. F. Casanueva
Pituitary.2024; 27(4): 381. CrossRef
Vertebral fractures in patients with non-functioning pituitary adenomas - a new frontier?
Nicholas A. Tritos
Pituitary.2024; 27(4): 311. CrossRef
Suspected silent pituitary somatotroph neuroendocrine tumor associated with acromegaly-like bone disorders: a case report
Tongxin Xiao, Xinxin Mao, Ou Wang, Yong Yao, Kan Deng, Huijuan Zhu, Lian Duan
BMC Endocrine Disorders.2024;[Epub] CrossRef
Skeletal fragility in pituitary disease: how can we predict fracture risk?
Fabio Bioletto, Alessandro Maria Berton, Marco Barale, Luigi Simone Aversa, Lorenzo Sauro, Michela Presti, Francesca Mocellini, Noemi Sagone, Ezio Ghigo, Massimo Procopio, Silvia Grottoli
Pituitary.2024; 27(6): 789. CrossRef
Vitamin D in pituitary driven osteopathies
Sabrina Chiloiro, Flavia Costanza, Elena Riccardi, Antonella Giampietro, Laura De Marinis, Antonio Bianchi, Alfredo Pontecorvi, Andrea Giustina
Pituitary.2024; 27(6): 847. CrossRef
GH receptor polymorphisms guide second-line therapies to prevent acromegaly skeletal fragility: preliminary results of a pilot study
Sabrina Chiloiro, Flavia Costanza, Antonella Giampietro, Amato Infante, Pier Paolo Mattogno, Flavia Angelini, Consolato Gullì, Liverana Lauretti, Mario Rigante, Alessandro Olivi, Laura De Marinis, Francesco Doglietto, Antonio Bianchi, Alfredo Pontecorvi
Frontiers in Endocrinology.2024;[Epub] CrossRef
Growth hormone and bone: a basic perspective
Simona Bolamperti, Isabella Villa, Luigi di Filippo
Pituitary.2024; 27(6): 745. CrossRef
Approach to the patient with controlled acromegaly and acromegalic arthropathy: clinical diagnosis and management
Iris C. M. Pelsma, Herman M. Kroon, Cornelie D. Andela, Enrike M. J. van der Linden, Margreet Kloppenburg, Nienke R. Biermasz, Kim M. J. A. Claessen
Pituitary.2024; 27(6): 824. CrossRef
Modern approach to bone comorbidity in prolactinoma
Meliha Melin Uygur, Sara Menotti, Simona Santoro, Andrea Giustina
Pituitary.2024; 27(6): 802. CrossRef
Novel approach to bone comorbidity in resistant acromegaly
Stefano Frara, Matteo Acanfora, Vincenzo Franzese, Maria Luisa Brandi, Marco Losa, Andrea Giustina
Pituitary.2024; 27(6): 813. CrossRef

Original Article

Mineral, Bone & Muscle
Characteristics Associated with Bone Loss after Spinal Cord Injury: Implications for Hip Region Vulnerability: Sora Han, Sungjae Shin, Onyoo Kim, Namki Hong; Endocrinol Metab. 2023;38(5):578-587. Published online October 10, 2023; DOI: https://doi.org/10.3803/EnM.2023.1795

7,852 View
101 Download
4 Web of Science
3 Crossref

Abstract PDF Supplementary Material PubReader ePub

Background
In individuals with spinal cord injury (SCI), bone loss progresses rapidly to the area below the level of injury, leading to an increased risk of fracture. However, there are limited data regarding SCI-relevant characteristics for bone loss and the degree of bone loss in individuals with SCI compared with that in non-SCI community-dwelling adults.
Methods
Data from men with SCI who underwent dual-energy X-ray absorptiometry at the National Rehabilitation Center (2008 to 2020) between 12 and 36 months after injury were collected and analyzed. Community-dwelling men were matched 1:1 for age, height, and weight as the control group, using data from the Korea National Health and Nutrition Examination Survey (KNHANES, 2008 to 2011).
Results
A comparison of the SCI and the matched control group revealed significantly lower hip region T-scores in the SCI group, whereas the lumbar spine T-score did not differ between groups. Among the 113 men with SCI, the paraplegia group exhibited significantly higher Z-scores of the hip region than the tetraplegia group. Participants with motor-incomplete SCI showed relatively preserved Z-scores of the hip region compared to those of the lumbar region. Moreover, in participants with SCI, the percentage of skeletal muscle displayed a moderate positive correlation with femoral neck Z-scores.
Conclusion
Men with SCI exhibited significantly lower bone mineral density of the hip region than community-dwelling men. Paraplegia rather than tetraplegia, and motor incompleteness rather than motor completeness were protective factors in the hip region. Caution for loss of skeletal muscle mass or increased adiposity is also required.

Citations

Citations to this article as recorded by

Multifaceted Pathophysiology and Secondary Complications of Chronic Spinal Cord Injury: Focus on Pressure Injury
Mario Martínez-Torija, Pedro F. Esteban, Angela Santos-De-La-Mata, Matilde Castillo-Hermoso, Eduardo Molina-Holgado, Rafael Moreno-Luna
Journal of Clinical Medicine.2025; 14(5): 1556. CrossRef
The impact of ADL disability in middle-aged and older adults on the incidence of hip fractures and the mediating role of depression: a longitudinal evidence from CHARLS
Chenyang Li, Congcong Luo, Jiayi Zhu, Ruonan You, Qiang Yuan, Ning Zhang, Ying Zhang
Frontiers in Medicine.2025;[Epub] CrossRef
Integrating sensitive motor tasks with histopathology detects sex differences in recovery after spinal cord injury
Emily A. Swarts, Ashley I. Munro, Courtney A. Bannerman, Julie R. Zielonka, Colleen E. Tordoff, Nader Ghasemlou, Faith H. Brennan
Experimental Neurology.2025; 394: 115417. CrossRef

Review Article

Mineral, Bone & Muscle
Nuclear Factor-Kappa B Regulation of Osteoclastogenesis and Osteoblastogenesis: Brendan F. Boyce, Jinbo Li, Zhenqiang Yao, Lianping Xing; Endocrinol Metab. 2023;38(5):504-521. Published online September 26, 2023; DOI: https://doi.org/10.3803/EnM.2023.501

15,746 View
245 Download
70 Web of Science
77 Crossref

Abstract PDF PubReader ePub

Maintenance of skeletal integrity requires the coordinated activity of multinucleated bone-resorbing osteoclasts and bone-forming osteoblasts. Osteoclasts form resorption lacunae on bone surfaces in response to cytokines by fusion of precursor cells. Osteoblasts are derived from mesenchymal precursors and lay down new bone in resorption lacunae during bone remodeling. Nuclear factorkappa B (NF-κB) signaling regulates osteoclast and osteoblast formation and is activated in osteoclast precursors in response to the essential osteoclastogenic cytokine, receptor activator of NF-κB ligand (RANKL), which can also control osteoblast formation through RANK-RANKL reverse signaling in osteoblast precursors. RANKL and some pro-inflammatory cytokines, including tumor necrosis factor (TNF), activate NF-κB signaling to positively regulate osteoclast formation and functions. However, these cytokines also limit osteoclast and osteoblast formation through NF-κB signaling molecules, including TNF receptor-associated factors (TRAFs). TRAF6 mediates RANKL-induced osteoclast formation through canonical NF-κB signaling. In contrast, TRAF3 limits RANKL- and TNF-induced osteoclast formation, and it restricts transforming growth factor β (TGFβ)-induced inhibition of osteoblast formation in young and adult mice. During aging, neutrophils expressing TGFβ and C-C chemokine receptor type 5 (CCR5) increase in bone marrow of mice in response to increased NF-κB-induced CC motif chemokine ligand 5 (CCL5) expression by mesenchymal progenitor cells and injection of these neutrophils into young mice decreased bone mass. TGFβ causes degradation of TRAF3, resulting in decreased glycogen synthase kinase-3β/β-catenin-mediated osteoblast formation and age-related osteoporosis in mice. The CCR5 inhibitor, maraviroc, prevented accumulation of TGFβ+/CCR5+ neutrophils in bone marrow and increased bone mass by inhibiting bone resorption and increasing bone formation in aged mice. This paper updates current understanding of how NF-κB signaling is involved in the positive and negative regulation of cytokine-mediated osteoclast and osteoblast formation and activation with a focus on the role of TRAF3 signaling, which can be targeted therapeutically to enhance bone mass.

Citations

Citations to this article as recorded by

Biomimetic aligned scale-like nanotopographic scaffold reprograms resorption-dominant remodeling in diabetic sockets to enhance alveolar ridge preservation
Jiawei Xing, Jiacheng Lv, Ze He, Bowen Zheng, Yingzhang Wu, Hanghang Liu, Shibo Liu, Yao Liu, Jiazhuang Xu, Zhongming Li, En Luo
Biomaterials.2027; 337: 124521. CrossRef
Lacticaseibacillus rhamnosus LGG Suppresses Osteoclastogenesis via TLR6/NF-κB Modulation and Attenuates Ovariectomy-Induced Bone Loss in Mice
Kangjun Xiong, Jianghua Li, Yaqing Liu, Yang Pan, Yiping Huang, Dongdong Zhan, Lutong Zhang, Ming Tang, Jing Li, Haohao Sun
Probiotics and Antimicrobial Proteins.2026; 18(3): 4523. CrossRef
Inflammatory bone loss and signaling pathways in periodontitis: mechanistic insights and emerging therapeutic strategies
Rafael Scaf de Molon, Rolando Vernal, Gabriela Ezequiel Oliveira, Joao Paulo Steffens, Edilson Ervolino, Leticia Helena Theodoro, Jeroen J. J. P. van den Beucken, Sotirios Tetradis
Bone Research.2026;[Epub] CrossRef
The Inflammation-Energy Metabolism Axis: A Central Driver of Sarcopenia-Osteoporosis: A Narrative Review
Yifan Jiang, Xiaonan Qi, Haijian Cui, Yingtao Huang, Yibo Lv, Yu Yang, Xiaosheng Yao, Dongxiang Yang
Calcified Tissue International.2026;[Epub] CrossRef
Osteoporosis After Menopause and After Drug Therapy: The Molecular Mechanism of Bone Loss and Its Treatment
Kelly I-Rong Lee, Jie-Hong Chen, Kuo-Hu Chen
International Journal of Molecular Sciences.2026; 27(2): 641. CrossRef
Mechanical Memory and NF-κB Signaling in Dental Pulp Stem Cell Odontogenic Differentiation
Maryam Ghaffari, Annie Shrestha
Journal of Endodontics.2026;[Epub] CrossRef
Cell signaling and transcriptional regulation of osteoclast lineage commitment, differentiation, bone resorption and diseases
Siyu Zhu, Ming-Qi Yan, Alasdair Masson, Wei Chen, Yi-Ping Li
Cell Discovery.2026;[Epub] CrossRef
In Silico Investigation Reveals IL-6 as a Key Target of Asiatic Acid in Osteoporosis: Insights from Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation
Wanatsanan Chulrik, Aman Tedasen, Nateelak Kooltheat, Rungruedee Kimseng, Thitinat Duangchan
Medical Sciences.2026; 14(1): 41. CrossRef
Diacerein Downregulates Nfkb, Induces ALP Activity and Inhibits Osteoblast Apoptosis in Alveolar Bone of Rats with Periodontitis
Paulo Sérgio Cerri, Lucas de Andrade Rodrigues, Lays Cristina Gouvea, Gabriella de Oliveira, Estela Sasso-Cerri
Biomedicines.2026; 14(2): 306. CrossRef
Surfactin Inhibits Osteoclast Differentiation by Negatively Regulating the Elk1-AP-1-NFATc1 Axis
Kazuki Maruyama, Ayaka Koga, Yuki Kodama, Ryota Yamasaki, Yoshie Nagai-Yoshioka, Jun J. Miyamoto, Kayoko Kuroishi, Kaori Gunjigake, Tatsuo Kawamoto, Wataru Ariyoshi
Biomedicines.2026; 14(1): 155. CrossRef
FXR in bone metabolism: An emerging regulator
S. M. Mahamudul Hassan Rizvi, Aihemaiti Shami, Yun Kan, Shengxiang Tao, Hui Liu
iScience.2026; 29(3): 114842. CrossRef
Association between HBV DNA levels and bone mineral density in antiviral-naive chronic hepatitis B patients
Xinyu Zhou, Xue Jing, Na Zu, Zhanghao Li, Xinjuan Kong, Shijin Wang
Frontiers in Endocrinology.2026;[Epub] CrossRef
Beyond the genome: GlycoRNAs as a nexus of glycobiology and RNA biology
Xinyu Miao, Jianbo Deng, Fei Cai, Yingying Ling, Ling Li, Yong Zhang, Shuang Yang
Glycoscience & Therapy.2026; 2(2): 100038. CrossRef
Effects of cisplatin and tamoxifen chemotherapy on peri‐implant bone remodeling around titanium implants in ovariectomized rats: An in vivo study
Luiz G. Fiorin, Henrique Rinaldi Matheus, Gabriela Carrara Simionato, Ester Oliveira Santos, Ruan Delmonica Barra, Francisley Avila Souza, Edilson Ervolino, Claudia Dellavia, Juliano M. de Almeida
Journal of Periodontology.2026; 97(9): 1949. CrossRef
Artesunate ameliorates Staphylococcus aureus-induced mandibular osteomyelitis and promotes osteogenic differentiation via NOD2/p65 signaling pathway
Enkang Tong, Xiaofei Dong, Yifan Ren, Lingxue Gong, Cuicui Zhao, Rongrong Nie, Xiangfeng Meng
International Immunopharmacology.2026; 175: 116472. CrossRef
CXCL5 suppresses osteoclastogenesis and protects against lipoteichoic acid-induced bone loss by modulating PLCγ2 and c-Fos signalling in gram-positive periprosthetic joint infection
Yuhan Chang, Pei-Heng Jiang, Yung-Heng Hsu, Kee-Chin Sia, Steve Wen-Neng Ueng, Mei-Feng Chen
Bone & Joint Research.2026; 15(3): 215. CrossRef
Investigating the Role of MicroRNAs in Mesenchymal Stem Cell Osteogenic Differentiation
Zhenglin Leng, Shenzhen Pan, Qiang Guo, Limin Liu, Zengshun Wang, Junfeng Ma, Haibin Zhou, Jingyuan Zhou
Journal of Biochemical and Molecular Toxicology.2026;[Epub] CrossRef
Impact of Quercetin on Bone-Related Diseases
Paweł Polak, Magdalena Dragan, Antoni Wojciech Oniszczuk, Emilia Skurko, Kamila Kasprzak-Drozd, Przemysław Niziński, Anna Oniszczuk, Karolina Wojtunik-Kulesza
Applied Sciences.2026; 16(7): 3151. CrossRef
SZQ‐3, a Novel Synthetic Chromone‐Maleimide Hybrid Targeting NF‐κB, Prevents Postmenopausal Osteoporosis by Modulating Mitochondrial Function in Bone Cells
Yichi Zhang, Tianle Jiang, Runqi Zhou, Wen Tong, Huayu Ye, Junhao Tu, Mengjia Yi, Xinyi Ma, Shuomin Chen, Yifan Ping, Bin Li, Yang Chen, Zengqiang Song, Yixin Mao, Shengbin Huang, Shufan Zhao
The FASEB Journal.2026;[Epub] CrossRef
Oxidative stress in bone healing: mechanisms, disease contexts, and therapeutic strategies
Wei Fu, Dandan Pan, Yuan Liu, Zuoqiang He, Xiaojiang Hu
European Journal of Medical Research.2026;[Epub] CrossRef
Causal Effects of Atrial Fibrillation and Warfarin Use on Osteoporosis Risk: A Two‐Sample Mendelian Randomization Analysis
Xiao Hu, Jiaqin Cai, Xiaoxia Wei, Hong Sun, Khaled F. M. Salem
International Journal of Genomics.2026;[Epub] CrossRef
The endocrine pathway during whole body vibration modulates the immune system and the osteogenesis in postmenopausal women with osteoporosis
Vasiliy Pyatin, Olga Maslova
Frontiers in Endocrinology.2026;[Epub] CrossRef
Cellular signaling crosstalk between osteoporosis and diabetes: Common mechanisms and therapeutic targets (Review)
Yangyi Cheng, Jingyuan Gao, Yuyang Yang, Lei Xing, Xiaoli Hou, Liu Zhang, Faming Tian
Biomedical Reports.2026; 25(1): 1. CrossRef
Stress-induced IL-6 regulation in pediatric bone growth disorders: current insights and therapeutic strategies
Zaineb Sohail, Norhayati binti Abd. Hadi, Azizur Rehman, Muhammad Asghar, Farasat Zaman
Frontiers in Endocrinology.2026;[Epub] CrossRef
Deoxycholic acid ameliorates postmenopausal osteoporosis by rebalancing BMSC differentiation and suppressing NF-κB signaling
Cui Wang, Lu Liu, Jialu Wu, Xianhao Huang, Junyi Liu, Ye Yi, Li Tian, Lingyun Lu, Xijie Yu
The Journal of Nutritional Biochemistry.2026; 157: 110438. CrossRef
Efficacy and hepatotoxicity of Psoralea corylifolia L.: A meta-analysis and machine learning assessment in postmenopausal osteoporosis
Hongjie Yang, Rui Tang, Yajin Ren, Zhen Chen, Tianen Zhan, Kaipeng Chen, Xiaohong Fan
Journal of Ethnopharmacology.2026; 371: 122099. CrossRef
Physcion modulates estrogen, RANKL, and bone-resorptive cytokines in ovariectomized rats: In vivo and in silico evaluation
Philip Cefas Abaya, Sanusi Bello Mada, Dorcas Bolanle James, Muhammad Sa’idu Tanko, Sanusi Babangida, Muhammad Auwal Saliu
Pharmacological Research - Natural Products.2026; 12: 100802. CrossRef
Research progress on the intervention of osteoporosis by Chinese herbal monomers based on the Nrf2/NF-κB/MAPK pathway
Wenjie Kou, Chenglong Guo, Xiaomin Lu, Zhe Zhang, Kaiwen Liu, Zhihuan Liu, Bin Jiang, Chengxiang Ma, Jishu Li, Jiandong Gao, Linzhong Cao, Xiaogang Zhang
Frontiers in Endocrinology.2026;[Epub] CrossRef
Inflammation mediated Osteoclastogenesis and bone resorption markers in Periodontitis subjects with and without type 2 diabetes- A Cross-sectional study
Ramalingam Mathangi, Ranganathan Parthasarathy, Nalini Devarajan, S. Bhuminathan, BagavadGita Jayaraman
Journal of Oral Biology and Craniofacial Research.2026; 16(4): 101484. CrossRef
Chemically profiled total saponins of Panax japonicus C.A. Meyer attenuate rheumatoid arthritis-associated bone erosion and modulate osteoclastogenesis-associated SRC/TRAF6/NF-κB signaling
Mei Yang, Jingkai Zhang, Xiang Guo, Yushen Chen, Zhigang Mei, Xiaoqiang Hou, Zhitao Feng
Journal of Ginseng Research.2026; : 101113. CrossRef
Osteoblast-specific deletion of NF-κB p65 enhances trabecular bone formation and BMP-2-induced osteogenesis in mice
Rifat Rezwana, Fumitaka Hiura, Aonan Li, Yini Zhuo, Mai Kuratani, Sho Tsukamoto, Takenobu Katagiri, Eijiro Jimi
Bone.2026; 211: 117992. CrossRef
Multiscale bone remodeling in COVID-19: from osteoimmune signaling to structural and mechanical impairment
G. Jiang, F. Buccino, L. M. Vergani
Frontiers in Bioengineering and Biotechnology.2026;[Epub] CrossRef
Isoschaftoside Inhibits Osteoclastogenesis by Suppressing the NF-κB and MAPK Pathways
Jangmi Yun, Ki Yong Lee, Byoungduck Park
Biomolecules & Therapeutics.2026; 34(4): 933. CrossRef
Non-canonical NF-κB drives a fate switch from germinal center to early effector B cells
Waqas Nawaz, Amos Fong, Miguel P. Cardoso, Jing Tang, Jenny Zhao, Michael Y. Li, Shinya Rai, Aidan Beresford, Waleed Alduaij, Merrill Boyle, Christian Steidl, David W. Scott, Leandro Venturutti
iScience.2026; 29(8): 116917. CrossRef
Advances in the study of the role of bone immunity in physiological and pathological processes related to bone metabolism
Zhuoru Jin, Lisheng Liu, Heran Wang, Yufei Wei, Zimo Zhou, Xiaohui Luo, Da Liu
International Immunopharmacology.2026; 187: 117219. CrossRef
Indole derivatives intervene osteoporosis via gut-bone axis
Wendong Wang
Frontiers in Cellular and Infection Microbiology.2026;[Epub] CrossRef
Anti-osteoclastogenic effects of the ethyl acetate fraction and lignans from Sambucus racemosa subsp. pendula
Ju-Hee Park, Trong Trieu Tran, Minju Gal, Seokhan Lee, Manh Tuan Ha, Okhwa Kim, Cheol Hwangbo, Byung-Sun Min, Jeong-Hyung Lee
Pharmacological Research - Natural Products.2026; 12: 100855. CrossRef
Epoxomicin-functionalized thermosensitive hydrogel rescues bone defects in osteoporosis by the NF-κB signaling pathway
Liqun Jiang, Qijia Sui, Chen Sun, Chen Li, Shuai Wang, Zijiao Zhang, Huiying Liu, Guowu Ma
Regenerative Biomaterials.2026;[Epub] CrossRef
CaMKIIγ inhibition attenuates osteoclastogenesis via the NF-κB–NFATc1 axis and protects against ovariectomy-induced osteoporosis
Yisen Qiu, Ningnan Fang, Bang An, Ganghong Teng, Hongsheng Luo, Weidong Wang, Yiwei Xu, Xinjia Wang
Cellular Signalling.2026; 148: 112800. CrossRef
A barrier-centered perspective on the gut-barrier-bone axis: a review of the core role of the intestinal barrier and related probiotics with nanocoatings
Wenbo Xu, Feilong Li, Yanmei Zhou, Chao Song, Yi Li, Zongchao Liu
Archives of Microbiology.2026;[Epub] CrossRef
Strontium-substituted hydroxyapatite nanoparticles as dual-function regulators of osteoblast mineralization and RANKL-induced osteoclastogenesis
Shiao-Wen Tsai, Cheng Li, Shu-ting Lee, Pai-An Hwang, Fu-Yin Hsu
Journal of Materials Science: Materials in Medicine.2026;[Epub] CrossRef
Investigating the Osteoprotective Potential of Holoptelia integrefolia through Multitarget Modulation of Bone Metabolic Pathways
Neha Verma, Apurva Prajapati, Shilpa Kumari, Hitesh D. Patel, Kanu Priya
Applied Biochemistry and Biotechnology.2026;[Epub] CrossRef
Exploring the role of TNF/TNFR superfamily and NF-?B pathway in regulating B7/CD28 expression in rheumatoid arthritis: An in-vitro study
Jingjing Liu
Pakistan Journal of Pharmaceutical Sciences.2026;[Epub] CrossRef
Nortrachelogenin Inhibits Receptor Activator of Nuclear Factor Kappa-B Ligand-Induced Nuclear Factor Kappa-B Signaling and Osteoclastogenesis
Lifang Zhang, Farwa Basit, Santosh Kumar, Vishwa Deepak
Drug Research.2026;[Epub] CrossRef
Chronic low-grade inflammation drives skeletal aging and neurocognitive decline: inflammaging as a central hub coupling bone–brain aging
Man Yu, Yu Wu, Ao Wang, Mei Wang, Yao Chen, Hang Ren, Yixin Zhang, Yingjie Liu, Shudong Wang, Xu Fan
Frontiers in Immunology.2026;[Epub] CrossRef
Intestinal–Bone Axis Mediated by Bifidobacterium: Mechanistic Analysis and Therapeutic Potential in Osteoporosis
Fadong Li, Haoze Zhang, Boran Zhang, Xingwen Xie, Ning Li
Microorganisms.2026; 14(9): 1985. CrossRef
A Study on the Protective Effect and Mechanism of Polygonatum sibiricum Aqueous Extract on Osteoporosis in Rats
Biguo Xie, Fuding Zhou, Hanyu Zhao, Yanan Li, Lexun Li, Ting Wang, Changsheng Shao, Peng Wang, Wenjun Chen
Current Nutrition & Food Science.2026; 22(5): 416. CrossRef
Cellular senescence and the SASP in skeletal ageing: convergent mechanisms of progressive bone loss in osteoporosis
Haotian Liu, Bingjun Lei
Biogerontology.2026;[Epub] CrossRef
Antibody-Mimicking Nanocluster Ameliorates Osteoporosis in Preclinical Model
Qing Yuan, Qiao-Zhi Li, Zhichao Zhang, Dongfang Xia, Haoran Dang, Liming Wang, Wenchao Niu, Zhen Chen, Liang Gao, Lina Zhao, Kai Cao, Xingfa Gao, Xueyun Gao
ACS Nano Medicine.2026;[Epub] CrossRef
The bidirectional role of neutrophils in the regulation of bone metabolism: a review of research progress and mechanism
Hengchang Su, Sinian Wang, Weibo Liu, Hao Zhou, Yiying Zhang, Renjun Peng, Zhongmin Chen, Huijie Yu, Zecheng Zhu, Fengsheng Li, Wenhua Liu, Suhe Dong
Frontiers in Immunology.2026;[Epub] CrossRef
Spatiotemporal regulation of the bone immune microenvironment via a ‘Zn2+-quercetin’ hierarchical delivery system for bone regeneration
Hengliang Sun, Yedan Chen, Xiaoqin Sang, Qingxiang Liu, Haoran Yu, Shaojun Hu, Yingji Mao, Li Zhang
Regenerative Biomaterials.2025;[Epub] CrossRef
The Role of Phlorotannins to Treat Inflammatory Diseases
K. H. I. N. M. Herath, Dineth Pramuditha Nagahawatta, Lei Wang, K. K. Asanka Sanjeewa
Chemistry.2025; 7(3): 77. CrossRef
Induction of HMOX1 by mesenchymal stem cell cytotherapy inhibits osteoclastogenesis and myeloma‐induced bone disease
Xin Li, Wen Ling, Bart Barlogie, Shmuel Yaccoby
Clinical and Translational Medicine.2025;[Epub] CrossRef
Comprehensive RNA-Seq Analysis of Human Osteoclast Function in Response to Bothrops moojeni Venom Fractions: Pathways of Bone Resorption and Cytoskeletal Disruption
Fernanda D’Amélio, Hugo Vigerelli, Rodrigo Pinheiro Araldi, Isabel de Fátima Correia Batista, Daniel Carvalho Pimenta, Irina Kerkis
Toxins.2025; 17(7): 358. CrossRef
Exploring capsaicin as a multi-target agent for osteoporosis through computational insights
Mazumder Adhish, Balaraman Madhan, I. Manjubala
In Silico Pharmacology.2025;[Epub] CrossRef
Validation of the therapeutic potential of soluble CD93 lectin-like domain in arthritis and its inhibitory role in inflammatory osteolysis
Shang-En Huang, Cheng-Hsiang Kuo, Hua-Lin Wu, Erna Sulistyowati, Fang-Tzu Lee, Chao-Han Lai, Jwu-Lai Yeh
International Immunopharmacology.2025; 166: 115533. CrossRef
Calcium Phosphates for Bone Tissue Regeneration—Influence of Synthesis Method on Physicochemical and Biological Properties
Julia Sadlik, Edyta Kosińska, Karina Niziołek, Mateusz Urbaniak, Agnieszka Sobczak-Kupiec, Dagmara Słota
Materials.2025; 18(21): 4945. CrossRef
Bisabolangelone targets CSF1R to impede osteoclastogenesis and attenuate estrogen-deficiency bone loss
Liang Mo, Yuxuan Xue, Xiaohang Zheng, Gang Wang, Jin Zou, Ziyu Zhao, Maoxiao Ma, Yuting Zhang, Hongduo Lu, Yinuo Fan, Bin Fang, Wei He, Jiake Xu, Yuhao Liu
Phytomedicine.2025; 148: 157472. CrossRef
Cynarin as a potent anti‑osteolytic agent: Targeting MAPK and Nrf2‑Keap1 pathways for osteoclast inhibition and bone protection
Rui Chao, Yexin Wang, Zhan Liu, Tianhao Wan, Yi Mao, Xinru Xie, Lei Sun, Weifeng Xu, Xuzhuo Chen, Shanyong Zhang
International Journal of Molecular Medicine.2025; 56(6): 1. CrossRef
Peptidoglycan Derived From Bifidobacterium animalis KL101 Inhibits RANKL‐Induced Osteoclastogenesis Targeting Oxidative Stress and Autophagy Pathways
Yu–Jeong Jee, Junghee Lee, Sejong Oh, Jee–Young Imm, Marcos Dos Santos Lima
Journal of Food Biochemistry.2025;[Epub] CrossRef
DNA methylation and immune regulation in osteoporosis: emerging epigenetic targets for drug discovery
Yingli Yang, Yao Yao, Xiaoyu Cai, Yaqi Tao, Zhengbing Zhuge, Jianhong Zhou, Caihong Zheng
Frontiers in Pharmacology.2025;[Epub] CrossRef
Impact of reactive oxygen species on bone regeneration in diabetes: Mechanisms and therapeutic strategies
Keyue Tian, Tianchu Xiong, Di Zeng, Ziheng Huang, Ruixi Liu, Feng Luo
Redox Biology.2025; 88: 103941. CrossRef
Paradoxical effects of parathyroidectomy and sodium thiosulfate in a hemodialysis patient with calciphylaxis: a case report of persistent metastatic calcification
RuiLing Luo, Huiying Xu, Xuan Li, Zihao Zhu, Shuai Sun, Jinling Wang, XueXun Chen
Frontiers in Medicine.2025;[Epub] CrossRef
Inflammatory impact of cigarette smoking on bone function and structure; a review of evidence
Yashar Shahbaz, Rasoul Shirmohammadi, Shirin Shamsghahfarokhi, Hooman Esfahani, Mobin Forghan, Hojjat Eghbali Jelodar, Leila Ashrafi, Mohammad Mousavi
Journal of Parathyroid Disease.2025; 13: e13302. CrossRef
Perirenal fat and alcohol consumption contribute to marginal bone loss after dental implant surgery in type 2 diabetes
Jelena S Jadzic, Vladan D Kekovic
World Journal of Diabetes.2025;[Epub] CrossRef
Photocurable hydrogel containing MOF nanoenzymes for comprehensive pulpitis treatment: antibacterial, anti-inflammatory, and osteogenic actions
Fei Xie, Chuanda Zhu, Man Qin, Zhenli Diao, Yuanyuan Wang
Journal of Nanobiotechnology.2025;[Epub] CrossRef
The Role of Rosavin in the Pathophysiology of Bone Metabolism
Piotr Wojdasiewicz, Paweł Turczyn, Anna Lach-Gruba, Łukasz A. Poniatowski, Daryush Purrahman, Mohammad-Reza Mahmoudian-Sani, Dariusz Szukiewicz
International Journal of Molecular Sciences.2024; 25(4): 2117. CrossRef
The role of monocyte/macrophage chemokines in pathogenesis of osteoarthritis: A review
Hao Luo, Linfeng Li, Song Han, Tao Liu
International Journal of Immunogenetics.2024; 51(3): 130. CrossRef
The effect of low-level laser therapy on osteoclast differentiation: Clinical implications for tooth movement and bone density
Chun-Yi Huang, Huynh Hoai Thuong Le, Hsiao-Chi Tsai, Chih-Hsin Tang, Jian-Hong Yu
Journal of Dental Sciences.2024; 19(3): 1452. CrossRef
Anti-arthritic and immunomodulatory efficacy of Micromeria biflora Benth extract and its fractions in rats by restoring oxidative stress, metalloproteinases, pro-inflammatory and anti-inflammatory cytokines network
Fakhria A. Al-Joufi, Ambreen Malik Uttra, Sumera Qasim, Urooj Iqbal, Nabeela Tabassum Sial, Noura M. Alhumaid
Inflammopharmacology.2024; 32(4): 2477. CrossRef
Evaluation of Immunohistochemical Biomarkers in Diabetic Wistar Rats with Periodontal Disease
Ioana Scrobota, Ioan Andrei Tig, Andrea Olivia Marcu, Georgiana Ioana Potra Cicalau, Liliana Sachelarie, Gilda Iova
Journal of Personalized Medicine.2024; 14(5): 527. CrossRef
The role of magnesium in the pathogenesis of osteoporosis
Lin Liu, Pan Luo, Pengfei Wen, Peng Xu
Frontiers in Endocrinology.2024;[Epub] CrossRef
Current Perspectives of Protein in Bone Tissue Engineering: Bone Structure, Ideal Scaffolds, Fabrication Techniques, Applications, Scopes, and Future Advances
Muhammad Umar Aslam Khan, Muhammad Azhar Aslam, Mohd Faizal Bin Abdullah, Goran M. Stojanović
ACS Applied Bio Materials.2024; 7(8): 5082. CrossRef
Effect of recombinant human bone morphogenetic protein-2 and osteoprotegerin-Fc in MC3T3-E1 cells: beyond challenges to success
Chang Hoon Lee
Journal of Rheumatic Diseases.2024; 31(3): 133. CrossRef
Promotion of Bone Formation in a Rat Osteoporotic Vertebral Body Defect Model via Suppression of Osteoclastogenesis by Ectopic Embryonic Calvaria Derived Mesenchymal Stem Cells
Yerin Yu, Somin Lee, Minsung Bock, Seong Bae An, Hae Eun Shin, Jong Seop Rim, Jun-oh Kwon, Kwang-Sook Park, Inbo Han
International Journal of Molecular Sciences.2024; 25(15): 8174. CrossRef
Identification of novel RANKL inhibitors through in silico analysis
Yingying Jiang, Xiaogang Luo, Zhanpeng Zheng, Shun Wen, Hongwei Gao, Cheng Xu, Min Jiang, Siyuan Wang
Bioorganic Chemistry.2024; 153: 107826. CrossRef
Genetic Deficiency of the Long Pentraxin 3 Affects Osteogenesis and Osteoclastogenesis in Homeostatic and Inflammatory Conditions
Valentina Granata, Dario Strina, Maria Lucia Schiavone, Barbara Bottazzi, Alberto Mantovani, Antonio Inforzato, Cristina Sobacchi
International Journal of Molecular Sciences.2023; 24(23): 16648. CrossRef

Original Article

Mineral, Bone & Muscle
Age-Dependent Association of Height Loss with Incident Fracture Risk in Postmenopausal Korean Women: Chaewon Lee, Hye-Sun Park, Yumie Rhee, Namki Hong; Endocrinol Metab. 2023;38(6):669-678. Published online September 1, 2023; DOI: https://doi.org/10.3803/EnM.2023.1734

8,629 View
125 Download
2 Web of Science
3 Crossref

Abstract PDF Supplementary Material PubReader ePub

Background
Height loss is a simple clinical measure associated with increased fracture risk. However, limited data exists on the association between height loss and fracture risk in postmenopausal Korean women. It is unknown whether this association varies with age.
Methods
Data on height loss over a 6-year period were collected from a community-based longitudinal follow-up cohort (Ansung cohort of the Korean Genome and Epidemiology Study). Incident fractures were defined based on self-reported fractures after excluding those due to severe trauma or toes/fingers. The association between incident fractures and height loss was investigated using a Cox proportional hazards model.
Results
During a median follow-up of 10 years after the second visit, 259/1,806 participants (median age, 64 years) experienced incident fractures. Overall, a 1 standard deviation (SD) decrease in height (1.6 cm/median 5.8 years) was associated with 9% increased risk of fracture (hazard ratio [HR], 1.09; P=0.037), which lost statistical significance after adjustment for covariates. When stratified into age groups (50–59, 60–69, 70 years or older), a 1 SD decrease in height remained a robust predictor of fracture in the 50 to 59 years age group after adjusting for covariates (adjusted hazard ratio [aHR], 1.52; P=0.003), whereas height loss was not an independent predictor of fracture in the 60 to 69 (aHR, 1.06; P=0.333) or the 70 years or older age groups (aHR, 1.05; P=0.700; P for interaction <0.05, for all).
Conclusion
Height loss during the previous 6 years was associated with an increased 10-year fracture risk in postmenopausal women in their 50s.

Citations

Citations to this article as recorded by

Evolving trends of hand injuries in Korea (2010-2023): a comprehensive analysis and implications for hand surgeons
Daihun Kang
Archives of Hand and Microsurgery.2025; 30(1): 15. CrossRef
Spine age estimation using deep learning in lateral spine radiographs and DXA VFA to predict incident fracture and mortality
Sang Wouk Cho, Namki Hong, Kyoung Min Kim, Young Han Lee, Chang Oh Kim, Hyeon Chang Kim, Yumie Rhee, Brian H. Chen, William D. Leslie, Steven R. Cummings
npj Aging.2025;[Epub] CrossRef
A Bone Health Optimization Framework for Malaysia: a position paper by the Malaysian Bone Health Optimization Network (MyBONe)
Joon-Kiong Lee, Juzaily Fekry Leong, Fu-Yuen Thong, Mohd Ariff Sharifudin, Azlina Amir Abbas, Nur Azree Ferdaus Kamudin, Sanjiv Rampal, Nor Faissal Yasin, Kwong-Weng Loh, Chee-Ken Chan, Paul James Mitchell
Archives of Osteoporosis.2024;[Epub] CrossRef

Review Articles

Thyroid
Evaluation and Management of Bone Health in Patients with Thyroid Diseases: A Position Statement of the Korean Thyroid Association: A Ram Hong, Ho-Cheol Kang; Endocrinol Metab. 2023;38(2):175-189. Published online April 27, 2023; DOI: https://doi.org/10.3803/EnM.2023.1701

27,926 View
510 Download
16 Web of Science
17 Crossref

Abstract PDF PubReader ePub

Thyroid hormones play an important physiological role in maintaining adult bone structure and strength. Consequently, thyroid dysfunction is related to skeletal outcomes. Overt hyperthyroidism is an established cause of high bone turnover with accelerated bone loss, leading to osteoporosis and increased fracture risk. Hyperthyroidism induced by thyroid-stimulating hormone-suppressive therapy in patients with differentiated thyroid cancer is a cause of secondary osteoporosis. In contrast, there is a lack of evidence on the negative impact of hypothyroidism on bone health. Considering the clinical updates on the importance of bone health in thyroid dysfunction, the Task Force from the Clinical Practice Guidelines Development Committee of the Korean Thyroid Association recently developed a position statement on the evaluation and management of bone health of patients with thyroid diseases, particularly focused on endogenous hyperthyroidism and thyroid-stimulating hormone-suppressive therapy-associated hyperthyroidism in patients with differentiated thyroid cancer. Herein, we review the Korean Thyroid Association’s position statement on the evaluation and management of bone health associated with thyroid diseases.

Citations

Citations to this article as recorded by

Progress in multiaxial coupling mechanisms of osteoporosis: insights from systems medicine on immune-inflammatory interactions, hormonal regulation, and metabolic imbalance
Manli Yan, Miyang Yang, Yaoqian Cai, Baoqing Zhang, Dingkun Lin, Xiang Li
Frontiers in Endocrinology.2026;[Epub] CrossRef
Secondary osteoporosis in a young woman: the hidden impact of functional hypothalamic amenorrhea
Hyunji Reem, Hyebin Kim, Seung Min Chung
Journal of Yeungnam Medical Science.2026; 43: 23. CrossRef
Thyroid and osteoporosis: Pathophysiology, clinical consequences, and management
Amritava Ghosh, K Nikhil Sanjeev
Thyroid Research and Practice.2026; 22(1): 29. CrossRef
Korean Thyroid Association Guidelines on the Management of Differentiated Thyroid Cancers; Part II. Follow-up Surveillance after Initial Treatment 2026
Eun Kyung Lee, Seung Heon Kang, Bon Seok Koo, Mijin Kim, Min Joo Kim, Bo Hyun Kim, Ji Won Kim, Dong Gyu Na, Sohyun Park, Ji-In Bang, Kyorim Back, Youngduk Seo, Young-Ik Son, Young Shin Song, Dong Yeob Shin, Jong-Hyuk Ahn, Hwa Young Ahn, So Won Oh, Ho-Ryun
International Journal of Thyroidology.2026; 19(1): 1. CrossRef
Interorgan Communications in Skeletal Pathophysiology: From Molecular Pathways to Multidisciplinary Therapies
Donghao Gan, Lei Qin, Guozhi Xiao
Research.2026;[Epub] CrossRef
Korean Thyroid Association Guidelines on the Management of Differentiated Thyroid Cancers, Part II: Follow-up Surveillance after Initial Treatment 2026
Eun Kyung Lee, Seung Heon Kang, Bon Seok Koo, Mijin Kim, Min Joo Kim, Bo Hyun Kim, Ji Won Kim, Dong Gyu Na, Sohyun Park, Ji-In Bang, Kyorim Back, Youngduk Seo, Young-Ik Son, Young Shin Song, Dong Yeob Shin, Jong-hyuk Ahn, Hwa Young Ahn, So Won Oh, Ho-Ryun
Endocrinology and Metabolism.2026; 41(4): 493. CrossRef
Increased risk of malignancy and osteoporosis in primary Sjögren’s syndrome with thyroid diseases: potential implication from T cells
Xiaomeng Cui, Jun Li, Yizhen Sang, Wei Liu, Yikang Lu, Wei Li, Li Ma, Xinying Liu
Rheumatology.2025; 64(5): 2828. CrossRef
Risk of Osteoporotic Fractures among Patients with Thyroid Cancer: A Nationwide Population-Based Cohort Study
Eu Jeong Ku, Won Sang Yoo, Yu Been Hwang, Subin Jang, Jooyoung Lee, Shinje Moon, Eun Kyung Lee, Hwa Young Ahn
Endocrinology and Metabolism.2025; 40(2): 225. CrossRef
Association between thyroid function and osteopenia or osteoporosis: a cross-sectional study in China
Ling Zhang, Chao Ma, Xin Yin, Fenglian Zhang, Xiuyan Fang, Chen Zhang, Lei Shang, Li Ma
Scientific Reports.2025;[Epub] CrossRef
Diabetes mellitus secondary to endocrine diseases: a position statement of the working group of the club of the Italian society of endocrinology (SIE)-Nutrition hormones and metabolism
Luigi Barrea, Massimiliano Caprio, Sebastio Perrini, Elisabetta Camajani, Andrea Crafa, Elena Gangitano, Stefania Gorini, Laura Sciacca, Ludovica Verde, Manuela Albertelli, Diego Ferone, Francesco Giorgino, Annamaria Colao, Gianluca Aimaretti, Giovanna Mu
Journal of Endocrinological Investigation.2025; 48(8): 1739. CrossRef
Osteoporotic fracture risk in hypoparathyroidism following total thyroidectomy: a retrospective nationwide cohort study
Eu Jeong Ku, Won Sang Yoo, Yu Been Hwang, Subin Jang, Jooyoung Lee, Shinje Moon, Eun Kyung Lee, Hwa Young Ahn
European Journal of Endocrinology.2025; 193(1): 39. CrossRef
A bibliometric analysis of the current state and future directions of osteoporosis pharmacological treatment
Xianxian Zhou, Hua Xiong, Dexi Hu
Frontiers in Medicine.2025;[Epub] CrossRef
Diagnosis and therapeutic approach to bone health in patients with hypopituitarism
Justyna Kuliczkowska-Płaksej, Aleksandra Zdrojowy-Wełna, Aleksandra Jawiarczyk-Przybyłowska, Łukasz Gojny, Marek Bolanowski
Reviews in Endocrine and Metabolic Disorders.2024; 25(3): 513. CrossRef
Osteoporosis, Osteoarthritis, and Subchondral Insufficiency Fracture: Recent Insights
Shunichi Yokota, Hotaka Ishizu, Takuji Miyazaki, Daisuke Takahashi, Norimasa Iwasaki, Tomohiro Shimizu
Biomedicines.2024; 12(4): 843. CrossRef
Acute hypercalcemic crisis: A narrative review with a focus on pregnancy
Nadia Sabbah
Annales d'Endocrinologie.2024; 85(6): 604. CrossRef
Review on the protective activity of osthole against the pathogenesis of osteoporosis
Jincai Chen, Xiaofei Liao, Juwen Gan
Frontiers in Pharmacology.2023;[Epub] CrossRef
Estudio comparativo tras la cirugía tiroidea y otras variables asociadas al desarrollo de osteoporosis en una cohorte latinoamericana
María Paula Ciliberti Artavia, Juan Sebastián Theran León, Jaime Alberto Gómez Ayala, Valentina Cabrera Peña, Rafael Guillermo Parales Strauch, Edgar Camilo Blanco Pimiento, Luis Andres Dulcey Sarmiento, Juan Camilo Martínez, Juan Camilo Mayorca, María Al
Revista Salud y Desarrollo.2023; 7(2): e605. CrossRef

Mineral, Bone & Muscle
New Insights into Calorie Restriction Induced Bone Loss: Linyi Liu, Clifford J. Rosen; Endocrinol Metab. 2023;38(2):203-213. Published online April 27, 2023; DOI: https://doi.org/10.3803/EnM.2023.1673

25,684 View
332 Download
23 Web of Science
25 Crossref

Abstract PDF PubReader ePub

Caloric restriction (CR) is now a popular lifestyle choice due to its ability in experimental animals to improve lifespan, reduce body weight, and lessen oxidative stress. However, more and more emerging evidence suggests this treatment requires careful consideration because of its detrimental effects on the skeletal system. Experimental and clinical studies show that CR can suppress bone growth and raise the risk of fracture, but the specific mechanisms are poorly understood. Reduced mechanical loading has long been thought to be the primary cause of weight loss-induced bone loss from calorie restriction. Despite fat loss in peripheral depots with calorie restriction, bone marrow adipose tissue (BMAT) increases, and this may play a significant role in this pathological process. Here, we update recent advances in our understanding of the effects of CR on the skeleton, the possible pathogenic role of BMAT in CR-induced bone loss, and some strategies to mitigate any potential side effects on the skeletal system.

Citations

Citations to this article as recorded by

20% Caloric Restriction did not Impact Bone Health nor Exercise-Induced Elevations in Bone Mass in Young Female Rats
Ken D. Sumida, Brady Slater, Haley Folta, Kassandra Lee, Sarina Karwande, Quinton Wong, S. Victoria Jaque, Frank Frisch
Calcified Tissue International.2026;[Epub] CrossRef
Skeletal effect of semaglutide and tirzepatide in patients with increased risk of fractures
Yi Liu, Dalia Walzer, Sarah Schmitz, Alpana P Shukla, Xiaoyue Ma, Dawn Chirko, Ilissa Pipia, Swetha Sathi, Uthman Shukairy, Michael Greenberg, Sangeeta R Kashyap, Emily M Stein
The Journal of Clinical Endocrinology & Metabolism.2026; 111(7): 1959. CrossRef
D, L-Buthionine-(S, R)-sulfoximine recapitulates the anti-obesity effects of sulfur amino acid restriction without the associated deleterious effects on bone in male mice
Naidu B. Ommi, Dwight A. L. Mattocks, Mark C. Horowitz, Sailendra N. Nichenametla
Aging.2026; 18(1): 82. CrossRef
Fueling failure or fostering fusion? A critical review of the potential effect of ketogenic, intermittent fasting, and low-carbohydrate diets on dental implant osseointegration
Faris A. Alshahrani, Noha Taymour
The Saudi Dental Journal.2026;[Epub] CrossRef
Diet-mediated bioenergetic flux: a double-edged sword for health and diseases
Mohammad Nasb, Anbang Luo, Lamis Dayoub, Minghui Wang, Ning Chen
Food Science and Human Wellness.2026; 15(4): 9250724. CrossRef
Bone as an endocrine regulator of lipid and energy metabolism
Hanghang Liu, Junyu Zhao, Linyi Liu, Wangyang Ying, Shibo Liu, En Luo, Clifford J. Rosen
Reviews in Endocrine and Metabolic Disorders.2026;[Epub] CrossRef
Adolescent dietary restriction improves cognition and frailty in aged female Wistar rats
Valentina Simeunovic, Aleksandra Mladenovic, Milica Prvulovic, Milena Jovic, Smilja Pracer, Srdjan Sokanovic, Susan Howlett
The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences.2026;[Epub] CrossRef
Weight Loss‐Dependent Changes in Body Composition and Bone Health in People With Obesity and Type 1 Diabetes Treated With Liraglutide, Semaglutide, or Tirzepatide
Ebaa Al Ozairi, Mohammad Irshad, Jumana Alkandri, Anant Mashankar, Stuart R. Gray, Carel W. le Roux
Diabetes/Metabolism Research and Reviews.2026;[Epub] CrossRef
Strategies for minimizing muscle loss during use of incretin‐mimetic drugs for treatment of obesity
Jeffrey I. Mechanick, W. Scott Butsch, Sandra M. Christensen, Osama Hamdy, Zhaoping Li, Carla M. Prado, Steven B. Heymsfield
Obesity Reviews.2025;[Epub] CrossRef
Calorie restriction induces mandible bone loss by regulating mitochondrial function
Linyi Liu, Phuong T. Le, Victoria E. DeMambro, Tiange Feng, Hanghang Liu, Wangyang Ying, Roland Baron, Clifford J. Rosen
Bone.2025; 190: 117326. CrossRef
Medium-Chain Fatty Acids Extracted from Black Soldier Fly (Hermetia illucens) Larvae Prevents High-Fat Diet-Induced Obesity In Vivo in C57BL/6J Mice
Kyu-Shik Lee, Min-Gu Lee, Kyuho Jeong, Eun-Young Yun, Tae-Won Goo
Animals.2025; 15(10): 1384. CrossRef
Novel strategies for medical management of obesity: mechanisms, clinical implications, and societal impacts—a report from the 25th Annual Harvard Nutrition Obesity Symposium
Gitanjali Srivastava, Sophia L Campbell, Conner R Hill, Takara L Stanley, Elizabeth A Lawson, Caroline M Apovian, Jaime P Almandoz, Lorenzo Leggio, Darius N Lakdawalla, Mohammad Dar, Carmela Socolovsky, Fatima Cody Stanford, Sarah Armstrong, Steven K Grin
The American Journal of Clinical Nutrition.2025; 122(3): 866. CrossRef
Calorie Restriction and Bone Health: Lessons from Bariatric Metabolic Surgery
Bukyung Kim
Endocrinology and Metabolism.2025; 40(3): 388. CrossRef
Addressing osteoblast senescence: Molecular pathways and the frontier of anti‐ageing treatments
Zhengdong Zhang, Pan Liu, Yu Song, Liang Ma, Yan Xu, Jie Lei, Bide Tong, Dingchao Zhu, Huaizhen Liang, Hongchuan Wang, Xingyu Zhou, Zixuan Ou, Junyu Wei, Hanpeng Xu, Di Wu, Shuchang Peng, Yifan Du, Zhi Du, Bingjin Wang, Zhiwei Liao, Wencan Ke, Kangcheng Z
Clinical and Translational Medicine.2025;[Epub] CrossRef
Association of Energy, Macronutrients, and Fiber Intakes with Bone Health in Adolescent Athletes
Clair Costa Miranda, André de Araújo Pinto, Tiago Rodrigues de Lima, Mateus Augusto Bim, Romulo Araujo Fernandes, Andreia Pelegrini
Calcified Tissue International.2025;[Epub] CrossRef
Recovery from immobilisation-associated osteoporosis with anti-resorptive and anabolic therapy
Maryell Urroz Lopez, Gregory Kline
BMJ Case Reports.2025; 18(9): e267469. CrossRef
Effects of weight-loss interventions on bone health in people living with obesity
Julien Paccou, Claudia Gagnon, Elaine W Yu, Clifford J Rosen
Journal of Bone and Mineral Research.2025; 40(12): 1319. CrossRef
Weight loss induced bone loss: mechanism of action and clinical implications
Hanghang Liu, Bolun Li, Linyi Liu, Wangyang Ying, Clifford J. Rosen
Bone Research.2025;[Epub] CrossRef
Impact of Dietary Patterns on Skeletal Health: A Systematic Review and Meta-Analysis of Bone Mineral Density, Fracture, Bone Turnover Markers, and Nutritional Status
Adhithya Mullath Ullas, Joseph Boamah, Amir Hussain, Ioanna Myrtziou, Ioannis Kanakis
Nutrients.2025; 17(24): 3845. CrossRef
Obesity, diabetes and risk of bone fragility: How BMAT behavior is affected by metabolic disturbances and its influence on bone health
Gregório Corrêa Guimarães, João Bosco Costa Coelho, João Gabriel Oliveira Silva, Ana Carolina Chalfun de Sant’Ana, Cássia Alves Carrilho de Sá, Júlia Marques Moreno, Lívia Marçal Reis, Camila Souza de Oliveira Guimarães
Osteoporosis International.2024; 35(4): 575. CrossRef
Bone Marrow Adipose Tissue Is Not Required for Reconstitution of the Immune System Following Irradiation in Male Mice
Jessica A. Keune, Carmen P. Wong, Adam J. Branscum, Scott A. Menn, Urszula T. Iwaniec, Russell T. Turner
International Journal of Molecular Sciences.2024; 25(4): 1980. CrossRef
Dietary restriction plus exercise change gene expression of Cxcl12 abundant reticular cells in female mice
Aoi Ikedo, Yuuki Imai
Journal of Bone and Mineral Metabolism.2024; 42(3): 271. CrossRef
Once-weekly semaglutide versus placebo in adults with increased fracture risk: a randomised, double-blinded, two-centre, phase 2 trial
Morten S. Hansen, Eva M. Wölfel, Shakespeare Jeromdesella, Jens-Jakob K. Møller, Charlotte Ejersted, Niklas R. Jørgensen, Richard Eastell, Stinus G. Hansen, Morten Frost
eClinicalMedicine.2024; 72: 102624. CrossRef
Calorie restriction in mice impairs cortical but not trabecular peak bone mass by suppressing bone remodeling
Linyi Liu, Phuong T Le, J Patrizia Stohn, Hanghang Liu, Wangyang Ying, Roland Baron, Clifford J Rosen
Journal of Bone and Mineral Research.2024;[Epub] CrossRef
Connecting bone metastasis, adipose tissue and adipokines: How does physical activity fit?
Paola Maroni, Marta Gomarasca, Michela Signo, Giovanni Lombardi
Advanced Exercise and Health Science.2024; 1(3): 149. CrossRef

Original Article

Mineral, Bone & Muscle
Persistence with Denosumab in Male Osteoporosis Patients: A Real-World, Non-Interventional Multicenter Study: Chaiho Jeong, Jeongmin Lee, Jinyoung Kim, Jeonghoon Ha, Kwanhoon Jo, Yejee Lim, Mee Kyoung Kim, Hyuk-Sang Kwon, Tae-Seo Sohn, Ki-Ho Song, Moo Il Kang, Ki-Hyun Baek; Endocrinol Metab. 2023;38(2):260-268. Published online April 27, 2023; DOI: https://doi.org/10.3803/EnM.2023.1663

8,846 View
165 Download
3 Web of Science
3 Crossref

Abstract PDF Supplementary Material PubReader ePub

Background
Persistence with denosumab in male patients has not been adequately investigated, although poor denosumab persistence is associated with a significant risk of rebound vertebral fractures.
Methods
We retrospectively evaluated 294 Korean male osteoporosis patients treated with denosumab at three medical centers and examined their persistence with four doses of denosumab injection over 24 months of treatment. Persistence was defined as the extent to which a patient adhered to denosumab treatment in terms of the prescribed interval and dose, with a permissible gap of 8 weeks. For patients who missed their scheduled treatment appointment(s) during the follow-up period (i.e., no-shows), Cox proportional regression analysis was conducted to explore the factors associated with poor adherence. Several factors were considered, such as age, prior anti-osteoporotic drug use, the treatment provider’s medical specialty, the proximity to the medical center, and financial burdens of treatment.
Results
Out of 294 male patients, 77 (26.2%) completed all four sequential rounds of the denosumab treatment. Out of 217 patients who did not complete the denosumab treatment, 138 (63.6%) missed the scheduled treatment(s). Missing treatment was significantly associated with age (odds ratio [OR], 1.03), prior bisphosphonate use (OR, 0.76), and prescription by non-endocrinologists (OR, 2.24). Denosumab was stopped in 44 (20.3%) patients due to medical errors, in 24 (11.1%) patients due to a T-score improvement over –2.5, and in five (2.3%) patients due to expected dental procedures.
Conclusion
Our study showed that only one-fourth of Korean male osteoporosis patients were fully adherent to 24 months of denosumab treatment.

Citations

Citations to this article as recorded by

Follow-on osteoporosis therapy after denosumab discontinuation among Medicare beneficiaries
Selvam R. Sendhil, Suzanne M. Cadarette, Sulbh Aggarwal, Arman Oganisian, Andrew R. Zullo, Sarah D. Berry, Michael A. Adegboye, Kaleen N. Hayes
Osteoporosis International.2026; 37(1): 81. CrossRef
Denosumab safety in men with osteoporosis: a disproportionality analysis of the FAERS database
Hou-hong Li, Li Wan, Si-jie He, Wen-long Xie
Naunyn-Schmiedeberg's Archives of Pharmacology.2026; 399(11): 16915. CrossRef
Denosumab

Reactions Weekly.2023; 1963(1): 206. CrossRef

Review Articles

Mineral, Bone & Muscle
Updates on Paget’s Disease of Bone: Yong Jun Choi, Young Bae Sohn, Yoon-Sok Chung; Endocrinol Metab. 2022;37(5):732-743. Published online October 25, 2022; DOI: https://doi.org/10.3803/EnM.2022.1575

17,985 View
568 Download
17 Web of Science
22 Crossref

Abstract PDF PubReader ePub

Paget’s disease of the bone is a prevalent bone disease characterized by disorganized bone remodeling; however, it is comparatively uncommon in East Asian countries, including China, Japan, and Korea. The exact cause still remains unknown. In genetically susceptible individuals, environmental triggers such as paramyxoviral infections are likely to cause the disease. Increased osteoclast activity results in increased bone resorption, which attracts osteoblasts and generates new bone matrix. Fast bone resorption and formation lead to the development of disorganized bone tissue. Increasing serum alkaline phosphatase or unique radiographic lesions may serve as the diagnostic indicators. Common symptoms include bone pain, bowing of the long bones, an enlarged skull, and hearing loss. The diagnosis is frequently confirmed by radiographic and nuclear scintigraphy of the bone. Further, bisphosphonates such as zoledronic acid and pamidronate are effective for its treatment. Moreover, biochemical monitoring is superior to the symptoms as a recurrence indicator. This article discusses the updates of Paget’s disease of bone with a clinical case.

Citations

Citations to this article as recorded by

Paget’s disease of bone in a North African population: clinical, imaging, and therapeutic insights from a Moroccan case series
Wassima Ridah, Kawtar Nassar, Ahlam Ajerouassi, Soukaina Zaher, Wafae Rachidi, Saadia Janani
Clinical Rheumatology.2026; 45(3): 1899. CrossRef
A 5-year Chinese longitudinal case report on the malignant transformation of spinal Paget disease
Yu Wang, Linlin Zhang, Huilin Yang, Qin Zhang
Medicine.2026; 105(5): e47190. CrossRef
Paget-like bone remodeling disorder in a red-tailed boa (Boa constrictor constrictor): diagnosis and management
Soong-Hee Youn, Na-Young Lee, Ki-Yong Shin, Hyeon-Joo Shin, Joon-Young Yang, Dae-Yong Kim
Journal of Veterinary Science.2026;[Epub] CrossRef
Benign fibro-osseous lesions are a rare pathology of the jaws and skull bones
I.N. Kostina, A.Yu. Drobyshev
Russian Journal of Stomatology.2026; 19(1): 85. CrossRef
Spectrum оf Pagеt's disеasеs
M. E. Balashova, G. V. Gubanova, A. I. Ryaboshapko, A. R. Bedaeva, A. M. Kurbanalieva, N. A. Kondakova
Perm Medical Journal.2026; 43(2): 34. CrossRef
Paget’s Disease Unveiled in a Primary Care Setting: A Case of High Alkaline Phosphatase
Nikhil A Nandkumar, Aruna Chakrala
Cureus.2026;[Epub] CrossRef
Genetic Bone Diseases: A Scoping Review of Pathology, Symptoms, Diagnosis, Treatment, and New Horizons
Colin Jones, Ambalangodage C. Jayasuriya
Advanced Genetics.2026;[Epub] CrossRef
Paget’s disease of bone: pathogenesis, ocular manifestations, and therapeutic strategies
Bei Li, Yifan Kang
Orphanet Journal of Rare Diseases.2026;[Epub] CrossRef
Synergistic application of concentrated growth factor and bone perforation technique in bisphosphonate-related-osteonecrosis of the jaw
Jun Sun, Huimin Chen, Jiayi Yan, Shurong Li, Yushan Ding, Jian Zhang
BMC Oral Health.2026;[Epub] CrossRef
Educational Case: Paget disease of bone
James Lee, Jonathan J. Light, Prajeeth K. Koyada, Davsheen Bedi, Matthew R. DiCaprio
Academic Pathology.2026; 13(4): 100289. CrossRef
Polyostotic Paget’s Disease of Bone Involving the Pelvis and Lumbar Spine in A 78-Year-Old Female: A Case Report
Ashutosh Yadav, Pushpa ., Sachin Kumar
International Journal of Science and Healthcare Research.2026; : 300. CrossRef
Signaling Dynamics in Osteogenesis: Unraveling Therapeutic Targets for Bone Generation
Xue D. Yang, Christopher L. Haga, Donald G. Phinney
Current Drug Targets.2025; 26(5): 350. CrossRef
The role of γδ T cells in flavivirus infections: Insights into immune defense and therapeutic opportunities
Qi Li, Meng Zhang, Bridget Kim, Samuel Soriano, Hridesh Mishra, Qiuyue Wang, Kevin C. Kain, Ran Wang, Daniela Weiskopf
PLOS Neglected Tropical Diseases.2025; 19(4): e0012972. CrossRef
Phalange osteolysis present as the initial manifestation of sarcoidosis in a young female
Yibin Zhang, Yinghua Wang, Ling Wang, Qingguo Wu, Weizhong Jin
Sage Open Medical Case Reports.2025;[Epub] CrossRef
Paget’s Disease of Bone and Normocalcemic Variant of Primary Hyperparathyroidism in an Osteoporotic Male: Exceptional Coexistence
Ana-Maria Gheorghe, Oana Petronela Ionescu, Mihai Costachescu, Oana-Claudia Sima, Mara Carsote
Reports.2025; 8(3): 180. CrossRef
Paget’s disease of bone as a rare cause of headache
A. I. Vasiliev, A. A. Tappakhov, T. E. Popova
Yakut Medical Journal.2025; (4): 141. CrossRef
Effects of Erythropoietin-Promoted Fracture Healing on Bone Turnover Markers in Cats
Radina Vasileva, Tsvetan Chaprazov, Aneliya Milanova
Journal of Functional Biomaterials.2024; 15(4): 106. CrossRef
Osteogenesis imperfecta type 10 and the cellular scaffolds underlying common immunological diseases
Alan Herbert
Genes & Immunity.2024; 25(4): 265. CrossRef
The Inner Ear: A Primer for Radiologists, Part 1: Anatomy, Physiology, and Intrinsic Abnormalities of the Otic Capsule
E. Zamora, C. Zamora
Neurographics.2024; 14(4): 267. CrossRef
Identifying Paget's Disease in the Elderly-an oft-missed Diagnosis
Arun Kumar, Ashish Verma, Upinder Kaur, Sankha Shubhra Chakrabarti
Balkan Medical Journal.2024;[Epub] CrossRef
Newly Diagnosed Monostotic Paget’s Disease of Bone during Living Kidney Donor Candidate Evaluation
Diana Jędrzejuk, Paweł Poznański, Paweł Szewczyk, Oktawia Mazanowska, Marek Bolanowski, Magdalena Krajewska, Dorota Kamińska
Biomedicines.2023; 11(2): 401. CrossRef
Paget's disease of bone in the patient presented with a bowed leg
Mehrzad Hajialiloo, Sepideh Tahsini Tekantapeh
Clinical Case Reports.2023;[Epub] CrossRef

Hypothalamus and Pituitary Gland
Independent Skeletal Actions of Pituitary Hormones: Se-Min Kim, Farhath Sultana, Funda Korkmaz, Daria Lizneva, Tony Yuen, Mone Zaidi; Endocrinol Metab. 2022;37(5):719-731. Published online September 28, 2022; DOI: https://doi.org/10.3803/EnM.2022.1573

11,971 View
287 Download
13 Web of Science
12 Crossref

Abstract PDF PubReader ePub

Over the past years, pituitary hormones and their receptors have been shown to have non-traditional actions that allow them to bypass the hypothalamus-pituitary-effector glands axis. Bone cells—osteoblasts and osteoclasts—express receptors for growth hormone, follicle stimulating hormone (FSH), thyroid stimulating hormone (TSH), adrenocorticotrophic hormone (ACTH), prolactin, oxytocin, and vasopressin. Independent skeletal actions of pituitary hormones on bone have been studied using genetically modified mice with haploinsufficiency and by activating or inactivating the receptors pharmacologically, without altering systemic effector hormone levels. On another front, the discovery of a TSH variant (TSH-βv) in immune cells in the bone marrow and skeletal action of FSHβ through tumor necrosis factor α provides new insights underscoring the integrated physiology of bone-immune-endocrine axis. Here we discuss the interaction of each pituitary hormone with bone and the potential it holds in understanding bone physiology and as a therapeutic target.

Citations

Citations to this article as recorded by

Deciphering inter-organ communication: The multi-organ-bone axis in osteoporosis and emerging therapeutic strategies
Ruiming Wen, Haixia Wang, Songtao Wang
Journal of Orthopaedic Translation.2026; 58: 101119. CrossRef
The influence of hormonal changes during pregnancy on bone metabolism - a mini review
Anna Brona, Barbara Stachowska, Marek Bolanowski, Jowita Halupczok-Żyła
Frontiers in Endocrinology.2026;[Epub] CrossRef
Plasma proteomic profiles reveal proteins and three characteristic patterns associated with osteoporosis: A prospective cohort study
Yi Zheng, Jincheng Li, Yucan Li, Jiacheng Wang, Chen Suo, Yanfeng Jiang, Li Jin, Kelin Xu, Xingdong Chen
Journal of Advanced Research.2025; 75: 491. CrossRef
Fracture risks in patients aged 50 years and older with panhypopituitarism: a nationwide cohort study
Seung Shin Park, Hyunmook Jeong, Chang Ho Ahn, Min Jeong Park, Sung Hye Kong, Sang Wan Kim, Chan Soo Shin, Yong Hwy Kim, Kwangsoo Kim, Jung Hee Kim
Osteoporosis International.2025; 36(10): 1951. CrossRef
Cushing’s disease and bone
Aleksandra Zdrojowy-Wełna, Barbara Stachowska, Marek Bolanowski
Pituitary.2024; 27(6): 837. CrossRef
Skeletal fragility in pituitary disease: how can we predict fracture risk?
Fabio Bioletto, Alessandro Maria Berton, Marco Barale, Luigi Simone Aversa, Lorenzo Sauro, Michela Presti, Francesca Mocellini, Noemi Sagone, Ezio Ghigo, Massimo Procopio, Silvia Grottoli
Pituitary.2024; 27(6): 789. CrossRef
Role of oxytocin in bone
Tianming Wang, Jianya Ye, Yongqiang Zhang, Jiayi Li, Tianxiao Yang, Yufeng Wang, Xiao Jiang, Qingqiang Yao
Frontiers in Endocrinology.2024;[Epub] CrossRef
Modern approach to bone comorbidity in prolactinoma
Meliha Melin Uygur, Sara Menotti, Simona Santoro, Andrea Giustina
Pituitary.2024; 27(6): 802. CrossRef
New tools for bone health assessment in secreting pituitary adenomas
Meliha Melin Uygur, Stefano Frara, Luigi di Filippo, Andrea Giustina
Trends in Endocrinology & Metabolism.2023; 34(4): 231. CrossRef
A Causality between Thyroid Function and Bone Mineral Density in Childhood: Abnormal Thyrotropin May Be Another Pediatric Predictor of Bone Fragility
Dongjin Lee, Moon Ahn
Metabolites.2023; 13(3): 372. CrossRef
The mechanism of oxytocin and its receptors in regulating cells in bone metabolism
Liu Feixiang, Feng Yanchen, Li Xiang, Zhang Yunke, Miao Jinxin, Wang Jianru, Lin Zixuan
Frontiers in Pharmacology.2023;[Epub] CrossRef
To investigate the mechanism of Yiwei Decoction in the treatment of premature ovarian insufficiency-related osteoporosis using transcriptomics, network pharmacology and molecular docking techniques
Weisen Fan, Yan Meng, Jing Zhang, Muzhen Li, Yingjie Zhang, Xintian Qu, Xin Xiu
Scientific Reports.2023;[Epub] CrossRef

Adrenal Gland
Long-Term Outcomes of Congenital Adrenal Hyperplasia: Anna Nordenström, Svetlana Lajic, Henrik Falhammar; Endocrinol Metab. 2022;37(4):587-598. Published online July 8, 2022; DOI: https://doi.org/10.3803/EnM.2022.1528

46,846 View
484 Download
34 Web of Science
38 Crossref

Abstract PDF PubReader ePub

A plethora of negative long-term outcomes have been associated with congenital adrenal hyperplasia (CAH). The causes are multiple and involve supra-physiological gluco- and mineralocorticoid replacement, excess adrenal androgens both intrauterine and postnatal, elevated steroid precursor and adrenocorticotropic hormone levels, living with a congenital condition as well as the proximity of the cytochrome P450 family 21 subfamily A member 2 (CYP21A2) gene to other genes. This review aims to discuss the different long-term outcomes of CAH.

Citations

Citations to this article as recorded by

The Use of Routine Laboratory 17‐Hydroxyprogesterone for Identification of Cases of 21‐Hydroxylase Deficiency Congenital Adrenal Hyperplasia
Joseph McElvaney, Salma R. Ali, Amy R. Frank, Sophie Longmuir, Jane McNeilly, Malika Alimussina, Ruth McGowan, Syed Faisal Ahmed
Clinical Endocrinology.2026; 104(2): 123. CrossRef
Clinical tools for evaluating congenital adrenal hyperplasia in resource-limited hospitals: a study at a tertiary hospital in Saudi Arabia
Daniah Alhazmi, Azzam Alabdulqader, Shahad Almeqbel, Raghad Alhuthil, Afaf Alsagheir
Frontiers in Endocrinology.2026;[Epub] CrossRef
Case Report: Compound heterozygous mutation comprising p.Pro31Leu and exons 1–3 ins/del variants in CYP21A2 causes non-classical congenital adrenal hyperplasia in a Chinese girl
Nan Li, Chao Lu, Harvest F. Gu, Xiaofei An
Frontiers in Pediatrics.2026;[Epub] CrossRef
Obesity in Classic Congenital Adrenal Hyperplasia: Mechanisms, Complications and Management
Jialin Mu, Yue Li, Meng Sun, Yulin Li, Panpan Li, Hui Zou
Clinical Endocrinology.2026; 105(3): 271. CrossRef
Advances in pharmacological treatment for congenital adrenal hyperplasia
Lara E. Graves, Henrik Falhammar
Current Opinion in Pediatrics.2026; 38(4): 434. CrossRef
Psychosocial retrospective follow-up of young adults with congenital adrenal hyperplasia
Kerstin Ekbom, Svetlana Lajic, Henrik Falhammar, Anna Nordenström
European Journal of Endocrinology.2026; 195(1): 124. CrossRef
Crinecerfont: emerging role in the management of congenital adrenal hyperplasia
Olga Fedorova, Henrik Falhammar
Expert Review of Endocrinology & Metabolism.2026; 21(5): 317. CrossRef
Congenital adrenal hyperplasia in children: a comprehensive review of clinical spectrum, diagnostic strategies, and management approaches
Dinesh Giri, Julie Alderson, Munibah Bashir, Mohamed Shalaby, Cara Williams, Julie Park
Journal of Pediatric Endocrinology and Metabolism.2026; 39(10): 961. CrossRef
Congenital adrenal hyperplasia, ovarian adrenal rest tumours and Addison’s disease: an exceptional clinical constellation
Yara Emara, Svenja Leibnitz, Anna Lauber-Biason, Richard J Auchus, Christoph T Berger, Nikolaos Ntoulias, Claudia Cavelti-Weder, Bettina Winzeler
BMJ Case Reports.2026; 19(8): e270310. CrossRef
Testicular adrenal rests tumours in congenital adrenal hyperplasia: unraveling prevalence, risk factors and new therapeutic horizons in adolescents
Irene Tizianel, Giulia Bovo, Pierluigi Mazzeo, Filippo Ceccato, Mattia Barbot
Frontiers in Adolescent Medicine.2026;[Epub] CrossRef
Prenatal androgens and female-advantaged cognition: A systematic review and Bayesian meta-analysis in congenital adrenal hyperplasia
Nicola Di Polito, Filippo Gambarota, Elizabeth Hampson, Agneta Herlitz
Neuroscience & Biobehavioral Reviews.2026; 191: 106877. CrossRef
Hospitalizations and outcomes in congenital adrenal hyperplasia across the lifespan: a population-based cohort study
Livia Hafner, Rahel Laager, Beat Mueller, Philipp Schuetz, Alexander Kutz
The Journal of Clinical Endocrinology & Metabolism.2026;[Epub] CrossRef
Cardiometabolic Aspects of Congenital Adrenal Hyperplasia
Robert Krysiak, Hedi L Claahsen-van der Grinten, Nicole Reisch, Philippe Touraine, Henrik Falhammar
Endocrine Reviews.2025; 46(1): 80. CrossRef
Glucocorticoid therapy in classic congenital adrenal hyperplasia: traditional and new treatment paradigms
Irina Bancos, Hyunwoo Kim, Henry K. Cheng, Mariam Rodriguez-Lee, Helen Coope, Samantha Cicero, Hannah Goldsmith, Vivian H. Lin, George S. Jeha
Expert Review of Endocrinology & Metabolism.2025; 20(1): 33. CrossRef
Challenges in Adolescent and Adult Males With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
Hedi L Claahsen-van der Grinten, Bas P H Adriaansen, Henrik Falhammar
The Journal of Clinical Endocrinology & Metabolism.2025; 110(Supplement): S25. CrossRef
Genetics in Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency and Clinical Implications
Paola Concolino, Henrik Falhammar
Journal of the Endocrine Society.2025;[Epub] CrossRef
Long-term outcomes of congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a retrospective study from a tertiary care center in Saudi Arabia
Haneen Aldalaan, Afaf Alsagheir, Nujud Alghamdi, Raghad Alhuthil, Maha Almslam, Mohamed H. Al-Hamed
Frontiers in Endocrinology.2025;[Epub] CrossRef
Causal associations between congenital adrenal hyperplasia and neuropsychiatric conditions- a Mendelian Randomization Study
Yang Liu, Xiaokun Gang, Yuan Gao, Guixia Wang
Endocrine.2025; 89(1): 291. CrossRef
The Chronobiology of Hormone Administration: “Doctor, What Time Should I Take My Medication?”
Elena Colonnello, Andrea Graziani, Rebecca Rossetti, Giacomo Voltan, Davide Masi, Carla Lubrano, Stefania Mariani, Mikiko Watanabe, Andrea Marcello Isidori, Alberto Ferlin, Lucio Gnessi
Endocrine Reviews.2025; 46(5): 670. CrossRef
What is the need for adrenalectomy in patients with congenital adrenal hyperplasia in the era of CRF1/ACTH inhibitors?
Olga Fedorova, Henrik Falhammar
Frontiers in Endocrinology.2025;[Epub] CrossRef
Hiperplasia suprarrenal congénita: crisis adrenal y genitales virilizados

Salud Jalisco.2025; 12(3): 180. CrossRef
Increased Prevalence of Accidents and Injuries in Congenital Adrenal Hyperplasia: A Population-based Cohort Study
Henrik Falhammar, Angelica Lindén Hirschberg, Agneta Nordenskjöld, Henrik Larsson, Anna Nordenström
The Journal of Clinical Endocrinology & Metabolism.2024; 109(3): e1175. CrossRef
International Newborn Screening Practices for the Early Detection of Congenital Adrenal Hyperplasia
Tracey A. Conlon, Colin P. Hawkes, Jennifer J. Brady, J. Gerard Loeber, Nuala Murphy
Hormone Research in Paediatrics.2024; 97(2): 113. CrossRef
Low renin forms of monogenic hypertension: review of the evidence
Ugochi Chinenye Okorafor, Uchechi Chioma Okorafor
Journal of Clinical Medicine of Kazakhstan.2024; 21(1): 14. CrossRef
Increased risk of nephrolithiasis: an emerging issue in children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Mariangela Chiarito, Crescenza Lattanzio, Vito D’Ascanio, Donatella Capalbo, Paolo Cavarzere, Anna Grandone, Francesca Aiello, Giorgia Pepe, Malgorzata Wasniewska, Thomas Zoller, Mariacarolina Salerno, Maria Felicia Faienza
Endocrine.2024; 84(2): 727. CrossRef
Memory in female adolescents with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Tania M. Espinosa Reyes, Dainy Cordero Martín, Miguel Ángel Álvarez, Henrik Falhammar
Endocrine.2024; 85(3): 1379. CrossRef
Fasting GLP-1 Levels in Women with PCOS and CAH
R. Robeva, G. Kirilov, A. Elenkova, S. Zacharieva
Acta Medica Bulgarica.2024; 51(4): 8. CrossRef
Exploring the Differential Diagnosis of Adrenal Adenoma in the Context of Situs Ambiguous: A Clinical Case Study
Pavel E. Stanchev, Mariya Dimitrova, Desislava Makakova, Boris Tilov
Medicina.2024; 60(12): 2010. CrossRef
Congenital adrenal hyperplasia: New biomarkers and adult treatments
Bleuenn Dreves, Yves Reznik, Antoine Tabarin
Annales d'Endocrinologie.2023; 84(4): 472. CrossRef
Interpretation of Steroid Biomarkers in 21-Hydroxylase Deficiency and Their Use in Disease Management
Kyriakie Sarafoglou, Deborah P Merke, Nicole Reisch, Hedi Claahsen-van der Grinten, Henrik Falhammar, Richard J Auchus
The Journal of Clinical Endocrinology & Metabolism.2023; 108(9): 2154. CrossRef
Impact of Newborn Screening on Adult Height in Patients With Congenital Adrenal Hyperplasia (CAH)
Heike Hoyer-Kuhn, Alexander J Eckert, Gerhard Binder, Walter Bonfig, Angelika Dübbers, Stefan Riedl, Joachim Woelfle, Helmuth G Dörr, Reinhard W Holl
The Journal of Clinical Endocrinology & Metabolism.2023; 108(11): e1199. CrossRef
Specialty grand challenge in adrenal endocrinology
Henrik Falhammar
Frontiers in Endocrinology.2023;[Epub] CrossRef
Contexts of care for people with differences of sex development
Alexandra E. Kulle, Martina Jürgensen, Ulla Döhnert, Lisa Malich, Louise Marshall, Olaf Hiort
Medizinische Genetik.2023; 35(3): 181. CrossRef
Cardiovascular risk in Cuban adolescents and young adults with congenital adrenal hyperplasia
Tania M. Espinosa Reyes, Alba Katherine Pesántez Velepucha, Julio Oscar Cabrera Rego, Wendy Valdés Gómez, Emma Domínguez Alonso, Henrik Falhammar
BMC Endocrine Disorders.2023;[Epub] CrossRef
Landscape of Adrenal Tumours in Patients with Congenital Adrenal Hyperplasia
Mara Carsote, Ana-Maria Gheorghe, Claudiu Nistor, Alexandra-Ioana Trandafir, Oana-Claudia Sima, Anca-Pati Cucu, Adrian Ciuche, Eugenia Petrova, Adina Ghemigian
Biomedicines.2023; 11(11): 3081. CrossRef
Editorial: Recent advances in diagnosis and treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Semra Çaglar Çetinkaya
Frontiers in Endocrinology.2023;[Epub] CrossRef
Approach of Heterogeneous Spectrum Involving 3beta-Hydroxysteroid Dehydrogenase 2 Deficiency
Andreea Gabriela Nicola, Mara Carsote, Ana-Maria Gheorghe, Eugenia Petrova, Alexandru Dan Popescu, Adela Nicoleta Staicu, Mihaela Jana Țuculină, Cristian Petcu, Ionela Teodora Dascălu, Tiberiu Tircă
Diagnostics.2022; 12(9): 2168. CrossRef
Effetti di Crinecerfont sulla secrezione di ACTH nell’iperplasia surrenalica congenita: uno studio di fase 2
Marianna Rita Stancampiano, Silvia Laura Carla Meroni, Giovanna Weber, Gianni Russo
L'Endocrinologo.2022; 23(6): 662. CrossRef

Original Articles

Mineral, Bone & Muscle
Bone Mineral Density Screening Interval and Transition to Osteoporosis in Asian Women: Hyunju Park, Heera Yang, Jung Heo, Hye Won Jang, Jae Hoon Chung, Tae Hyuk Kim, Yong-Ki Min, Sun Wook Kim; Endocrinol Metab. 2022;37(3):506-512. Published online June 9, 2022; DOI: https://doi.org/10.3803/EnM.2022.1429

15,423 View
147 Download
9 Web of Science
12 Crossref

Abstract PDF PubReader ePub

Background
Bone mineral density (BMD) testing is indicated for women aged 65 years, but screening strategies for osteoporosis are controversial. Currently, there is no study focusing on the BMD testing interval in Asian populations. The current study aimed to evaluate the estimated time interval for screening osteoporosis.
Methods
We conducted a study of 6,385 subjects aged 50 years and older who underwent dual-energy X-ray absorptiometry screening more than twice at Samsung Medical Center as participants in a routine health checkup. Subjects were divided based on baseline T-score into mild osteopenia (T-score, <–1.0 to >–1.5), moderate osteopenia (T-score, ≤–1.5 to >–2.0), and severe osteopenia (T-score, ≤–2.0 to >–2.5). Information about personal medical and social history was collected by a structured questionnaire.
Results
The adjusted estimated BMD testing interval for 10% of the subjects to develop osteoporosis was 13.2 years in mild osteopenia, 5.0 years in moderate osteopenia, and 1.5 years in severe osteopenia.
Conclusion
Our study provides extended information about BMD screening intervals in Asian female population. Baseline T-score was important for predicting BMD screening interval, and repeat BMD testing within 5 years might not be necessary in mild osteopenia subjects.

Citations

Citations to this article as recorded by

Mechanical regulation of mesenchymal stem cell osteogenesis, bone matrix homoeostasis, and skeletal pathology
Udipt R. Das, Hussain Jaffery, Penelope M. Tsimbouri, Matthew J. Dalby
Journal of Tissue Engineering.2026;[Epub] CrossRef
Radiography and Subject Data Integration for Osteoporosis Detection Using Dingo Optimization Based Deep Belief Network Model
Dhanyavathi A, Veena M B
Optical Memory and Neural Networks.2026; 35(2): 276. CrossRef
Evaluation of Repeat Scan Rates and Service Utilization Patterns in DXA Examinations: A Retrospective Analysis of 35,827 Scans
Sadık Emre Erginoğlu, Nihat Yiğit, Ali Said Nazlıgül, Nuri Koray Ülgen, Mehmet Orçun Akkurt
Turkish Journal of Osteoporosis.2026;[Epub] CrossRef
Clinical and Laboratory Predictors of Bone Mineral Density Trajectories and Osteoporosis Progression: A Retrospective Longitudinal Cohort Study
Layal K. Jambi, Saeed M. Kabrah
Journal of Clinical Medicine.2026; 15(17): 6581. CrossRef
Profile of Patients with Decreased Bone Density Aged Over 50 Years Old with Cases of Femoral Neck Fracture, Thoracic Vertebral Compression Fracture, Lumbar Vertebral Compression Fracture, and Distal Radius Fracture in Dr. Soetomo General Academic Hospital
Arlingga Pratama, Gadis Meinar Sari, Dwikora Novembri Utomo
JUXTA: Jurnal Ilmiah Mahasiswa Kedokteran Universitas Airlangga.2025; 16(1): 1. CrossRef
Geotemporal disparities in hip fractures burden among individuals aged ≥55 years (1990–2021) with projections to 2050
Yuan Gu, Yingqi Chen, Wenzhao Li, Ningning Cheng, Songyun Deng, Yuan Ma, Daorong Xu, Jikun Qian
Frontiers in Public Health.2025;[Epub] CrossRef
Medium-term transition rates to osteoporosis: DXA analysis in older Asians
Vu Pham Thao Vy, Yi-Chien Lu, James F. Griffith, Ying Chin Lin, Chun-Hsiang Chan, John J. Carey, Wing P. Chan
Archives of Osteoporosis.2025;[Epub] CrossRef
A randomized controlled trial of the effect of raloxifene plus cholecalciferol versus cholecalciferol alone on bone mineral density in postmenopausal women with osteopenia
Sungjae Shin, Namki Hong, Yumie Rhee
JBMR Plus.2024;[Epub] CrossRef
Divergent associations of inflammatory markers with bone turnover markers in elderly patients with osteoporotic fractures
Jian Xu, Yue-qin Guo, Shao-han Guo, Min-zhe Xu, Chong Li, Ya-qin Gong, Ke Lu
Scientific Reports.2024;[Epub] CrossRef
CT Thresholds for Spinal Bone Mineral Attenuation to Prioritize Eligible Older Women for Osteoporosis Screening
Seo Yeon K. Orite, Bryn Higuchi, Hyo-Chun Yoon, Lana H. Gimber
Open Journal of Radiology.2024; 14(02): 92. CrossRef
Effects of Bazedoxifene/Vitamin D Combination Therapy on Serum Vitamin D Levels and Bone Turnover Markers in Postmenopausal Women with Osteopenia: A Randomized Controlled Trial
Chaiho Jeong, Jeonghoon Ha, Jun-Il Yoo, Young-Kyun Lee, Jung Hee Kim, Yong-Chan Ha, Yong-Ki Min, Dong-Won Byun, Ki-Hyun Baek, Ho Yeon Chung
Journal of Bone Metabolism.2023; 30(2): 189. CrossRef
Bone-modifying agents for non–small-cell lung cancer patients with bone metastases during the era of immune checkpoint inhibitors: A narrative review
Jinyoung Kim, Chaiho Jeong, Jeongmin Lee, Jeonghoon Ha, Ki-Hyun Baek, Seohyun Kim, Tai Joon An, Chan Kwon Park, Hyoung Kyu Yoon, Jeong Uk Lim
Seminars in Oncology.2023; 50(3-5): 105. CrossRef

Mineral, Bone & Muscle
Real-World Safety and Effectiveness of Denosumab in Patients with Osteoporosis: A Prospective, Observational Study in South Korea: Yumie Rhee, Dong-Gune Chang, Jeonghoon Ha, Sooa Kim, Yusun Lee, Euna Jo, Jung-Min Koh; Endocrinol Metab. 2022;37(3):497-505. Published online June 3, 2022; DOI: https://doi.org/10.3803/EnM.2022.1427

15,264 View
403 Download
19 Web of Science
22 Crossref

Abstract PDF PubReader ePub

Background
The efficacy and safety of denosumab have been established in a phase 3, randomized, placebo-controlled trial in Korean postmenopausal women with osteoporosis. This postmarketing surveillance study was aimed to investigate the safety and effectiveness of denosumab in Korean real-world clinical practice.
Methods
Patients with osteoporosis who had received denosumab per the Korean approved indications in the postmarketing setting between September 2014 and September 2019 were enrolled. The primary endpoint was the incidence of adverse events (AEs) and adverse drug reactions (ADRs). The secondary endpoint was the percent change from baseline in bone mineral density (BMD) of the lumbar spine, total hip, and femoral neck.
Results
Of the 3,221 patients enrolled, 3,185 were included in the safety analysis set; 2,973 (93.3%) were female, and the mean± standard deviation (SD) age was 68.9±9.9 years. The mean±SD study period was 350.0±71.4 days. AEs, fatal AEs, and ADRs occurred in 19.3%, 0.8%, and 1.6%, respectively. The most frequent AEs, occurring in >0.5% of patients, were dizziness (0.7%), arthralgia (0.7%), back pain (0.6%), and myalgia (0.6%). Hypocalcemia occurred in 0.3% of patients. There were no cases of osteonecrosis of the jaw and atypical femoral fracture. Mean±SD percent change from baseline in BMD of the lumbar spine, total hip, and femoral neck was 7.3%±23.6%, 3.6%±31.4%, and 3.2%±10.7%, respectively.
Conclusion
The safety and effectiveness of denosumab in Korean patients with osteoporosis in this study were comparable with those in the Korean randomized controlled trial, with no new safety findings.

Citations

Citations to this article as recorded by

Therapeutic strategy for exosome-based bone regeneration to osteoporosis: Challenges and potential solutions
Anoop Puthiyoth Dayanandan, Alvin Bacero Bello, Yoshie Arai, Sang Jin Lee, Soo-Hong Lee
Journal of Advanced Research.2026; 84: 361. CrossRef
The Survival of Dental Implants in Post‐Menopausal Women Receiving Denosumab: A Retrospective Cohort Study
Junghye Hwang, Youngjae Yoon, Garam Byun, Byung‐Joon Choi, Joo‐Young Ohe, Baek‐Soo Lee, Junho Jung
Clinical Implant Dentistry and Related Research.2026;[Epub] CrossRef
Effectiveness and safety of denosumab on osteoporosis treatment in kidney transplant recipients
Jin Kyung Kwon, Yaerim Kim, Jin Hyuk Paek, Kyubok Jin, Seungyeup Han, Woo Yeong Park
Kidney Research and Clinical Practice.2026; 45(5): 818. CrossRef
Long-Term Efficacy and Safety of Denosumab: Insights beyond 10 Years of Use
Jeonghoon Ha, Youn-Ju Lee, Jinyoung Kim, Chaiho Jeong, Yejee Lim, Jeongmin Lee, Ki-Hyun Baek
Endocrinology and Metabolism.2025; 40(1): 47. CrossRef
Does the Use of Denosumab in Combination with bDMARDs or tsDMARDs Increase the Risk of Infection in Patients with Osteoporosis and Inflammatory Rheumatic Diseases?
Salim Mısırcı, Ali Ekin, Burcu Yağız, Belkıs Nihan Coşkun, Mustafa Çağatay Büyükuysal, Ediz Dalkılıç, Yavuz Pehlivan
Journal of Clinical Medicine.2025; 14(17): 6090. CrossRef
Denosumab for Osteoporosis Treatment in Rheumatic Diseases: What Do We Know 15 Years Post Approval?
Stanley B. Cohen, Kenneth G. Saag
The Journal of Rheumatology.2025; 52(9): 855. CrossRef
Comparison of the Efficacy of Denosumab in Patients at High or Very High Risk of Osteoporotic Fractures
Yeong-Gwon Jo, Sung Hyuk Yoon, Woo-Kie Min
Journal of Korean Society of Spine Surgery.2025; 32(3): 54. CrossRef
Revolutionizing osteoporosis management: the emerging role of immunotherapeutic and next-generation therapies
Ali Afshari, Jafar Karami, Mitra Abbasifard
Inflammopharmacology.2025; 33(12): 7217. CrossRef
Effects of Sequential Anti-Resorptive Agents on Bone Mineral Density Following Denosumab Withdrawal: A Multicenter Real-World Study in Korea (MAXCARE Study)
Jeonghoon Ha, Kyong Yeun Jung, Kyoung Jin Kim, Seong Hee Ahn, Hyo-Jeong Kim, Yoon-Sok Chung
Endocrinology and Metabolism.2025; 40(5): 748. CrossRef
DENOSUMAB: A NEW ERA IN OSTEOPOROSIS MANAGEMENT IN VIETNAM
Nguyen Van Tuan, Ho Pham Thuc Lan
Tạp chí Sức khỏe và Lão hóa.2025; 1(5): 4. CrossRef
Updated Advances on Drugs and Bone-Targeting Nanoparticles for Osteoporosis Therapy: Carrier Materials, Modification, Function Mechanism, and Applications—A Systematic Review
Yehao Lin, Yidong Xu, Siyue Zhou, Junyu Liu, Min Zhang, Baoxin Zhang, Haixia Chen
Pharmaceuticals.2025; 18(12): 1809. CrossRef
Two-year outcomes of denosumab treatment for osteoporosis comparing the effects of calcium and vitamin D supplementation
Young-Ho Cho, Seong-Eun Byun, Hwan-Hee Lee
Scientific Reports.2025;[Epub] CrossRef
Prevalence of denosumab-induced hypocalcemia: a retrospective observational study of patients routinely monitored with ionized calcium post-injection
Anna Spångeus, Johan Rydetun, Mischa Woisetschläger
Osteoporosis International.2024; 35(1): 173. CrossRef
Cost-consequence analysis of continuous denosumab therapy for osteoporosis treatment in South Korea
Seungju Cha, Minjeong Sohn, Hyowon Yang, Eric J. Yeh, Ki-Hyun Baek, Jeonghoon Ha, Hyemin Ku
BMC Musculoskeletal Disorders.2024;[Epub] CrossRef
Denosumab and the Risk of Diabetes in Patients Treated for Osteoporosis
Huei-Kai Huang, Albert Tzu-Ming Chuang, Tzu-Chi Liao, Shih-Chieh Shao, Peter Pin-Sung Liu, Yu-Kang Tu, Edward Chia-Cheng Lai
JAMA Network Open.2024; 7(2): e2354734. CrossRef
A real-world disproportionality analysis of FDA adverse event reporting system (FAERS) events for denosumab
Yue He, Rong Zhang, Huarui Shen, Yingqi Liu
Frontiers in Pharmacology.2024;[Epub] CrossRef
Denosumab in Osteoporosis: Predicting Long-Term Efficacy beyond 10 Years
Jeongmin Lee, Youn-Ju Lee, Jeonghoon Ha
Journal of Bone Metabolism.2024; 31(3): 246. CrossRef
Adverse Effects of Denosumab in Kidney Transplant Recipients: A 20-Year Retrospective Single-Center Observation Study in Central Taiwan
Tsung-Yin Tsai, Zi-Hong You, Shang-Feng Tsai, Ming-Ju Wu, Tung-Min Yu, Ya-Wen Chuang, Yung-Chieh Lin, Ya-Lian Deng, Chiann-Yi Hsu, Cheng-Hsu Chen
Transplantation Proceedings.2023; 55(4): 837. CrossRef
Persistence with Denosumab in Male Osteoporosis Patients: A Real-World, Non-Interventional Multicenter Study
Chaiho Jeong, Jeongmin Lee, Jinyoung Kim, Jeonghoon Ha, Kwanhoon Jo, Yejee Lim, Mee Kyoung Kim, Hyuk-Sang Kwon, Tae-Seo Sohn, Ki-Ho Song, Moo Il Kang, Ki-Hyun Baek
Endocrinology and Metabolism.2023; 38(2): 260. CrossRef
Effect of Denosumab on Bone Density in Postmenopausal Osteoporosis: A Comparison with and without Calcium Supplementation in Patients on Standard Diets in Korea
Chaiho Jeong, Jinyoung Kim, Jeongmin Lee, Yejee Lim, Dong-Jun Lim, Ki-Hyun Baek, Jeonghoon Ha
Journal of Clinical Medicine.2023; 12(21): 6904. CrossRef
Denosumab

Reactions Weekly.2022; 1919(1): 221. CrossRef
Denosumab, an effective osteoporosis treatment option for men
Sung Hye Kong
The Korean Journal of Internal Medicine.2022; 37(5): 947. CrossRef

Review Article

Mineral, Bone & Muscle
Interplay of Vitamin D and CYP3A4 Polymorphisms in Endocrine Disorders and Cancer: Siva Swapna Kasarla, Vannuruswamy Garikapati, Yashwant Kumar, Sujatha Dodoala; Endocrinol Metab. 2022;37(3):392-407. Published online June 3, 2022; DOI: https://doi.org/10.3803/EnM.2021.1349

18,217 View
278 Download
14 Web of Science
19 Crossref

Abstract PDF PubReader ePub

Vitamin D has received considerable optimistic attention as a potentially important factor in many pathological states over the past few decades. However, the proportion of the active form of vitamin D metabolites responsible for biological activity is highly questionable in disease states due to flexible alterations in the enzymes responsible for their metabolism. For instance, CYP3A4 plays a crucial role in the biotransformation of vitamin D and other drug substances. Food-drug and/or drug-drug interactions, the disease state, genetic polymorphism, age, sex, diet, and environmental factors all influence CYP3A4 activity. Genetic polymorphisms in CYP450-encoding genes have received considerable attention in the past few decades due to their extensive impact on the pharmacokinetic and dynamic properties of drugs and endogenous substances. In this review, we focused on CYP3A4 polymorphisms and their interplay with vitamin D metabolism and summarized the role of vitamin D in calcium homeostasis, bone diseases, diabetes, cancer, other diseases, and drug substances. We also reviewed clinical observations pertaining to CYP3A4 polymorphisms among the aforementioned disease conditions. In addition, we highlighted the future perspectives of studying the pharmacogenetics of CYP3A4, which may have potential clinical significance for developing novel diagnostic genetic markers that will ascertain disease risk and progression.

Citations

Citations to this article as recorded by

Covalent inhibitors of human cytochrome P450 3A4: research advances and future perspectives
Dong-Zhu Tu, Zhang-Ping Xiao, Shu-Yan Liu, Xue-Yan Hu, Jing-Xuan Lei, Jia-Hao Gong, Feng Zhang, Xin-Xin Ding, Zi-Ru Dai, Jiang Zheng, Ling Yang, Guang-Bo Ge
Coordination Chemistry Reviews.2026; 546: 217028. CrossRef
Unraveling the mechanisms of bisphenol A-Induced lupus nephritis through network toxicology and machine learning approaches
Zhongfu Tang, Ming Li, Lili Cheng, Junjie Chen, Chuanbing Huang
International Journal of Environmental Health Research.2026; 36(5): 864. CrossRef
Novel Genetic Susceptibility Markers for Breast Cancer in Iraqi Women: First Evidence of CYP3A4*1B Protective Effects and GSTP1/MTHFR Risk Associations
Wisam Hindawi Hoidy, Mohammed Ouda Orabiy, Shaimaa Mohsen Essa, Layth Samir Jasim
Clinical Breast Cancer.2026; 26(3): 176. CrossRef
Unraveling the Mechanisms of Osteoporosis Triggered by Methylparaben and Monomethyl Phthalate through Integrated Mendelian Randomization, In Silico Simulations, and Experimental Validation
Hailong Liu, Xin Xu, Longzhuo Du, Wencan Zhang, Yongyuan Guo, Fujian Zhang, Houyi Sun, Haipeng Si, Peilai Liu
Environmental Science & Technology.2026; 60(1): 228. CrossRef
Bile acids as therapeutic agents
Brandon Vu, Ryo Kawamoto, Priscila Villalba-Davila, Xinzhong Dong, Wikrom Karnsakul
Frontiers in Pharmacology.2026;[Epub] CrossRef
Cytochrome P450 3A gene family in gastric cancer: Unveiling diagnostic biomarkers and therapeutic targets for personalized treatment
Jun-Kun Zhu, Jing Wang
World Journal of Clinical Oncology.2025;[Epub] CrossRef
Investigations on the dysregulated genes in high-fat-fed mice infected with Prevotella intermedia and their possible role in the development of hepatocellular carcinoma
Yathin Reddy Putta, Anitha Pandi, Jayaseelan Vijayashree Priyadharsini
Folia Medica.2025;[Epub] CrossRef
Investigation of single nucleotide polymorphisms of human vitamin D receptor gene and their subsequent effects on the receptor structure and function by in silico methods
Mitali Das, Rajkrishna Biswas, Mrinmoyee Sengupta
International Journal of Research in Medical Sciences.2025; 13(4): 1563. CrossRef
Probe-substrate assay reveals the inhibition of CYP1A2, 2C9, and 3A4 by Senkyunolide A in human liver microsomes
Ruidong Wang, Tian Zuo, Yue Du, Jian Zai, Lijun Zhu, Qi Zhan
Xenobiotica.2025; 55(7): 566. CrossRef
Anti-epileptic medication induced disturbed calcium-vitamin D metabolism: A behavioral analysis using association rule mining technique
Pradeep K Dabla, Kamal Upreti, Divakar Singh, Anju Singh, Vinod Puri, Adina E Stanciu, Nafija Serdarevic, Damien Gruson
World Journal of Experimental Medicine.2025;[Epub] CrossRef
Type 1 Diabetes Autoimmunity: To What Extent Vitamin D is Beneficial
Haitham Al-Madhagi, Baskaran Gunasekaran
Biochemistry Research International.2025;[Epub] CrossRef
Revealing the association between vitamin D metabolic pathway gene variants and lung cancer risk: a systematic review and meta-analysis
Mohamed I. Elsalahaty, Samar Sami Alkafaas, Aya O. Bashir, Khaled A. El-Tarabily, Mohamed T. El-Saadony, Eman H. Yousef
Frontiers in Genetics.2024;[Epub] CrossRef
Vitamin D in Melanoma: Potential Role of Cytochrome P450 Enzymes
Mohamed Ben-Eltriki, Erysa J. Gayle, Jhoanne M. Paras, Louisa Nyame-Addo, Manik Chhabra, Subrata Deb
Life.2024; 14(4): 510. CrossRef
Explore the mechanism of Astragalus membranaceus and Poria cocos drug pair in improving immunity based on network pharmacology
Yuting Bai, Na Ning, Jianjun Zhao, Guoqing Chen, Yuhua Du, Shicong Huang, Xilong Jiang, Xuelan Feng, Yuanyuan Feng, Yi Nan, Ling Yuan
Medicine.2024; 103(25): e38531. CrossRef
Imiglucerase, cholecalciferol, and bone-diet in skeletal health management of type I Gaucher disease patients: a pilot study and systematic review
Antonio Barbato, Anita Vergatti, Alfonso Giaquinto, Ilaria Libera Pizzulo, Ludovica Perna, Giuseppe Perruolo, Veronica Abate, Michelina Sibilio, Ciro Mainolfi, Ernesto Soscia, Gianpaolo De Filippo, Pietro Formisano, Ferruccio Galletti, Pasquale Strazzullo
JBMR Plus.2024;[Epub] CrossRef
Heat stress as a potential risk factor for vitamin D deficiency
Martina Balducci, Letizia Pruccoli, Andrea Tarozzi
Medical Hypotheses.2023; 176: 111085. CrossRef
Association and Haplotype Analysis of the PON1, ITGB3 and CYP3A4 Genes, Strong Candidates for Familial Coronary Artery Disease Susceptibility
Faruk SAYDAM, İrfan DEĞİRMENCİ, Alparslan BİRDANE, Cansu ÖZBAYER, Taner ULUS, Mahmut ÖZDEMİR, Necmi ATA, Hasan Veysi GÜNEŞ
Online Türk Sağlık Bilimleri Dergisi.2023; 8(1): 81. CrossRef
Association of flame retardants, polybrominated diethyl ethers (PBDEs), with vitamin D in female subjects
Alexandra E. Butler, Edwina Brennan, Daniel S. Drage, Thozhukat Sathyapalan, Stephen L. Atkin
Chemosphere.2023; 338: 139488. CrossRef
Genetic variations of CYP3A4 on the metabolism of itraconazole in vitro
Sai-li Xie, Xiayan Zhu, Nanyong Gao, Qianmeng Lin, Chaojie Chen, Yun-jun Yang, Jian-ping Cai, Guo-xin Hu, Ren-ai Xu
Food and Chemical Toxicology.2023; 181: 114101. CrossRef

Original Articles

Hypothalamus and Pituitary Gland
Metabolic Impacts of Discontinuation and Resumption of Recombinant Human Growth Hormone Treatment during the Transition Period in Patients with Childhood-Onset Growth Hormone Deficiency: Yun Jeong Lee, Yunha Choi, Han-Wook Yoo, Young Ah Lee, Choong Ho Shin, Han Saem Choi, Ho-Seong Kim, Jae Hyun Kim, Jung Eun Moon, Cheol Woo Ko, Moon Bae Ahn, Byung-Kyu Suh, Jin-Ho Choi; Endocrinol Metab. 2022;37(2):359-368. Published online April 25, 2022; DOI: https://doi.org/10.3803/EnM.2021.1384

14,850 View
256 Download
15 Web of Science
15 Crossref

Abstract PDF Supplementary Material PubReader ePub

Background
Discontinuing growth hormone (GH) treatment during the transition to adulthood has been associated with adverse health outcomes in patients with childhood-onset growth hormone deficiency (CO-GHD). This study investigated the metabolic changes associated with interrupting GH treatment in adolescents with CO-GHD during the transition period.
Methods
This study included 187 patients with CO-GHD who were confirmed to have adult GHD and were treated at six academic centers in Korea. Data on clinical parameters, including anthropometric measurements, metabolic profiles, and bone mineral density (BMD) at the end of childhood GH treatment, were collected at the time of re-evaluation for GHD and 1 year after treatment resumption.
Results
Most patients (n=182, 97.3%) had organic GHD. The median age at treatment discontinuation and re-evaluation was 15.6 and 18.7 years, respectively. The median duration of treatment interruption was 2.8 years. During treatment discontinuation, body mass index Z-scores and total cholesterol, low-density lipoprotein, and non-high-density lipoprotein (HDL) cholesterol levels increased, whereas fasting glucose levels decreased. One year after GH treatment resumption, fasting glucose levels, HDL cholesterol levels, and femoral neck BMD increased significantly. Longer GH interruption (>2 years, 60.4%) resulted in worse lipid profiles at re-evaluation. The duration of interruption was positively correlated with fasting glucose and non-HDL cholesterol levels after adjusting for covariates.
Conclusion
GH treatment interruption during the transition period resulted in worse metabolic parameters, and a longer interruption period was correlated with poorer outcomes. GH treatment should be resumed early in patients with CO-GHD during the transition period.

Citations

Citations to this article as recorded by

Dyslipidemias associated with endocrine disorders: a position statement of the working group of the nutrition hormones and metabolism club of the italian society of endocrinology (SIE)
Giovanna Muscogiuri, Manuela Albertelli, Giorgio Arnaldi, Luigi Barrea, Giuseppe Bellastella, Marco Bonomi, Marina Caputo, Massimiliano Caprio, Angelo Cignarelli, Ludovico Di Gioia, Francesco Frasca, Davide Ferrari, Alessandra Gambineri, Valentina Gasco,
Journal of Endocrinological Investigation.2026; 49(8): 1699. CrossRef
Impact of non-weight-dependent low-dose somatropin on bone accrual in childhood-onset GH deficient in the transition: an 18-month randomized controlled trial
Valesca Mansur Kuba, Antonia B.S. Castro, Cláudio Leone, Durval Damiani
Jornal de Pediatria.2025; 101(2): 255. CrossRef
Sex-Specific Cardiovascular Risks and Mortality in Patients with Panhypopituitarism: A Nationwide Cohort Study
Seung Shin Park, Hyunmook Jeong, Chang Ho Ahn, Min Jeong Park, Yong Hwy Kim, Kwangsoo Kim, Jung Hee Kim
Endocrinology and Metabolism.2025; 40(3): 469. CrossRef
Ghrelin regulating liver activity and its potential effects on liver fibrosis and Echinococcosis
Jiang Zhu, Tanfang Zhou, Meng Menggen, Kalibixiati Aimulajiang, Hao Wen
Frontiers in Cellular and Infection Microbiology.2024;[Epub] CrossRef
Composición de la microbiota en pacientes con déficit de hormona de crecimiento antes y después de recibir tratamiento
Patricia García Navas, María Yolanda Ruíz del Prado, Pablo Villoslada Blanco, Emma Recio Fernández, María Ruíz del Campo, Patricia Pérez Matute
Anales de Pediatría.2024; 100(6): 404. CrossRef
Composition of the microbiota in patients with growth hormone deficiency before and after treatment with growth hormone
Patricia García Navas, María Yolanda Ruíz del Prado, Pablo Villoslada Blanco, Emma Recio Fernández, María Ruíz del Campo, Patricia Pérez Matute
Anales de Pediatría (English Edition).2024; 100(6): 404. CrossRef
Clinical Management of Postoperative Growth Hormone Deficiency in Hypothalamic-Pituitary Tumors
Pedro Iglesias
Journal of Clinical Medicine.2024; 13(15): 4307. CrossRef
An Overview of Cardiovascular Risk in Pituitary Disorders
Georgia Ntali, Vyron Markussis, Alexandra Chrisoulidou
Medicina.2024; 60(8): 1241. CrossRef
The role of IGF1 in determining body composition in children and adolescents with growth hormone deficiency and those with idiopathic short stature
Hussein Zaitoon, Michal Yackobovitch-Gavan, Eyas Midlej, Adi Uretzky, Irina Laurian, Anna Dorfman, Hagar Interator, Yael Lebenthal, Avivit Brener
Endocrine.2024; 86(3): 1110. CrossRef
Policy for transitioning childhood-onset growth hormone deficiency from pediatric to adult endocrine care in Belgium
Willem Staels, Jean De Schepper, Marianne Becker, Philippe Lysy, Daniel Klink, Karl Logghe, Marieken den Brinker, Anne Rochtus, Bruno Lapauw, Martine Cools, Orsalia Alexopoulou, Marie Bex, Bernard Corvilain, Laurent Crenier, Christophe De Block, Julian Do
Frontiers in Endocrinology.2024;[Epub] CrossRef
Transition Period and Young Adulthood in Patients with Childhood Onset Growth Hormone Deficiency (COGHD): Impact of Growth Hormone Replacement on Bone Mass and Body Composition
Mirjana Doknic, Marko Stojanovic, Aleksandra Markovic
International Journal of Molecular Sciences.2024; 25(19): 10313. CrossRef
Baseline Clinical Factors Associated with Cessation of Growth Hormone Therapy in Patients with Severe Growth Hormone Deficiency - Real World Evidence
Nageswary Nadarajah, Emmanuel Ssemmondo, Shani Brooks, Remi Akinyombo, Kazeem Adeleke, Harshal Deshmukh, Thozhukat Sathyapalan
International Journal of Endocrinology and Metabolism.2024;[Epub] CrossRef
Clinical and genetic features of childhood-onset congenital combined pituitary hormone deficiency: a retrospective, single-center cohort study
Yoonha Lee, Young Ah Lee, Jung Min Ko, Choong Ho Shin, Yun Jeong Lee
Annals of Pediatric Endocrinology & Metabolism.2024; 29(6): 379. CrossRef
Relationship between the Stimulated Peak Growth Hormone Level and Metabolic Parameters in Children with Growth Hormone Deficiency
Seong Yong Lee
The Ewha Medical Journal.2023;[Epub] CrossRef
Dyslipidaemia and growth hormone deficiency – A comprehensive review
Matthias Hepprich, Fahim Ebrahimi, Emanuel Christ
Best Practice & Research Clinical Endocrinology & Metabolism.2023; 37(6): 101821. CrossRef

Mineral, Bone & Muscle
Effect of Vitamin D Supplementation on Risk of Fractures and Falls According to Dosage and Interval: A Meta-Analysis: Sung Hye Kong, Han Na Jang, Jung Hee Kim, Sang Wan Kim, Chan Soo Shin; Endocrinol Metab. 2022;37(2):344-358. Published online April 25, 2022; DOI: https://doi.org/10.3803/EnM.2021.1374

29,691 View
554 Download
46 Web of Science
59 Crossref

Abstract PDF Supplementary Material PubReader ePub

Background
Although recent studies comparing various dosages and intervals of vitamin D supplementation have been published, it is yet to be elucidated whether there is an appropriate dose or interval to provide benefit regarding fracture risk. We aimed to assess the published evidence available to date regarding the putative beneficial effects of vitamin D supplements on fractures and falls according to various dosages and intervals.
Methods
We performed a meta-analysis of randomized controlled studies reporting associations between vitamin D supplementation and the risks of fractures and falls in PubMed, EMBASE, and Cochrane library. Studies with supplements of ergocalciferol or calcitriol, those with a number of event ≤10, or those with a follow-up duration of less than 6 months were also excluded.
Results
Thirty-two studies were included in the final analysis. Vitamin D supplementation with daily dose of 800 to 1,000 mg was associated with lower risks of osteoporotic fracture and fall (pooled relative risk [RR], 0.87; 95% confidence interval [CI], 0.78 to 0.97 and RR, 0.91; 95% CI, 0.85 to 0.98), while studies with <800 or >1,000 mg/day did not. Also, among intervals, daily administration of vitamin D was associated with the reduced risk of falls, while intermittent dose was not. Also, patients with vitamin D deficiency showed a significant risk reduction of falls after vitamin D supplementation.
Conclusion
Daily vitamin D dose of 800 to 1,000 IU was the most probable way to reduce the fracture and fall risk. Further studies designed with various regimens and targeted vitamin D levels are required to elucidate the benefits of vitamin D supplements.

Citations

Citations to this article as recorded by

Supplémentation quotidienne ou intermittente en vitamine D chez les personnes avec ou à risque d’ostéoporose : position du GRIO
Marie-Eva Pickering, Jean-Claude Souberbielle, Anne Boutten, Véronique Breuil, Karine Briot, Roland Chapurlat, Patrice Fardellone, Rose-Marie Javier, Eugénie Koumakis, Bernard Cortet
Revue du Rhumatisme.2026; 93(5): 677. CrossRef
The role of vitamin D in fracture healing: Insights from basic science, clinical studies, and future directions
Jacob M. Johnson, Simbarashe J. Peresuh, Manjot Singh, Jeffrey Okewunmi, Michel A. Arcand, Joseph A. Gil
Journal of Orthopaedic Reports.2026; 5(3): 100759. CrossRef
Nutrition and Liver Disease
Allison Franz, Henry Shay, Irina Kirpich, Craig J. McClain
Seminars in Liver Disease.2026; 46(01): 063. CrossRef
The Effect of Vitamin D3 Supplementation on the Risk of Falls in a General Population—The Finnish Vitamin D Trial
Toni Rikkonen, Sari Hantunen, Heikki Kröger, Christel Lamberg‐Allardt, JoAnn E. Manson, Tarja Nurmi, Marjo Tuppurainen, Ari Voutilainen, Tomi‐Pekka Tuomainen, Jyrki K. Virtanen
Journal of the American Geriatrics Society.2026; 74(6): 1548. CrossRef
Guía de Práctica Clínica multidisciplinaria para la osteoporosis en Colombia: recomendaciones basadas en la evidencia y adaptadas al contexto nacional
Geraldine Altamar-Canales, Daniel G. Fernández-Ávila, Miguel Ángel González-Reyes, Francisco Bernardo Linares-Restrepo, Adriana Medina-Orjuela, Francisco Oscar Fernando Rosero-Olarte, Javier Armando Velásquez-Mendoza, Ximena Castro-Flórez, Edgar Eduardo C
Revista Colombiana de Reumatología.2026; 33(2): 504840. CrossRef
Low Dose Versus High Dose Vitamin D for Treatment of Nutritional Rickets: A Systematic Review and Meta-analysis
Davinder Kaur, Lovely Jain, Pooja Dewan, Meenakshi Malik, Aashima Dabas, Abhishek Purohit, Pranita Pradhan, Kulbir Kaur, Joseph L. Mathew
Indian Pediatrics.2026; 63(5): 357. CrossRef
Revisiting the Role of Vitamin D in Fracture Prevention in the Era of Mega-Trials
Sung Hye Kong
Endocrinology and Metabolism.2026;[Epub] CrossRef
Vitamin K as an Endocrine Modulator: Mechanistic Links to Glucose Metabolism and Beyond
Wojciech Matuszewski, Mikołaj Madeksza, Michał Szklarz, Aleksandra Rutkiewicz, Joanna Rutkowska, Joanna Maria Harazny
Nutrients.2026; 18(8): 1183. CrossRef
Nutritional Interventions to Optimize Orthobiologic Therapy Quality in Type 2 Diabetes Mellitus: Molecular Mechanisms and Clinical Framework: A Narrative Review
Márcia da Silva Santos, Fábio Ramos Costa, João Protásio Netto, Gabriel Silva Santos, Rubens Martins, Luyddy Pires, André Kruel, Gabriel Azzini, José Fábio Lana
International Journal of Molecular Sciences.2026; 27(9): 3749. CrossRef
Recommendations for the diagnosis, prevention and treatment of osteoporosis in men
N.V. Grygorieva, М.О. Коrzh, M.D. Tronko, B.M. Mankovsky, R.I. Yatsyshyn, I.Yu. Golovach, S.S. Strafun, S.I. Smiyan, Yu.M. Gurzhenko, D.G. Rekalov, O.D. Nikitin, V.L. Orlenko, G.O. Protsenko, A.V. Kalashnikov, V.Ye. Luchytskyi, А.S. Musiіenko
TRAUMA.2026; 27(2): 170. CrossRef
Vitamin D in Type 2 Diabetes Mellitus According to Diabetic Kidney Disease Stage: What Is the Target in Clinical Practice?
João Soares Felício, Lícia Oliveira Ruivo, Inessa Silveira Bezerra, Maria Eduarda Nunes Avelar do Carmo, Isabel Jacob Fernandes, Beatriz Dias Lobo, Lilian de Souza D’Albuquerque Silva, Franciane Trindade Cunha de Melo, Ana Carolina Contente Braga de Souza
Nutrients.2026; 18(9): 1408. CrossRef
Revisiting the Role of Vitamin D in Fracture Prevention in the Era of Mega-Trials
Sung Hye Kong
Endocrinology and Metabolism.2026; 41(2): 203. CrossRef
Calcium, vitamin D, or combined supplementation to prevent fractures and falls: systematic review and meta-analysis
Olivier Massé, Claudia Mei Mercurio, Sébastien Dupuis, Maya Al Sahwi, Alexandra Arruda, Gabriel Dallaire, Katherine Desforges, Nicolas Dugré, David Williamson
BMJ.2026; 393: e088050. CrossRef
Multidisciplinary clinical practice guideline for osteoporosis in Colombia: Evidence-based recommendations adapted to the national context
Geraldine Altamar-Canales, Daniel G. Fernández-Ávila, Miguel Ángel González-Reyes, Francisco Bernardo Linares-Restrepo, Adriana Medina-Orjuela, Francisco Oscar Fernando Rosero-Olarte, Javier Armando Velásquez-Mendoza, Ximena Castro-Flórez, Edgar Eduardo C
Revista Colombiana de Reumatología (English Edition).2026; 33(2): 504840. CrossRef
Preventing Hip (Proximal Femoral) Fractures: An Evidence-Based Review for Clinicians
Toshiyuki Kawai, Yaichiro Okuzu, Yusuke Takaoka, Daichi Natsume, Shuichi Matsuda
Journal of Clinical Medicine.2026; 15(16): 6148. CrossRef
High‐Dose Vitamin D Supplementation for Fall Prevention: Clinical Nuances and Safety Considerations
Linxuan Hou, Ruifeng Li, Enpeng Gu, Qinzong Li, Linjue Wang
Journal of the American Geriatrics Society.2026;[Epub] CrossRef
Vitamin D: Physiology, Pharmacology and Clinical Evidence for Supplementation—A Narrative Review
Jyrki K. Virtanen
Basic & Clinical Pharmacology & Toxicology.2026;[Epub] CrossRef
Effect of vitamin D supplementation on bone health in Black, Asian and other non-White ethnic adults: a systematic review and meta-analysis
Honglin Dong, Jamilatu Y Shardow, Kathleen Mulligan, Patrick Oyibo, Shashi Hirani
The American Journal of Clinical Nutrition.2026; : 101548. CrossRef
Daily or intermittent vitamin D supplementation in patients with or at risk of osteoporosis: Position statement from the GRIO
Marie-Eva Pickering, Jean-Claude Souberbielle, Anne Boutten, Véronique Breuil, Karine Briot, Roland Chapurlat, Patrice Fardellone, Rose-Marie Javier, Eugénie Koumakis, Bernard Cortet
Joint Bone Spine.2025; 92(3): 105858. CrossRef
Hip Fracture Patterns Among Hispanic Seniors: Risk Factors and Implications
Nikhil Mathur, John Knight, Monica Betancourt-Garcia, Gregery Pequeno, Michael Serra-Torres
Cureus.2025;[Epub] CrossRef
Clinical efficacy of vitamin D in the prevention of osteoporosis and fractures in elderly patients
K.K. Kurbanova, A.A. Kovaleva, A.V. Akopyan, D.M. Rak, A.S. Shuliakova
Russian Journal of Preventive Medicine.2025; 28(5): 103. CrossRef
Bone Health in Women
Brenna Gibbons, Julia Lubsen, Andrea Ildiko Martonffy
Primary Care: Clinics in Office Practice.2025; 52(2): 353. CrossRef
ACG Clinical Guideline: Malnutrition and Nutritional Recommendations in Liver Disease
Ashwani K. Singal, Robert J. Wong, Srinivasan Dasarathy, Manal F. Abdelmalek, Brent A. Neuschwander-Tetri, Berkeley N. Limketkai, Jessica Petrey, Craig J. McClain
American Journal of Gastroenterology.2025; 120(5): 950. CrossRef
Significance of Vitamins in Health Promotion and Disease Prevention
Kiyoshi Tanaka, Akiko Kuwabara, Misora Ao, Hiroaki Kanouchi
The Japanese Journal of Nutrition and Dietetics.2025; 83(3): 87. CrossRef
Advances in the management of osteoporosis
Caroline Wei Shan Hoong, Dominik Saul, Sundeep Khosla, Jad G Sfeir
BMJ.2025; 390: e081250. CrossRef
Efficacy of Vitamin D Supplementation on the Risk of Falls Among Community-Dwelling Older Adults: A Systematic Review and Meta-Analysis
Raquel Torres-Lopez, Núria Obradors, Roberto Elosua, Rafael Azagra-Ledesma, Marta Zwart
Journal of Clinical Medicine.2025; 14(17): 6117. CrossRef
Vitamin D, muscle strength and function in South Asian women aged ≥ 60 years living in the North of England: a cross-sectional observational study
Sabeen Zahra, Fraser Wiggins, Bernard M. Corfe, Elizabeth A. Williams
European Journal of Nutrition.2025;[Epub] CrossRef
Association Between Herpes Zoster and Risk of Incident Fragility Fractures in US Veterans: A Matched Cohort Study
Calif A. A. Yousuf, Julie A. Womack, Roger J. Bedimo, Christopher T. Rentsch, Charlotte Warren‐Gash
Journal of the American Geriatrics Society.2025; 73(12): 3778. CrossRef
Beyond bones: Revisiting the role of vitamin D in chronic liver disease
Rodrigo Guerrero-Guerrero, Osvely Mendez-Guerrero, Anaisa Carranza-Carrasco, Farid Tejeda, Astrid Ardon-Lopez, Nalu Navarro-Alvarez
World Journal of Hepatology.2025;[Epub] CrossRef
Socio-Demographic, Environmental, and Clinical Factors Influencing Osteoporosis Control in Community Pharmacies of Lahore Pakistan
Muhammad Zahid Iqbal, Aqsa Malik, Naeem Mubarak, Tahneem Yaseen, Seerat Shahzad, Khalid M. Orayj, Saad S. Alqahtani
Healthcare.2025; 13(24): 3291. CrossRef
Vitamin D in Endocrine Disorders: A Broad Overview of Evidence in Musculoskeletal, Thyroid, Parathyroid, and Reproductive Disorders
Balazs Lengyel, Richard Armos, Bence Bojtor, Andras Kiss, Balint Tobias, Henriett Piko, Anett Illes, Eszter Horvath, Zsuzsanna Putz, Istvan Takacs, Janos P. Kosa, Peter Lakatos
Pharmaceuticals.2025; 19(1): 54. CrossRef
Association Between Vitamin D Deficiency and Bone Mineral Density in Type 2 Diabetes: A cross-sectional study
Waleed Arshad, Muzna Kashif, Malik faraz Ahmad
DEVELOPMENTAL MEDICO-LIFE-SCIENCES.2025; 2(8): 27. CrossRef
Ukrainian Consensus on Diagnosis and Management of Vitamin D Deficiency in Adults
Nataliia Grygorieva, Mykola Tronko, Volodymir Kovalenko, Serhiy Komisarenko, Tetiana Tatarchuk, Ninel Dedukh, Mykola Veliky, Serhiy Strafun, Yulia Komisarenko, Andrii Kalashnikov, Valeria Orlenko, Volodymyr Pankiv, Oleg Shvets, Inna Gogunska, Svitlana Reg
Nutrients.2024; 16(2): 270. CrossRef
Vitamin D Supplementation: A Review of the Evidence Arguing for a Daily Dose of 2000 International Units (50 µg) of Vitamin D for Adults in the General Population
Pawel Pludowski, William B. Grant, Spyridon N. Karras, Armin Zittermann, Stefan Pilz
Nutrients.2024; 16(3): 391. CrossRef
Clinical Characteristics and Outcomes of Limb Fractures in Saudi Children
Lamia Aldhbiban, Fai Alhoshan, Raghad Alomari, Shahad A Almatrafi, Yousef Alanazi, Samir Alsayegh, Haifa Y Alfaraidi, Ayman H Jawadi, Fahad N Aljuraibah
Cureus.2024;[Epub] CrossRef
The interplay of rheumatoid arthritis and osteoporosis: exploring the pathogenesis and pharmacological approaches
Nikhil Gupta, Navjot Kanwar, Anchal Arora, Kavin Khatri, Abhinav Kanwal
Clinical Rheumatology.2024; 43(5): 1421. CrossRef
The multi-faceted nature of age-associated osteoporosis
A.E. Smit, O.C. Meijer, E.M. Winter
Bone Reports.2024; 20: 101750. CrossRef
Vitamin D Deficiency in Patients With Low-Energy Hip Fractures in Accordance With the Mediterranean Paradox
Christos Konstantinidis, Ourania Psoma, Christos Kotsias, Vasileios Panagiotopoulos , Sotiris Plakoutsis, Dimitrios Tsiampas, Dimitrios Vardakas, Dimitrios Giotis
Cureus.2024;[Epub] CrossRef
Effect of vitamin D, calcium, or combined supplementation on fall prevention: a systematic review and updated network meta-analysis
Long Tan, Ruiqian He, Xiaoxue Zheng
BMC Geriatrics.2024;[Epub] CrossRef
Analysis of medication treatment for women with osteoporosis: A real-world retrospective study from Chinese tertiary grade A hospital
Xiaolei Liu, Zhenling Zhu, Xianli Wang
Bone Reports.2024; 21: 101778. CrossRef
New insights into dairy management and the prevention and treatment of osteoporosis: The shift from single nutrient to dairy matrix effects—A review
Kaili Wang, Xu Zhao, Sijia Yang, Xiaoxi Qi, Aili Li, Wei Yu
Comprehensive Reviews in Food Science and Food Safety.2024;[Epub] CrossRef
The Importance of Vitamin K and the Combination of Vitamins K and D for Calcium Metabolism and Bone Health: A Review
Jan O. Aaseth, Trine Elisabeth Finnes, Merete Askim, Jan Alexander
Nutrients.2024; 16(15): 2420. CrossRef
The role of anti-osteoporosis drugs in fall risk
Gianpaolo Voltan, Nicola Veronese
International Journal of Bone Fragility.2024; 4(1): 2. CrossRef
Pharmacologic or genetic interference with atrogene signaling protects against glucocorticoid-induced musculoskeletal and cardiac disease
Amy Y. Sato, Meloney Cregor, Kevin McAndrews, Charles A. Schurman, Eric Schaible, Jennifer Shutter, Punit Vyas, Bhawana Adhikari, Monte S. Willis, Marjan Boerma, Tamara Alliston, Teresita Bellido
JCI Insight.2024;[Epub] CrossRef
Vitamin D levels and bone mineral density: a prospective cross-sectional analysis of young orthopedic trauma patients at a rural United States trauma center
Michael Booth, Kenneth Sabacinski, Colleen Watkins, Erin Butcho, Emilie Kramer, Lukas Meadows, Michelle A. Bramer
Journal of Trauma and Injury.2024; 37(4): 276. CrossRef
Preventing Osteoporosis Caused by Vitamin D Deficiency: Nursing Interventions, Nutritional Approaches, and Laboratory Monitoring
Fatima Naif Mabrok Aljohani, Nehad Ali Mohammed Malhawi, Hana Aldafi Haywan Alanazi, Munırah Sumaydan Hamoud Aljohan, Reham Saud Abdulaziz Alahmad, Abdulazız Mohammed Abdullah Alshehrı, Eman Mohammed Abdullah Al Hazim, Hamad Alı Mohammed Alqaed,
International Journal of Computational and Experimental Science and Engineering.2024;[Epub] CrossRef
Association of vitamin and/or nutritional supplements with fall among patients with diabetes: A prospective study based on ACCORD and UK Biobank
Lingfang He, Tianqi Ma, Guogang Zhang, Xunjie Cheng, Yongping Bai
Frontiers in Nutrition.2023;[Epub] CrossRef
Vitamin D and Calcium in Osteoporosis, and the Role of Bone Turnover Markers: A Narrative Review of Recent Data from RCTs
Gavriela Voulgaridou, Sousana K. Papadopoulou, Paraskevi Detopoulou, Despoina Tsoumana, Constantinos Giaginis, Foivi S. Kondyli, Evgenia Lymperaki, Agathi Pritsa
Diseases.2023; 11(1): 29. CrossRef
Recent advances in the identification of related factors and preventive strategies of hip fracture
Yaohui Yu, Yudan Wang, Xiaoli Hou, Faming Tian
Frontiers in Public Health.2023;[Epub] CrossRef
Can Nutrition Contribute to a Reduction in Sarcopenia, Frailty, and Comorbidities in a Super-Aged Society?
Sadao Yoshida, Ryo Shiraishi, Yuki Nakayama, Yasuko Taira
Nutrients.2023; 15(13): 2991. CrossRef
Safety Profile of Vitamin D in Italy: An Analysis of Spontaneous Reports of Adverse Reactions Related to Drugs and Food Supplements
Valentina Maggini, Giada Crescioli, Ilaria Ippoliti, Eugenia Gallo, Francesca Menniti-Ippolito, Adelaide Chiaravalloti, Vittorio Mascherini, Roberto Da Cas, Simona Potenza, Giulia Gritti, Maria Galiulo, Laura Sottosanti, Alfredo Vannacci, Niccolò Lombardi
Journal of Clinical Medicine.2023; 12(14): 4726. CrossRef
Cholecalciferol Use Is Associated With a Decreased Risk of Incident Morphometric Vertebral Fractures in Acromegaly
Sabrina Chiloiro, Stefano Frara, Irene Gagliardi, Antonio Bianchi, Antonella Giampietro, Margherita Medici, Agnese Allora, Luigi di Filippo, Maria Rosaria Ambrosio, Alfredo Pontecorvi, Maria Chiara Zatelli, Laura De Marinis, Andrea Giustina
The Journal of Clinical Endocrinology & Metabolism.2023; 109(1): e58. CrossRef
Proceedings of the 2023 Santa Fe Bone Symposium: Progress and Controversies in the Management of Patients with Skeletal Diseases
E. Michael Lewiecki, Teresita Bellido, John P. Bilezikian, Jacques P. Brown, Azeez Farooki, Christopher S. Kovacs, Brendan Lee, William D. Leslie, Michael R. McClung, Mark L. Prasarn, Deborah E. Sellmeyer
Journal of Clinical Densitometry.2023; 26(4): 101432. CrossRef
Diagnosis, prevention and treatment of vitamin D deficiency in adults: Ukrainian experts consensus statement
N.V. Grygorieva, M.D. Tronko, V.M. Kovalenko, S.V. Komisarenko, T.F. Tatarchuk, N.V. Dedukh, M.M. Veliky, S.S. Strafun, Y.I. Komisarenko, A.V. Kalashnikov, V.L. Orlenko, V.I. Pankiv, O.V. Shvets, I.V. Gogunska, S.I. Regeda
PAIN, JOINTS, SPINE.2023; 13(2): 60. CrossRef
Serum 25-Hydroxyvitamin D Level Is Negatively Associated with Fatigue in Elderly Maintenance Hemodialysis Patients
Menglin Pang, Lin Chen, Na Jiang, Mengmeng Jiang, Baofeng Wang, Lili Wang, Xiao-yan Jia
Kidney and Blood Pressure Research.2023; 48(1): 231. CrossRef
Vitamin D for Clinical Diseases in Women: An Indispensable Factor in Medicine and Dentistry
Dario Calafiore, Leonzio Fortunato, Mario Migliario
Journal of Clinical Medicine.2022; 11(11): 3104. CrossRef
Malnutrition in Older Adults—Effect on Falls and Fractures: A Narrative Review
Malgorzata Kupisz-Urbanska, Ewa Marcinowska-Suchowierska
Nutrients.2022; 14(15): 3123. CrossRef
Role of vitamin D supplementation in the management of musculoskeletal diseases: update from an European Society of Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) working group
Thierry Chevalley, Maria Luisa Brandi, Kevin D. Cashman, Etienne Cavalier, Nicholas C. Harvey, Stefania Maggi, Cyrus Cooper, Nasser Al-Daghri, Oliver Bock, Olivier Bruyère, Mario Miguel Rosa, Bernard Cortet, Alfonso J. Cruz-Jentoft, Antonio Cherubini, Bes
Aging Clinical and Experimental Research.2022; 34(11): 2603. CrossRef
The Relationship of Osteoporosis with Menopause: Review of Article
Hadeel Anwar Alsarraje, *Liqaa Khalel Alhyali
International Journal of Research in Medical Sciences and Technology.2022; 14(01): 127. CrossRef

Review Article

Mineral, Bone & Muscle
Discontinuing Denosumab: Can It Be Done Safely? A Review of the Literature: Wei Lin Tay, Donovan Tay; Endocrinol Metab. 2022;37(2):183-194. Published online April 14, 2022; DOI: https://doi.org/10.3803/EnM.2021.1369

45,186 View
1,472 Download
36 Web of Science
37 Crossref

Abstract PDF PubReader ePub

Denosumab, which has been approved for the treatment of osteoporosis since 2010, is a fully humanised monoclonal antibody against a cytokine, receptor activator of nuclear factor kappa B ligand (RANKL), involved in bone resorption. Continued use of denosumab results in a potent and sustained decrease in bone turnover, an increase in bone mineral density (BMD), and a reduction in vertebral and hip fractures. The anti-resorptive effects of denosumab are reversible upon cessation, and this reversal is accompanied by a transient marked increase in bone turnover that is associated with bone loss, and of concern, an increased risk of multiple vertebral fractures. In this review, we outline the effects of denosumab withdrawal on bone turnover markers, BMD, histomorphometry, and fracture risk. We provide an update on recent clinical trials that sought to answer how clinicians can transition away from denosumab safely with follow-on therapy to mitigate bone loss and summarise the recommendations of various international guidelines.

Citations

Citations to this article as recorded by

Follow-on osteoporosis therapy after denosumab discontinuation among Medicare beneficiaries
Selvam R. Sendhil, Suzanne M. Cadarette, Sulbh Aggarwal, Arman Oganisian, Andrew R. Zullo, Sarah D. Berry, Michael A. Adegboye, Kaleen N. Hayes
Osteoporosis International.2026; 37(1): 81. CrossRef
Selective deletion of the membrane-bound isoform of CSF1 in vivo augments the anabolic response to PTH without impairing bone resorption
Gang-Qing Yao, Meiling Zhu, Karl Insogna
Bone Reports.2026; 28: 101896. CrossRef
Denosumab treatment after percutaneous vertebroplasty for osteoporotic vertebral compression fractures: Long-term follow-up of pain relief, bone mineral density changes, and risk of refracture
Qinglong Li, Huagang Shi, Xing Chen, Simao Song
Journal of Orthopaedic Surgery.2026;[Epub] CrossRef
Osteoporosis After Menopause and After Drug Therapy: The Molecular Mechanism of Bone Loss and Its Treatment
Kelly I-Rong Lee, Jie-Hong Chen, Kuo-Hu Chen
International Journal of Molecular Sciences.2026; 27(2): 641. CrossRef
Bidirectional crosstalk between the bone extracellular matrix and lysosomes in bone remodeling and osteoporosis
Chang Zhou, Xinyue Hu, Yichen Jing, Jiaheng Zhang, Jing Tao, Xinyi Ouyang, Jiaqian Tang, Guomin Zhang, Huiping Liu
Frontiers in Endocrinology.2026;[Epub] CrossRef
Medicinal-chemistry-driven strategies for the synthesis of antiosteoclastogenic small molecules targeting RANKL and its downstream signaling pathways
Abdul Basit, Siyuan Wang
European Journal of Medicinal Chemistry.2026; 308: 118665. CrossRef
Lysosomal functions in the osteoimmune microenvironment: a novel perspective in osteoporosis research
Chang Zhou, Jing Tao, Jiaheng Zhang, Yunfeng Yu, Xinyi Ouyang, Ronghui Li, Xianguang Deng, Mengyuan Li, Jun Qing, Huiping Liu, Guomin Zhang
International Immunopharmacology.2026; 176: 116487. CrossRef
Phase 3 study comparing the efficacy and safety of proposed biosimilar RGB-14-P with denosumab in postmenopausal women with osteoporosis: results from the transition (switch) phase
Serge Ferrari, Lothar Seefried, Dénes Páll, Ombretta Viapiana, Jan Rosa, Jerzy Supronik, Rodina Nestorova Licheva, Joachim Kiefer, Norbert Jeszenői, Károly Horvát-Karajz, Enikő Jókai, István Takács
Osteoporosis International.2026; 37(5): 1209. CrossRef
Fecal microbiota transplantation ameliorates postmenopausal osteoporosis by restoring intestinal barrier function and suppressing inflammation in ovariectomized rats
Biyong Deng, Yuwen Shangguan, Xianfeng Wang, Litao Yan, Yue Qiu
European Journal of Medical Research.2026;[Epub] CrossRef
2025 Singapore consensus statements on the management of osteoporosis
Linsey Gani, Siok Bee Chionh, Nur Azizah Allameen, Elizabeth Jiahui Chan, Manju Chandran, Bertrand Chew, Ivan Chua, Swee Sen Foo, Intekhab Islam, Tang Ching Lau, Vivien Lim, Wen Yi Lim, Alvin Ng, Rani Ramason, Donovan Tay, Jason Shau Khng Lim, Eu-Leong Yo
Annals of the Academy of Medicine Singapore.2026; 55(5): 252. CrossRef
Pre-teriparatide anti-osteoporosis medication therapy and fracture-related hospitalization in patients at very high fracture risk
Shao-Chi Fu, Yi-Chien Lu, Ning-Huei Sie, Chih-Chien Hung, Chung-Yi Li, Rong-Sen Yang, Shau-Huai Fu, Chen-Yu Wang
Osteoporosis International.2026;[Epub] CrossRef
Atypical ulnar fracture induced by chronic mechanical overload in the absence of antiresorptive therapy: A case report
Suk Ha Jeon, Sanglim Lee
Journal of Musculoskeletal Surgery and Research.2026; 10: 568. CrossRef
Is Dose Reduction After Initial Treatment With Denosumab Associated With Subsequent Skeletal-related Events, Osteonecrosis of the Jaw, or Osteoporotic Fractures in Patients With Metastatic Carcinoma? A Nationwide Retrospective Comparative Study
Xi-Qian Heng, Wei-Hsin Lin, Chun-Chieh Yeh, Liang-Yen Liu, Cheng-Han Chung, Hung-Kuan Yen, Fang-Lan Chang, Ho-Min Chen, Ming-Hsiao Hu, Shau-Huai Fu, Chen-Yu Wang, Olivier Q. Groot
Clinical Orthopaedics & Related Research.2026;[Epub] CrossRef
Challenges in Sequential Antiresorptive Therapy After Long-Term Denosumab Discontinuation: A Case Report and Narrative Review of the Literature
Maria-Evangelia Koloutsou, Melina Despina Pieper, Maria Mateniadou, Angeliki Papapanagiotou, Athanasios D. Anastasilakis, Polyzois Makras, Maria P. Yavropoulou
Journal of Clinical Medicine.2026; 15(14): 5443. CrossRef
Longitudinal osteoporosis therapy: treat-to-target and sequential strategies—a narrative review
Irakli Tskhakaia, Maria I. Danila
Therapeutic Advances in Musculoskeletal Disease.2026;[Epub] CrossRef
Preventing Hip (Proximal Femoral) Fractures: An Evidence-Based Review for Clinicians
Toshiyuki Kawai, Yaichiro Okuzu, Yusuke Takaoka, Daichi Natsume, Shuichi Matsuda
Journal of Clinical Medicine.2026; 15(16): 6148. CrossRef
Antiresorptive Use and Risk of Hip Fracture in Older Women with Osteoporosis: Findings from a Real-World National Database of 21,332 Women
Bernardo A. Cedeno-Veloz, Juan Erviti, Marta Gutiérrez-Valencia, Leire Leache, Luis Carlos Saiz, Alba M. Rodríguez García, Nicolás Martínez-Velilla
Journal of Clinical Medicine.2026; 15(16): 6224. CrossRef
Potent bisphosphonate therapy for preventing fractures after denosumab discontinuation in osteoporosis
Asim Shah, Suleman Khan, Syeda Vilay Zehra Rizvi, Kanza Farhan, Misbah Uddin, Syeda Umme Abiha Rizvi, Sabika Fatima, Ang Raj Karan, Aizaz Anwar Khalid, Ahmad Ali, Somaiya Ahmed
Medicine.2026; 105(36): e50542. CrossRef
Multiple vertebral fractures after antiosteoporotic medications discontinuation: A comparative study to evaluate the potential rebound effect of denosumab
Mar Martín-Pérez, Beatriz Sánchez-Delgado, Patricia García-Poza, Sergio López-Álvarez, Elisa Martín-Merino
Bone.2025; 190: 117325. CrossRef
Naïve Bayes is an interpretable and predictive machine learning algorithm in predicting osteoporotic hip fracture in-hospital mortality compared to other machine learning algorithms
Jo-Wai Douglas Wang, Mathew V. Kiang
PLOS Digital Health.2025; 4(1): e0000529. CrossRef
Osteoporosis in Older Men: Informing Patient Management and Improving Health-Related Outcomes
Carmelinda Ruggiero, Carla Caffarelli, Valeria Calsolaro, Laura Tafaro, Francesca Riuzzi, Valentina Bubba, Nicola Napoli, Marika Ferracci, Patrizia Mecocci, Andrea Giusti, Giuseppe Rinonapoli
Drugs & Aging.2025; 42(1): 21. CrossRef
Long-Term Efficacy and Safety of Denosumab: Insights beyond 10 Years of Use
Jeonghoon Ha, Youn-Ju Lee, Jinyoung Kim, Chaiho Jeong, Yejee Lim, Jeongmin Lee, Ki-Hyun Baek
Endocrinology and Metabolism.2025; 40(1): 47. CrossRef
Disorders of bone and mineral metabolism in pregnancy and lactation: A case based clinical review
Manju Chandran, Sarah Ying Tse Tan
Osteoporosis and Sarcopenia.2025; 11(1): 1. CrossRef
Axillaridine A suppresses osteoclastogenesis and alleviates ovariectomy-induced bone loss via inhibition of RANKL-mediated RANK signaling pathways
Jin Li, Jing Xu, Zhe Jiang, Meiyan Duan, Yingqi Yin, Zemin Xiang, Xuanjun Wang, Jun Sheng, Titi Liu, Huanhuan Xu
Food Science and Human Wellness.2025; 14(6): 9250397. CrossRef
The relationship between osteoporosis treatment history and receipt of a second zoledronic acid dose
Natalia Konstantelos, Sandra Kim, Angela M. Cheung, Andrea M. Burden, Paul Grootendorst, Suzanne M. Cadarette
Osteoporosis International.2025; 36(11): 2197. CrossRef
A randomised Phase 3 study comparing the efficacy and safety of proposed denosumab biosimilar RGB-14-P and reference denosumab in women with postmenopausal osteoporosis
Lothar Seefried, Serge Ferrari, Dénes Páll, Ombretta Viapiana, Jan Rosa, Jerzy Supronik, Rodina Nestorova Licheva, Joachim Kiefer, Norbert Jeszenői, Károly Horvát-Karajz, Enikő Jókai, István Takács
Osteoporosis International.2025; 36(12): 2497. CrossRef
Modern prescribing practices and perspectives among Indian Orthopaedicians on Denosumab in osteoporosis: a cross-sectional survey
S. K. Mahendra, Sucheta Mehta, Devika Dhonde, Krishna Shriram Dhanasekaran
International Journal of Research in Orthopaedics.2025; 11(6): 1459. CrossRef
Effects of Sequential Anti-Resorptive Agents on Bone Mineral Density Following Denosumab Withdrawal: A Multicenter Real-World Study in Korea (MAXCARE Study)
Jeonghoon Ha, Kyong Yeun Jung, Kyoung Jin Kim, Seong Hee Ahn, Hyo-Jeong Kim, Yoon-Sok Chung
Endocrinology and Metabolism.2025; 40(5): 748. CrossRef
Denosumab: A Useful Addition to the Armamentarium for the Management of Male Osteoporosis
Jijith Krishnan, Sham Santhanam, Bhuwan Singh, Salim Patel, Divya G Bhojwani, Sameer Muchhala
Cureus.2024;[Epub] CrossRef
Enhancing Treatment Success in Osteoporosis: Optimising the Use of Teriparatide

European Medical Journal.2024; : 49. CrossRef
Denosumab combined with chemotherapy followed by anlotinib in the treatment of multiple metastases of malignant peripheral nerve sheath tumor: a case report and literature review
Qian Chen, Haocheng Cui, Kai Zheng, Ming Xu, Xiuchun Yu
Frontiers in Oncology.2024;[Epub] CrossRef
The use of denosumab in osteoporosis – an update on efficacy and drug safety
Dima L. Diab, Nelson B. Watts
Expert Opinion on Drug Safety.2024; 23(9): 1069. CrossRef
Denosumab in Osteoporosis: Predicting Long-Term Efficacy beyond 10 Years
Jeongmin Lee, Youn-Ju Lee, Jeonghoon Ha
Journal of Bone Metabolism.2024; 31(3): 246. CrossRef
Osteoporose – Definition, Risikoerfassung, Diagnose, Prävention und Therapie (Update 2024)
Hans Peter Dimai, Christian Muschitz, Karin Amrein, Rosemarie Bauer, Daniel Cejka, Rudolf Wolfgang Gasser, Reinhard Gruber, Judith Haschka, Timothy Hasenöhrl, Franz Kainberger, Katharina Kerschan-Schindl, Roland Kocijan, Jürgen König, Norbert Kroißenbrunn
Wiener klinische Wochenschrift.2024; 136(S16): 599. CrossRef
Denosumab stimulates spermatogenesis in infertile men with preserved Sertoli cell capacity
Christine H. Andreassen, Rune Holt, Li Juel Mortensen, Nadia Krarup Knudsen, John E. Nielsen, Nadia Nicholine Poulsen, Sam K. Yahyavi, Ida M. Boisen, Zhihui Cui, Luisina Ongaro, Jasmin P. Hjerresen, Birgitte G. Toft, Thomas Hasselager, Niklas R. Jørgensen
Cell Reports Medicine.2024; 5(10): 101783. CrossRef
Loss of lower extremity bone mineral density 1 year after denosumab is discontinued in persons with subacute spinal cord injury
Christopher M. Cirnigliaro, Michael F. La Fountaine, J. Scott Parrott, Steven C. Kirshblum, Susan J. Sauer, Sue A. Shapses, Isa A. McClure, William A. Bauman
Osteoporosis International.2023; 34(4): 741. CrossRef
Persistence with Denosumab in Male Osteoporosis Patients: A Real-World, Non-Interventional Multicenter Study
Chaiho Jeong, Jeongmin Lee, Jinyoung Kim, Jeonghoon Ha, Kwanhoon Jo, Yejee Lim, Mee Kyoung Kim, Hyuk-Sang Kwon, Tae-Seo Sohn, Ki-Ho Song, Moo Il Kang, Ki-Hyun Baek
Endocrinology and Metabolism.2023; 38(2): 260. CrossRef

Original Articles

Mineral, Bone & Muscle Big Data Articles (National Health Insurance Service Database)
10-Year Fracture Risk in Postmenopausal Women with Osteopenia and Osteoporosis in South Korea: Yeon-Hee Baek, Sun Wook Cho, Han Eol Jeong, Ju Hwan Kim, Yunji Hwang, Jeffrey L. Lange, Ju-Young Shin; Endocrinol Metab. 2021;36(6):1178-1188. Published online December 16, 2021; DOI: https://doi.org/10.3803/EnM.2021.1215

15,345 View
330 Download
26 Web of Science
28 Crossref

Abstract PDF Supplementary Material PubReader ePub

Background
In South Korea, women aged 66 years are eligible for complimentary bone mineral density (BMD) screening via the National Screening Program for Transitional Ages. We aimed to evaluate the 10-year fracture risk in women receiving BMD screening between January 2008 and December 2015.
Methods
BMD was classified as normal (T-score ≥–1.0 standard deviation [SD]), osteopenia (T-score <–1.0 SD and >–2.5 SD), and osteoporosis (T score ≤–2.5 SD) from dual-energy X-ray absorptiometry. Follow-up continued from the screening date until a diagnosis for clinical fragility fracture (including sites of the vertebrae, hip, pelvis, clavicle, humerus, forearm, wrist, lower leg, and ankle), censored at the earliest date of trauma, death, or December 2017; fracture was ascertained using diagnostic codes from the National Health Insurance Service database. A multivariable Cox proportional hazard model was used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for the risk of fracture in women with osteopenia or osteoporosis relative to women with normal BMD.
Results
Among the 271,197 women screened, 44.0% had osteopenia and 35.2% had osteoporosis. The 10 year cumulative incidence of fragility fractures was 31.1%, 37.5%, and 44.3% in women with normal BMD, osteopenia, and osteoporosis, respectively. Fracture risk was higher in women with osteopenia (HR, 1.31; 95% CI, 1.28 to 1.34) and osteoporosis (HR, 1.68; 95% CI, 1.64 to 1.72) than in women with normal BMD.
Conclusion
Women with osteopenia and women with osteoporosis, identified by the national BMD screening program, demonstrated a substantially elevated risk of fracture.

Citations

Citations to this article as recorded by

Utilizing QUS envelope statistics imaging to predict the risk of vertebral fractures in postmenopausal women
Chiao-Yin Wang, Yu-Ching Lin, Ya-Chun Tang, Po-Hsiang Tsui
Ultrasonics.2026; 157: 107803. CrossRef
Epidemiological changes and surgical trends of distal radius fractures in adults over 50 years during the COVID-19 pandemic in Korea: a nationwide repeated cross-sectional study
Han-Kook Yoon, So Ra Yoon, Kee-Bum Hong, Youngsu Jung, SeongJu Choi, Jun-Ku Lee
Journal of Musculoskeletal Trauma.2026; 39(1): 12. CrossRef
Development of a novel anthropomorphic bone phantoms for mimicking osteoporosis in medical imaging development
Jingrui Hu, Junning Chen, Steve Wells, Karen Knapp
Bone.2026; 205: 117803. CrossRef
Nationwide Big Data Studies of Endocrine Diseases Using the Korean National Health Information Database: Research Trends and Standardization of Operational Definitions
Sun Wook Cho, Jung Hee Kim, Kyoung Jin Kim, Beom-Jun Kim, Mee Kyoung Kim, Eun Jung Rhee
Endocrinology and Metabolism.2026; 41(1): 86. CrossRef
Visceral Adiposity, Rather than Reduced Appendicular Lean Mass, Characterizes Elderly Hip Fracture Patients with Type 2 Diabetes: A Cross-Sectional DXA Analysis
Hyuna Kang, Minkyu Choi, Youngkyun Roh, Yonghyun Yoon, Jihyo Hwang
Journal of Clinical Medicine.2026; 15(6): 2284. CrossRef
Impact of bone mineral density testing in the national health screening program on osteoporosis-related medical visits and fractures among women
Jae Hyeok Lim, Jiyeon Chun, Gyung-Joo Min, Dan Bi Kim, Jisu Ko, Eun-Cheol Park
Archives of Osteoporosis.2026;[Epub] CrossRef
Multimorbidity patterns among fragility fracture patients aged 50 + years in China and the US
Qi Meng, Yi Wang, Linghua Yang, Ann M. Vuong, William D. Leslie, Lisa M. Lix, Sumbal Javaid, Bo Kan, Shuman Yang
Osteoporosis International.2026;[Epub] CrossRef
Fracture Risk Stratification by REMS: A 5 Years Prospective Longitudinal Multicentre Study
Carla Caffarelli, Maria Luisa Brandi, Giuseppe Girasole, Andrea Giusti, Maurizio Muratore, Stefano Gonnelli
Calcified Tissue International.2026;[Epub] CrossRef
Concentration and genetic regulation of sex hormone binding globulin and fracture risk in older women
Yuanyuan Wang, Chenglong Yu, Rakibul M. Islam, Sultana Monira Hussain, Anna L. Barker, Paul Lacaze, John J. McNeil, Susan R. Davis
Climacteric.2025; 28(2): 184. CrossRef
Twenty-Year Trends in Osteoporosis Treatment and Post-Fracture Care in South Korea: A Nationwide Study
Kyoung Jin Kim, Kyoung Min Kim, Young-Kyun Lee, Jihye Kim, Hoyeon Jang, Jaiyong Kim, Ha Young Kim
Journal of Bone Metabolism.2025; 32(1): 57. CrossRef
Inositols and Bone Health: Potential Therapeutic Applications in Osteoporosis Prevention and Treatment
Fiammetta Cipriani, Lucio Gnessi, Mikiko Watanabe, Roberto Baldelli
Nutrients.2025; 17(12): 1999. CrossRef
Association between osteoporosis and risk of dementia: a Korean women nationwide population-based cohort study
Min Young Chun, Jimin Jeon, Seok Jong Chung, Jinkwon Kim
Osteoporosis International.2025; 36(10): 1987. CrossRef
Efficacy and Safety of Zoledronate for Osteopenia and Osteoporosis in Postmenopausal Women: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Jinzhu Liu, Wei Lin, Zirui Zhan
Journal of Clinical Question.2025;[Epub] CrossRef
Nonalcoholic fatty liver disease may increase the risk of osteoporosis in middle aged adults: a 12-year longitudinal analysis from the Korean Genome and Epidemiology Study (KoGES)
Jihye Lee, Yun-Jung Yang
Archives of Osteoporosis.2025;[Epub] CrossRef
Individualized Fracture Prevention for Postmenopausal Women with Osteopenia
Jisu Mun, Meeran Kim, Jaeyen Song, Younjee Chung, Jungyoon Park, Junghyun Park
Journal of Menopausal Medicine.2025; 31(3): 138. CrossRef
Beyond the T-Score: Individualized Fracture Prevention in Osteopenia
Ji Yeon Han
Journal of Menopausal Medicine.2025; 31(3): 133. CrossRef
Understanding the long-term impact of incident osteoporotic fractures on healthcare utilization and costs in Korean postmenopausal women
S. Han, S. Kim, E.J. Yeh, H.S. Suh
Osteoporosis International.2024; 35(2): 339. CrossRef
Duration of osteoporosis treatment to reduce the risk of subsequent osteoporotic fracture and all-cause mortality in elderly hip fracture patients in a Korean real-world study
Soong Joon Lee, Minjoon Cho, Hojoon Lee, Hyuna Lim, Jae Hyup Lee
Archives of Osteoporosis.2024;[Epub] CrossRef
Do Patients with Benign Paroxysmal Positional Vertigo Have a Higher Prevalence of Osteoporosis? A Systematic Review and Meta-Analysis
Chul-Ho Kim, Keunho Kim, Yeonjoo Choi
Journal of Personalized Medicine.2024; 14(3): 303. CrossRef
Prediction models incorporating second metacarpal cortical index for osteoporosis in rheumatoid arthritis: Externally validated machine learning models developed using data from the KURAMA cohort
Ryohei Saito, Takayuki Fujii, Koichi Murata, Akira Onishi, Kosaku Murakami, Masao Tanaka, Koichiro Ohmura, Tadashi Yasuda, Akio Morinobu, Shuichi Matsuda
International Journal of Rheumatic Diseases.2024;[Epub] CrossRef
Big Data Research in the Field of Endocrine Diseases Using the Korean National Health Information Database
Sun Wook Cho, Jung Hee Kim, Han Seok Choi, Hwa Young Ahn, Mee Kyoung Kim, Eun Jung Rhee
Endocrinology and Metabolism.2023; 38(1): 10. CrossRef
Chronic airway disease as a major risk factor for fractures in osteopenic women: Nationwide cohort study
Sung Hye Kong, Ae Jeong Jo, Chan Mi Park, Kyun Ik Park, Ji Eun Yun, Jung Hee Kim
Frontiers in Endocrinology.2023;[Epub] CrossRef
Biomimetic Porous Magnesium Alloy Scaffolds Promote the Repair of Osteoporotic Bone Defects in Rats through Activating the Wnt/β-Catenin Signaling Pathway
Yuanchao Zhu, Gaozhi Jia, Yifei Yang, Jian Weng, Su Liu, Mengwei Zhang, Geng Zhang, Haotian Qin, Yixiao Chen, Qi Yang, Guangyin Yuan, Fei Yu, Hui Zeng
ACS Biomaterials Science & Engineering.2023; 9(6): 3435. CrossRef
Correlation between bone mineral density and bone metabolic markers in postmenopausal women with osteoporotic fractures at different C-terminal telopeptide of type 1 collagen levels: a retrospective analysis study
Xiaonan Zhu, Lin Chen, Ling Pan, Yuexi Zeng, Qiang Fu, Yanbin Liu, Yongde Peng, Yufan Wang, Li You
Menopause.2023; 30(11): 1139. CrossRef
Age-Dependent Association of Height Loss with Incident Fracture Risk in Postmenopausal Korean Women
Chaewon Lee, Hye-Sun Park, Yumie Rhee, Namki Hong
Endocrinology and Metabolism.2023; 38(6): 669. CrossRef
A Meaningful Journey to Predict Fractures with Deep Learning
Jeonghoon Ha
Endocrinology and Metabolism.2022; 37(4): 617. CrossRef
The Efficacy of Selective Estrogen Receptor Modulators Monotherapies in Postmenopausal Women with Osteopenia
Kyung Wook Kim, Young Il Kim, Ki-Choul Kim
Journal of Bone Metabolism.2022; 29(3): 185. CrossRef
Correlation of Psoas Muscle Index with Fragility Vertebral Fracture: A Retrospective Cross-Sectional Study of Middle-Aged and Elderly Women
Yihui Zhang, Yilihamu Dilixiati, Wei Jiang, Xiufeng Cao, Yuanyuan Chen, Hui Guo, Christian-Heinz Anderwald
International Journal of Endocrinology.2022; 2022: 1. CrossRef

Mineral, Bone & Muscle
Changes in Serum Dickkopf-1, RANK Ligand, Osteoprotegerin, and Bone Mineral Density after Allogeneic Hematopoietic Stem Cell Transplantation Treatment: Eunhee Jang, Jeonghoon Ha, Ki-Hyun Baek, Moo Il Kang; Endocrinol Metab. 2021;36(6):1211-1218. Published online December 8, 2021; DOI: https://doi.org/10.3803/EnM.2021.1248

8,224 View
126 Download
4 Web of Science
5 Crossref

Abstract PDF PubReader ePub

Background
Dickkopf-1 (DKK1) regulates bone formation by inhibiting canonical Wnt/β-catenin pathway signaling, and indirectly enhances osteoclastic activity by altering the expression ratio of receptor activator of nuclear factor-κB ligand (RANKL) relative to osteoprotegerin (OPG). However, it is difficult to explain continued bone loss after allogeneic stem cell transplantation (allo-SCT) in terms of changes in only RANKL and OPG. Few studies have evaluated changes in DKK1 after allo-SCT.
Methods
We prospectively enrolled 36 patients with hematologic malignancies who were scheduled for allo-SCT treatment. Serum DKK1, OPG, and RANKL levels were measured before (baseline), and at 1, 4, 12, 24, and 48 weeks after allo-SCT treatment. Bone mineral density (BMD) was assessed using dual-energy X-ray absorptiometry before (baseline) and 24 and 48 weeks after allo-SCT treatment.
Results
After allo-SCT treatment, the DKK1 level decreased rapidly, returned to baseline during the first 4 weeks, and remained elevated for 48 weeks (P<0.0001 for changes observed over time). The serum RANKL/OPG ratio peaked at 4 weeks and then declined (P<0.001 for changes observed over time). BMD decreased relative to the baseline at all timepoints during the study period, and the lumbar spine in female patients had the largest decline (–11.3%±1.6% relative to the baseline at 48 weeks, P<0.05).
Conclusion
Serum DKK1 levels rapidly decreased at 1 week and then continued to increase for 48 weeks; bone mass decreased for 48 weeks following engraftment in patients treated with allo-SCT, suggesting that DKK1-mediated inhibition of osteoblast differentiation plays a role in bone loss in patients undergoing allo-SCT.

Citations

Citations to this article as recorded by

Pharmacological modes of plant-derived compounds for targeting inflammation in rheumatoid arthritis: A comprehensive review on immunomodulatory perspective
Laiba Nazakat, Shaukat Ali, Muhammad Summer, Fakiha Nazakat, Shehzeen Noor, Anfah Riaz
Inflammopharmacology.2025; 33(4): 1537. CrossRef
Advances in the study and treatment of glucocorticoid osteoporosis: A review
Xingyu Song, Yaheng Zhang, Hongtao Yang, Fujun Xiong, FengFeng Chen
Medicine.2025; 104(22): e42668. CrossRef
Fractures incidence and its association on mortality in multiple myeloma patients: a nationwide cohort study (CAREMM-2105 study)
Jeonghoon Ha, Suein Choi, Sung-Soo Park, Seulji Moon, Jinseon Han, Jeongyoon Lee, Ki-Hyun Baek, Seunghoon Han, Chang-Ki Min
Scientific Reports.2025;[Epub] CrossRef
Fracture risk and assessment in adults with cancer
Carrie Ye, William D. Leslie
Osteoporosis International.2023; 34(3): 449. CrossRef
Short-Term Impact of Hematopoietic Stem Cell Transplantation in Leukemia Patients on Bone Bio Markers, Electrolytes and Blood Profile
Rhythm Joshi, Zehva Khan, Aakriti Garg, Nidhi, Ubada Aqeel, Dinesh Bhurani, Mohd.Ashif Khan
OBM Transplantation.2023; 07(02): 1. CrossRef

Mineral, Bone & Muscle
Comparison of the Effects of Various Antidiabetic Medication on Bone Mineral Density in Patients with Type 2 Diabetes Mellitus: Jeonghoon Ha, Yejee Lim, Mee Kyoung Kim, Hyuk-Sang Kwon, Ki-Ho Song, Seung Hyun Ko, Moo Il Kang, Sung Dae Moon, Ki-Hyun Baek; Endocrinol Metab. 2021;36(4):895-903. Published online August 9, 2021; DOI: https://doi.org/10.3803/EnM.2021.1026

13,143 View
283 Download
12 Web of Science
11 Crossref

Abstract PDF PubReader ePub

Background
Prospective comparative studies on the effects of various antidiabetic agents on bone metabolism are limited. This study aimed to assess changes in bone mass and biochemical bone markers in postmenopausal patients with type 2 diabetes mellitus (T2DM).
Methods
This prospective, multicenter, open-label, comparative trial included 264 patients with T2DM. Patients who had received a metformin, or sulfonylurea/metformin combination (Group 1); a thiazolidinedione combination (Group 2); a dipeptidyl peptidase-4 inhibitor (gemigliptin) combination (Group 3); or an sodium-glucose cotransporter 2 inhibitor (empagliflozin) combination (Group 4) were prospectively treated for 12 months; bone mineral density (BMD) and bone turnover marker (BTM) changes were evaluated.
Results
The femoral neck BMD percentage changes were −0.79%±2.86% (Group 1), −2.50%±3.08% (Group 2), −1.05%±2.74% (Group 3), and −1.24%±2.91% (Group 4) (P<0.05). The total hip BMD percentage changes were −0.57%±1.79% (Group 1), −1.74%±1.48% (Group 2), −0.75%±1.87% (Group 3), and −1.27%±1.72% (Group 4) (P<0.05). Mean serum BTM (C-terminal type 1 collagen telopeptide and procollagen type 1 amino-terminal propeptide) levels measured during the study period did not change over time or differ between groups.
Conclusion
Significant bone loss in the femoral neck and total hip was associated with thiazolidinedione combination regimens. However, bone loss was not significantly associated with combination regimens including gemigliptin or empagliflozin. Caution should be exercised during treatment with antidiabetic medications that adversely affect the bone in patients with diabetes at a high risk of bone loss.

Citations

Citations to this article as recorded by

Osteoporosis risk with sodium–glucose cotransporter 2 inhibitors versus thiazolidinediones in older women with diabetes
Hyeon Jeong Lee, Pusoon Chun
Journal of Bone and Mineral Metabolism.2026; 44(3): 375. CrossRef
Dapagliflozin Improves High‐Fat Diet‐Induced Cognitive Impairment in Female Mice
Xiaolin Chen, Mingxia Fan, Zhuoni Xiao, Xiaoxing Xiong
Brain and Behavior.2025;[Epub] CrossRef
Proteases and Osteoporosis: A Comprehensive Review of Their Role in Bone Health
Syed Sufian Ahmad, Faraha Ahmed, Sayeed Ahmad, Mohammad Ahmed Khan
Current Drug Targets.2025; 26(7): 489. CrossRef
Meta-Analysis on the Association Between DPP-4 Inhibitors and Bone Mineral Density and Osteoporosis
Lili Huang, Wei Zhong, Xinghuan Liang, Huijuan Wang, Shi-en Fu, Zuojie Luo
Journal of Clinical Densitometry.2024; 27(1): 101455. CrossRef
A multicentre, double‐blind, placebo‐controlled, randomized, parallel comparison, phase 3 trial to evaluate the efficacy and safety of pioglitazone add‐on therapy in type 2 diabetic patients treated with metformin and dapagliflozin
Soo Lim, Seung‐Hwan Lee, Kyung‐Wan Min, Chang Beom Lee, Sang Yong Kim, Hye Jin Yoo, Nan Hee Kim, Jae Hyeon Kim, Seungjoon Oh, Jong Chul Won, Hyuk Sang Kwon, Mi Kyung Kim, Jung Hwan Park, In‐Kyung Jeong, Sungrae Kim
Diabetes, Obesity and Metabolism.2024; 26(6): 2188. CrossRef
Bone Loss in Diabetes Mellitus: Diaporosis
Krisztina Kupai, Hsu Lin Kang, Anikó Pósa, Ákos Csonka, Tamás Várkonyi, Zsuzsanna Valkusz
International Journal of Molecular Sciences.2024; 25(13): 7269. CrossRef
The multiple actions of dipeptidyl peptidase 4 (DPP-4) and its pharmacological inhibition on bone metabolism: a review
L. M. Pechmann, F. I. Pinheiro, V. F. C. Andrade, C. A. Moreira
Diabetology & Metabolic Syndrome.2024;[Epub] CrossRef
The effect of antidiabetic drugs on bone metabolism: a concise review
Stavroula Psachna, Maria Eleni Chondrogianni, Konstantinos Stathopoulos, Antonis Polymeris, Antonios Chatzigeorgiou, Efstathios Chronopoulos, Symeon Tournis, Eva Kassi
Endocrine.2024; 87(3): 907. CrossRef
Responsible Use of Oral Corticosteroids in People with Comorbid Diabetes: An Expert Consensus
Banshi Saboo, Shashank Joshi, Amit Gupta, Anuj Maheshwari, Bharat Saboo, Brij Mohan Makkar, Ganapathi Bantwal, Jothydev Kesavadev, L Sreenivasamurthy, Mangesh Tiwaskar, Manoj Chawla, Minakshisundaram Shunmugavelu, Nagendra Kumar Singh, Pratap Jethwani, Sa
Journal of the Association of Physicians of India.2024; 72(7): 79. CrossRef
Association of Bone Turnover Markers with Type 2 Diabetes Mellitus and Microvascular Complications: A Matched Case-Control Study
Yilin Hou, Xiaoyu Hou, Qian Nie, Qiuyang Xia, Rui Hu, Xiaoyue Yang, Guangyao Song, Luping Ren
Diabetes, Metabolic Syndrome and Obesity.2023; Volume 16: 1177. CrossRef
Complementary effects of dapagliflozin and lobeglitazone on metabolism in a diet-induced obese mouse model
Yun Kyung Lee, Tae Jung Oh, Ji In Lee, Bo Yoon Choi, Hyen Chung Cho, Hak Chul Jang, Sung Hee Choi
European Journal of Pharmacology.2023; 957: 175946. CrossRef

Review Article

Mineral, Bone & Muscle
Operationalizing Treat-to-Target for Osteoporosis: E. Michael Lewiecki; Endocrinol Metab. 2021;36(2):270-278. Published online March 24, 2021; DOI: https://doi.org/10.3803/EnM.2021.970

14,016 View
440 Download
12 Web of Science
15 Crossref

Abstract PDF PubReader ePub

Treat-to-target (TTT) for osteoporosis is a concept for individualizing patient treatment decisions that focuses on achieving an acceptable level of fracture risk rather than response to treatment alone. While a response to treatment is essential in order to achieve an acceptable level of risk, it is not necessarily sufficient. Some patients have a good response to treatment yet remain at high level of fracture risk. Since there is no way to directly measure bone strength in patients treated for osteoporosis, a surrogate measurement must be used. Bone mineral density (BMD) is commonly used to select patients for treatment and has emerged as the most useful surrogate for assessing reduction of fracture risk after treatment is started. Recent large meta-regression studies have shown a robust correlation between larger increases in BMD with treatment and greater reductions in fracture risk. Application of TTT for osteoporosis involves assessing fracture risk before starting treatment and initiating treatment with an agent that is most likely to reduce fracture risk to an acceptable level, represented by a target BMD T-score, over a reasonable period of time. This review offers suggestions for implementing TTT for osteoporosis in clinical practice and managing patients who fail or succeed in reaching the target. More study is needed to fully validate the use of TTT for osteoporosis for initiating and modifying treatments to reduce fracture risk.

Citations

Citations to this article as recorded by

Is the difficult-to-manage concept applicable to osteoporosis?
Cécile Philippoteaux, Elena Tsourdi, Julien Paccou
Joint Bone Spine.2026; 93(3): 105996. CrossRef
Role of Bone Turnover Markers and Bone Mineral Density in Monitoring Bone Health at One- and Three-Year Post-antiresorptive Therapy Initiation in Patients With Osteoporosis: A Retrospective Cohort Study
Ahmed T Al-Jumaily, Batseba Bereket Araya, Ashiyana Malil, Chakraborty Oung, Flavian Joseph, Tripti Joshi
Cureus.2026;[Epub] CrossRef
Recommendations for the diagnosis, prevention and treatment of osteoporosis in men
N.V. Grygorieva, М.О. Коrzh, M.D. Tronko, B.M. Mankovsky, R.I. Yatsyshyn, I.Yu. Golovach, S.S. Strafun, S.I. Smiyan, Yu.M. Gurzhenko, D.G. Rekalov, O.D. Nikitin, V.L. Orlenko, G.O. Protsenko, A.V. Kalashnikov, V.Ye. Luchytskyi, А.S. Musiіenko
TRAUMA.2026; 27(2): 170. CrossRef
Le concept « difficult-to-manage » est-il applicable à l’ostéoporose ?
Cécile Philippoteaux, Elena Tsourdi, Julien Paccou
Revue du Rhumatisme.2026;[Epub] CrossRef
Diagnosis and treatment of osteoporosis: 2026 recommendations of the Polish Society for Rheumatology
Piotr Leszczyński, Cezary Iwaszkiewicz, Zbigniew Michał Żuber, Brygida Kwiatkowska, Bogdan Piotr Batko, Katarzyna Krystyna Pawlak-Buś
Rheumatology.2026;[Epub] CrossRef
Longitudinal osteoporosis therapy: treat-to-target and sequential strategies—a narrative review
Irakli Tskhakaia, Maria I. Danila
Therapeutic Advances in Musculoskeletal Disease.2026;[Epub] CrossRef
Tratamiento de la osteoporosis en la práctica clínica: cuándo, a quién, cómo y durante cuánto tiempo
R. Arboiro Pinel
Revista Clínica Española.2026; : 502614. CrossRef
Treatment of osteoporosis in clinical practice: when, whom, how, and for how long
R. Arboiro Pinel
Revista Clínica Española (English Edition).2026; : 502614. CrossRef
First‐line treatment of osteoporosis with osteoanabolic therapy: a new opportunity
Jasna Aleksova, Peter Ebeling
Internal Medicine Journal.2025; 55(8): 1232. CrossRef
Efficacy of a single 5 mg zoledronic acid infusion in preventing bone loss and fracture in postmenopausal women with breast cancer
Han-Sang Baek, Kabsoo shin, Jinyoung Kim, Chaiho Jeong, Jeongmin Lee, Yejee Lim, Ki-Hyun Baek, Jeonghoon Ha
Journal of Bone and Mineral Metabolism.2024; 42(6): 720. CrossRef
Treatment sequencing using the dual amylin and calcitonin receptor agonist KBP-336 and semaglutide results in durable weight loss
Anna Thorsø Larsen, Morten A. Karsdal, Kim Henriksen
European Journal of Pharmacology.2023; 954: 175837. CrossRef
Osteoporosis: Spotlight on current approaches to pharmacological treatment
Dilşad Sindel
Turkish Journal of Physical Medicine and Rehabilitation.2023; 69(2): 140. CrossRef
Postmenopausal Osteoporosis
Caren G. Solomon, Marcella Donovan Walker, Elizabeth Shane
New England Journal of Medicine.2023; 389(21): 1979. CrossRef
Prevalence and Risk Factors of T-Score Spine-Hip Discordance in Patients with Osteoporotic Vertebral Compression Fracture
Byung-Ho Yoon, Ho Won Kang, Su Min Kim, Young Do Koh
Journal of Bone Metabolism.2022; 29(1): 43. CrossRef
Pharmacological treatment of osteoporosis: 2022 update
Yunkyung Jeon, In-Joo Kim
Journal of the Korean Medical Association.2022; 65(4): 241. CrossRef

Original Articles

Clinical Study
Romosozumab in Postmenopausal Korean Women with Osteoporosis: A Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study: Ki-Hyun Baek, Yoon-Sok Chung, Jung-Min Koh, In Joo Kim, Kyoung Min Kim, Yong-Ki Min, Ki Deok Park, Rajani Dinavahi, Judy Maddox, Wenjing Yang, Sooa Kim, Sang Jin Lee, Hyungjin Cho, Sung-Kil Lim; Endocrinol Metab. 2021;36(1):60-69. Published online February 24, 2021; DOI: https://doi.org/10.3803/EnM.2020.848

15,218 View
497 Download
26 Web of Science
29 Crossref

Abstract PDF Supplementary Material PubReader ePub

Background
This phase 3 study evaluated the efficacy and safety of 6-month treatment with romosozumab in Korean postmenopausal women with osteoporosis.
Methods
Sixty-seven postmenopausal women with osteoporosis (bone mineral density [BMD] T-scores ≤–2.5 at the lumbar spine, total hip, or femoral neck) were randomized (1:1) to receive monthly subcutaneous injections of romosozumab (210 mg; n=34) or placebo (n=33) for 6 months.
Results
At month 6, the difference in the least square (LS) mean percent change from baseline in lumbar spine BMD (primary efficacy endpoint) between the romosozumab (9.5%) and placebo (–0.1%) groups was significant (9.6%; 95% confidence interval, 7.6 to 11.5; P<0.001). The difference in the LS mean percent change from baseline was also significant for total hip and femoral neck BMD (secondary efficacy endpoints). After treatment with romosozumab, the percent change from baseline in procollagen type 1 N-terminal propeptide transiently increased at months 1 and 3, while that in C-terminal telopeptide of type 1 collagen showed a sustained decrease. No events of cancer, hypocalcemia, injection site reaction, positively adjudicated atypical femoral fracture or osteonecrosis of the jaw, or positively adjudicated serious cardiovascular adverse events were observed. At month 9, 17.6% and 2.9% of patients in the romosozumab group developed binding and neutralizing antibodies, respectively.
Conclusion
Treatment with romosozumab for 6 months was well tolerated and significantly increased lumbar spine, total hip, and femoral neck BMD compared with placebo in Korean postmenopausal women with osteoporosis (ClinicalTrials.gov identifier NCT02791516).

Citations

Citations to this article as recorded by

Assessment of the efficacy and safety of anti-sclerostin antibody therapy for osteoporosis in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials
Lianzhi Chen, Qingwen Wang, Mingxi Gu
Frontiers in Endocrinology.2026;[Epub] CrossRef
Sclerostin in Vascular Calcification: Hypoxia-Driven Regulation and Therapeutic Modulation by Natural Products
Seungyeon Yeon, Sai-Wang Seto, Jyoti Deep Bhuyan, Dennis Chang, Chun Guang Li, Mitchell Low¹
Current Atherosclerosis Reports.2026;[Epub] CrossRef
An updated perspective of post-fracture rehabilitation: focus on osteoporotic fracture outcomes amid novel wave of bone forming intervention
Oana-Claudia Sima, Veronica Cumpata, Mihai Costachescu, Dana Terzea, Mara Carsote, Emi Marinela Preda
Balneo and PRM Research Journal.2026;[Epub] CrossRef
Is Early Injection-Site Reaction Associated With the Efficacy of Romosozumab?
Takaomi Kobayashi, Tomonori Kobayakawa, Tadatsugu Morimoto, Yukio Nakamura
Cureus.2026;[Epub] CrossRef
The influence of anti-osteoporotic drugs on fracture risk, bone mineral density, and side effect in senile osteoporosis treatment: a network meta-analysis of randomized controlled trials
Zongyi Zhou, Qiwei Yang, Lu Liu, Weiying Guo, Feng Xu, Yadong Liu, Xin Li, Yanhua Wu, Nan Zhou, Hanxin Yao, Chengluan Xuan, Yuanyi Wang
Heliyon.2026; 12(11): e45032. CrossRef
Romosozumab increases bone mineral density in postmenopausal Chinese women with osteoporosis: A randomised phase three study
Zhang Zhenlin, Xue Qingyun, Chen Decai, Chao Aijun, Huo Yanan, Zhu Mei, Cao Xu, Lin Hua, Xu Youjia, Cheng Qun, Yang Huilin, Xu Xiaoyan, Li Yujie, Du Xuan, Jiang Jun, Gao LingLing, Rosario-Jansen Theresa, Bauer Lars, Xia Weibo
Journal of Orthopaedic Translation.2026; 59: 101135. CrossRef
Proxied therapeutic inhibition on sclerostin and atrial fibrillation risk
Yu Qian, Peng-Lin Guan, Jingyan Hu, Ming-Yu Han, Yi-Hu Fang, Wei-Lin Wang, Saber Khederzadeh, Yun-Piao Hou, Mo-Chang Qiu, Jian-Hua Gao, Cheng-Da Yuan, Fei Huang, David Karasik, Ching-Lung Cheung, Liu Yang, Yong Wang, Chao Zheng, Lin Bo, Hou-Feng Zheng
Communications Medicine.2026;[Epub] CrossRef
Cardiovascular Safety of Romosozumab Compared to Commonly Used Anti-osteoporosis Medications in Postmenopausal Osteoporosis: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials
Shih-Hao Cheng, William Chu, Wen-Hsiang Chou, Woei-Chyn Chu, Yi-No Kang
Drug Safety.2025; 48(1): 7. CrossRef
Mechanisms Underlying Medication‐Related Osteonecrosis of the Jaw
Kyeongho Lee, Kihun Kim, June Yeon Kim, Jin‐Woo Kim, Young‐Hoon Kang, Yun Hak Kim, Sung‐Jin Kim
Oral Diseases.2025; 31(4): 1073. CrossRef
Effect of precise health management combined with physical rehabilitation on bone biomarkers in senile osteoporosis patients
Litao Chen, Xiaojing Yan, Yongjian Liu, Yongbin Pei, Jin Zhou, Lei Zhang, Zhixing Du
Scientific Reports.2025;[Epub] CrossRef
Real-World Evaluation of 12-Month Romosozumab Treatment in Korean Women with Severe Osteoporosis: Potential Synergy with Hormone Therapy
Jung Yoon Park, Hyoung Moo Park, Jae-Yen Song, Kyung Jin Hwang, Mee-Ran Kim, Youn-Jee Chung
Journal of Clinical Medicine.2025; 14(9): 2958. CrossRef
Assessing the Efficacy of Romosozumab in Postmenopausal Osteoporosis
Bartolomé Lladó Ferrer, Marina Soledad Moreno Garcia, Sara Rojas Herrera, César Antonio Egües Dubuc, Gonzalo Mariscal, Juan Buades Mateu
JCR: Journal of Clinical Rheumatology.2025; 31(6): e119. CrossRef
Role of Sclerostin in Cardiovascular System
Ning Zhang, Luyao Wang, Xiaofei Li, Xin Yang, Xiaohui Tao, Hewen Jiang, Yuanyuan Yu, Jin Liu, Sifan Yu, Yuan Ma, Baoting Zhang, Ge Zhang
International Journal of Molecular Sciences.2025; 26(10): 4552. CrossRef
Mechanisms of the Ershiwuwei Guijiu Pill in Treating Postmenopausal Osteoporosis Based on Network Analysis and Experimental Validation
Fanglin Duan, Li-Xue Zhang, Muhammad Naveed, Peifeng Wu, Yao Yu, Muhammad Zia Ahmad, Dongfang Dai, Jannat Bibi, Fenghui Li, Changxing Li
Journal of Evidence-Based Integrative Medicine.2025;[Epub] CrossRef
Efficacy comparison of 6-month romosozumab plus denosumab versus 12-month romosozumab in Koreans
Seung-Eun Lee, Seong Hee Ahn, Beom-Jun Kim, Seung Hun Lee, Ha Young Kim, Seongbin Hong, Jung-Min Koh
European Journal of Endocrinology.2025; 193(5): 527. CrossRef
Branched‑chain amino acid metabolism and bone metabolism: Implications for osteoporosis pathogenesis and therapeutic strategies (Review)
Qi Xiao, Haimin Zeng, Ruhui Yang, Yuxin Zhan, Fangzhen Lin, Bofan Chen, Xiang Chen
International Journal of Molecular Medicine.2025; 57(2): 1. CrossRef
Efficacy and safety of romosozumab: a meta-analysis of placebo-controlled trials
Takaomi Kobayashi, Megumi Hara, Chisato Shimanoe, Tadatsugu Morimoto, Mawatari Masaaki, Koji Ito, Takafumi Shimazaki
Journal of Bone and Mineral Metabolism.2024; 42(5): 492. CrossRef
Treatment effects, adverse outcomes and cardiovascular safety of romosozumab – Existing worldwide data: A systematic review and meta-analysis
Ronald Man Yeung Wong, Pui Yan Wong, Chaoran Liu, Hei Yuet Wong, Man Ki Fong, Ning Zhang, Wing Hoi Cheung, Sheung Wai Law
Journal of Orthopaedic Translation.2024; 48: 107. CrossRef
Romosozumab for the treatment of osteoporosis – a systematic review
V.-N. Mäkinen, A. S. Sølling, M. McClung, B. L. Langdahl
Journal of Endocrinological Investigation.2024; 48(3): 547. CrossRef
A pharmacovigilance analysis of FDA adverse event reporting system events for romosozumab
Zepeng Chen, Ming Li, Shuzhen Li, Yuxi Li, Junyan Wu, Kaifeng Qiu, Xiaoxia Yu, Lin Huang, Guanghui Chen
Expert Opinion on Drug Safety.2023; 22(4): 339. CrossRef
Evaluation of the efficacy and safety of romosozumab (evenity) for the treatment of osteoporotic vertebral compression fracture in postmenopausal women: A systematic review and meta‐analysis of randomized controlled trials (CDM‐J)
Wenbo Huang, Masashi Nagao, Naohiro Yonemoto, Sen Guo, Takeshi Tanigawa, Yuji Nishizaki
Pharmacoepidemiology and Drug Safety.2023; 32(6): 671. CrossRef
Efficacy and Cardiovascular Safety of Romosozumab: A Meta-analysis and Systematic Review
Seo-Yong Choi, Jeong-Min Kim, Sang-Hyeon Oh, Seunghyun Cheon, Jee-Eun Chung
Korean Journal of Clinical Pharmacy.2023; 33(2): 128. CrossRef
Clinical Studies On Romosozumab: An Alternative For Individuals With A High Risk Of Osteoporotic Fractures: A Current Concepts Review (Part I)
E. Carlos Rodriguez-Merchan, Alonso Moreno-Garcia, Hortensia De la Corte-Rodriguez
SurgiColl.2023;[Epub] CrossRef
Romosozumab in osteoporosis: yesterday, today and tomorrow
Dong Wu, Lei Li, Zhun Wen, Guangbin Wang
Journal of Translational Medicine.2023;[Epub] CrossRef
Efficacy and safety of anti-sclerostin antibodies in the treatment of osteoporosis: A meta-analysis and systematic review
Frideriki Poutoglidou, Efthimios Samoladas, Nikolaos Raikos, Dimitrios Kouvelas
Journal of Clinical Densitometry.2022; 25(3): 401. CrossRef
Benefits of lumican on human bone health: clinical evidence using bone marrow aspirates
Yun Sun Lee, So Jeong Park, Jin Young Lee, Eunah Choi, Beom-Jun Kim
The Korean Journal of Internal Medicine.2022; 37(4): 821. CrossRef
What is the risk of cardiovascular events in osteoporotic patients treated with romosozumab?
I. R. Reid
Expert Opinion on Drug Safety.2022; 21(12): 1441. CrossRef
Proxied Therapeutic Inhibition on Wnt Signaling Antagonists and Risk of Cardiovascular Diseases: Multi-Omics Analyses
Yu Qian, Cheng-Da Yuan, Saber Khederzadeh, Ming-Yu Han, Hai-Xia Liu, Mo-Chang Qiu, Jian-Hua Gao, Wei-Lin Wang, Yun-Piao Hou, Guo-Bo Chen, Ke-Qi Liu, Lin Xu, David Karasik, Shu-Yang Xie, Hou-Feng Zheng
SSRN Electronic Journal .2022;[Epub] CrossRef
Multi-Omics Analyses Identify Pleiotropy and Causality Between Circulating Sclerostin and Atrial Fibrillation
Yu Qian, Peng-Lin Guan, Saber Khederzadeh, Ke-Qi Liu, Cheng-Da Yuan, Ming-Yu Han, Hai-Xia Liu, Mo-Chang Qiu, Jian-Hua Gao, Wei-Lin Wang, Yun-Piao Hou, Guo-Bo Chen, Lin Xu, David Karasik, Shu-Yang Xie, sheng zhifeng, Hou-Feng Zheng
SSRN Electronic Journal .2022;[Epub] CrossRef

Endocrine Research
Transformation of Mature Osteoblasts into Bone Lining Cells and RNA Sequencing-Based Transcriptome Profiling of Mouse Bone during Mechanical Unloading: A Ram Hong, Kwangsoo Kim, Ji Yeon Lee, Jae-Yeon Yang, Jung Hee Kim, Chan Soo Shin, Sang Wan Kim; Endocrinol Metab. 2020;35(2):456-469. Published online June 24, 2020; DOI: https://doi.org/10.3803/EnM.2020.35.2.456; Correction in: Endocrinol Metab 2021;36(6):1314

13,994 View
200 Download
14 Web of Science
16 Crossref

Abstract PDF Supplementary Material PubReader ePub

Background
We investigated RNA sequencing-based transcriptome profiling and the transformation of mature osteoblasts into bone lining cells (BLCs) through a lineage tracing study to better understand the effect of mechanical unloading on bone loss.
Methods
Dmp1-CreERt2(+):Rosa26R mice were injected with 1 mg of 4-hydroxy-tamoxifen three times a week starting at postnatal week 7, and subjected to a combination of botulinum toxin injection with left hindlimb tenotomy starting at postnatal week 8 to 10. The animals were euthanized at postnatal weeks 8, 9, 10, and 12. We quantified the number and thickness of X-gal(+) cells on the periosteum of the right and left femoral bones at each time point.
Results
Two weeks after unloading, a significant decrease in the number and a subtle change in the thickness of X-gal(+) cells were observed in the left hindlimbs compared with the right hindlimbs. At 4 weeks after unloading, the decrease in the thickness was accelerated in the left hindlimbs, although the number of labeled cells was comparable. RNA sequencing analysis showed downregulation of 315 genes in the left hindlimbs at 2 and 4 weeks after unloading. Of these, Xirp2, AMPD1, Mettl11b, NEXN, CYP2E1, Bche, Ppp1r3c, Tceal7, and Gadl1 were upregulated during osteoblastogenic/osteocytic and myogenic differentiation in vitro.
Conclusion
These findings demonstrate that mechanical unloading can accelerate the transformation of mature osteoblasts into BLCs in the early stages of bone loss in vivo. Furthermore, some of the genes involved in this process may have a pleiotropic effect on both bone and muscle.

Citations

Citations to this article as recorded by

Lactoferrin-EGCG covalent complex promotes osteoblast differentiation via TGF-β/BMP signaling pathway
FengJiao FAN, XiaoNi LIAN, ZhenNi ZHAI, HongKai XIE, HuiLing CHEN, JiaJie YIN, XiaoYi JIANG, Jian DING, Yong FANG
SCIENTIA SINICA Vitae.2026; 56(7): 1748. CrossRef
Tceal7 is a BRG1-regulated target of calcineurin signaling that promotes myoblast differentiation
Sandhya Yadav, Tapan Sharma, Monserrat Olea-Flores, Teresita Padilla-Benavides, Anthony N. Imbalzano, Giuseppina Caretti
PLOS One.2026; 21(9): e0358038. CrossRef
Unraveling the dynamics of osteoblast differentiation in MC3T3-E1 cells: Transcriptomic insights into matrix mineralization and cell proliferation
Heein Yoon, Seung Gwa Park, Hye-Rim Shin, Ki-Tae Kim, Young-Dan Cho, Jae-I Moon, Woo-Jin Kim, Hyun-Mo Ryoo
Bone.2025; 194: 117442. CrossRef
Branched‑chain amino acid metabolism and bone metabolism: Implications for osteoporosis pathogenesis and therapeutic strategies (Review)
Qi Xiao, Haimin Zeng, Ruhui Yang, Yuxin Zhan, Fangzhen Lin, Bofan Chen, Xiang Chen
International Journal of Molecular Medicine.2025; 57(2): 1. CrossRef
Synthetic composites versus calcium phosphate cements in bone regeneration: A narrative review
Oana Dima, Andreea Cristiana Didilescu, Claudiu Constantin Manole, Cornelis Pameijer, Claudiu Călin
Annals of Anatomy - Anatomischer Anzeiger.2024; 255: 152273. CrossRef
Insights and implications of sexual dimorphism in osteoporosis
Yuan-Yuan Zhang, Na Xie, Xiao-Dong Sun, Edouard C. Nice, Yih-Cherng Liou, Canhua Huang, Huili Zhu, Zhisen Shen
Bone Research.2024;[Epub] CrossRef
Rationale of using magnetically sensitive biomaterials in bone tissue therapy: a review
Pavel A. Markov, Elena Y. Kostromina, Anatoliy D. Fesyun, Petr S. Eremin
Bulletin of Rehabilitation Medicine.2024; 23(3): 69. CrossRef
METTLing in Stem Cell and Cancer Biology
John G. Tooley, James P. Catlin, Christine E. Schaner Tooley
Stem Cell Reviews and Reports.2023; 19(1): 76. CrossRef
Three's a crowd – why did three N-terminal methyltransferases evolve for one job?
Meghan M. Conner, Christine E. Schaner Tooley
Journal of Cell Science.2023;[Epub] CrossRef
Unlocking the mysteries of alpha-N-terminal methylation and its diverse regulatory functions
Panyue Chen, Rong Huang, Tony R. Hazbun
Journal of Biological Chemistry.2023; 299(7): 104843. CrossRef
Examining Mechanisms for Voltage-Sensitive Calcium Channel-Mediated Secretion Events in Bone Cells
Perla C. Reyes Fernandez, Christian S. Wright, Mary C. Farach-Carson, William R. Thompson
Calcified Tissue International.2023; 113(1): 126. CrossRef
Reactivation of Bone Lining Cells are Attenuated Over Repeated Anti-sclerostin Antibody Administration
A Ram Hong, Jae-Yeon Yang, Ji Yeon Lee, Joonho Suh, Yun-Sil Lee, Jung-Eun Kim, Sang Wan Kim
Calcified Tissue International.2022; 111(5): 495. CrossRef
Purine metabolism in the development of osteoporosis
Keda Yang, Jie Li, Lin Tao
Biomedicine & Pharmacotherapy.2022; 155: 113784. CrossRef
Effects of Gabapentin and Pregabalin on Calcium Homeostasis: Implications for Physical Rehabilitation of Musculoskeletal Tissues
Perla C. Reyes Fernandez, Christian S. Wright, Stuart J. Warden, Julia Hum, Mary C. Farach-Carson, William R. Thompson
Current Osteoporosis Reports.2022; 20(6): 365. CrossRef
Calvaria Bone Transcriptome in Mouse Models of Osteogenesis Imperfecta
Pierre Moffatt, Iris Boraschi-Diaz, Juliana Marulanda, Ghalib Bardai, Frank Rauch
International Journal of Molecular Sciences.2021; 22(10): 5290. CrossRef
Age-related neurodegeneration and cognitive impairments of NRMT1 knockout mice are preceded by misregulation of RB and abnormal neural stem cell development
James P. Catlin, Leandro N. Marziali, Benjamin Rein, Zhen Yan, M. Laura Feltri, Christine E. Schaner Tooley
Cell Death & Disease.2021;[Epub] CrossRef

Clinical Study
Gemigliptin Inhibits Interleukin-1β–Induced Endothelial-Mesenchymal Transition via Canonical-Bone Morphogenetic Protein Pathway: Oak-Kee Hong, Seong-Su Lee, Soon Jib Yoo, Min-Kyung Lee, Mee-Kyoung Kim, Ki-Hyun Baek, Ki-Ho Song, Hyuk-Sang Kwon; Endocrinol Metab. 2020;35(2):384-395. Published online June 24, 2020; DOI: https://doi.org/10.3803/EnM.2020.35.2.384

12,139 View
160 Download
18 Web of Science
17 Crossref

Abstract PDF Supplementary Material PubReader ePub

Background
Endothelial-to-mesenchymal transition (EndMT) contributes to inflammatory conditions inducing conversion of endothelial cells (ECs) into activated fibroblasts, promoting fibrotic diseases. Pro-inflammatory cytokine is the most potent inducer of EndMT. We investigated inhibition of interleukin-1β (IL-1β)-induced EndMT by gemigliptin, a dipeptidyl peptidase-IV inhibitor.
Methods
We exposed human umbilical vein endothelial cells (HUVECs) to 10 ng/mL IL-1β/20 μM gemigliptin and analyzed the expression of endothelial, smooth muscle, mesenchymal, and osteoblastic markers, bone morphogenetic protein (BMP), Smad, and non-Smad signaling pathway proteins.
Results
Morphological changes showed gemigliptin blocked IL-1β-induced EndMT, upregulated EC markers, and downregulated smooth muscle and mesenchymal markers. IL-1β activation of HUVECs is initiated by the BMP/Smad and non-smad BMP signaling pathways. Gemigliptin inhibited IL-1β induction of BMP2 and 7, activin receptor type IA, BMP receptor type IA, and BMP receptor type II. Reversal of IL-1β-mediated inhibition of BMP-induced Smad1/5/8, Smad2, and Smad3 phosphorylation by gemigliptin suggests involvement of the Smad pathway in gemigliptin action. In the non-Smad BMP pathway, gemigliptin treatment significantly increased the deactivation of extracellular regulated protein kinase (ERK), p38, and JNK by IL-1β. Gemigliptin treatment suppressed BMP-2-induced expression of key osteoblastic markers including osterix, runt-related transcription factor 2, and hepcidin during IL-1β-induced EndMT.
Conclusion
We demonstrated a novel protective mechanism of gemigliptin against fibrosis by suppressing IL-1β-induced EndMT.

Citations

Citations to this article as recorded by

RNA-seq and ChIP-seq reveal microplastics induce endothelial-mesenchymal transition via HK2-mediated histone lactylation in pulmonary hypertension
Chuyan Long, Mouwen Lin, Wenjie Wang, Yang Liu, Zixi Huang, Zhenyan Xu
Vascular Pharmacology.2026; 162: 107571. CrossRef
Vascular calcification: pathogenic mechanisms, signaling crosstalk and translational therapeutics
Rui Hua, Bao Qiao, Xuehao Liu, Bingchen Jiang, Jinlei Wu, Chuanxin Zhang, Han Liu, Bailu Wang, Shujian Wei, Yuguo Chen
Signal Transduction and Targeted Therapy.2026;[Epub] CrossRef
Broadening horizons: molecular mechanisms and disease implications of endothelial-to-mesenchymal transition
Cheng Qian, Guanglu Dong, Chunmei Yang, Weiwei Zheng, Chongjin Zhong, Qiuhong Shen, Yin Lu, Yang Zhao
Cell Communication and Signaling.2025;[Epub] CrossRef
The mechanism of curcumin protecting against IL-1β-induced oxidative stress and inflammation in chondrocytes via the Bmp2/Smad5/Runx2 pathway
Jinlei Li, Weitong Liu, Tao Wang, Yanbo Wang, Guang Yang, Jiankun Chen, Yongsheng Xu, Jingfan Yang
Cytotechnology.2025;[Epub] CrossRef
MFGE8 regulates the EndoMT of HLMECs through the BMP signaling pathway and fibrosis in acute lung injury
Qingqiang Shi, Huang Liu, Hanghang Wang, Ling Tang, Qi Di, Daoxin Wang
Respiratory Research.2025;[Epub] CrossRef
Molecular mechanisms of endothelial–mesenchymal transition and its pathophysiological feature in cerebrovascular disease
Huimin Jiang, Yifan Zhou, Weiyue Zhang, Hui Li, Wei Ma, Xunming Ji, Chen Zhou
Cell & Bioscience.2025;[Epub] CrossRef
Human cathelicidin peptide LL-37 induces endothelial-to-mesenchymal transition
Kaori Suzuki, Mari Ohkuma, Isao Nagaoka
Bioscience, Biotechnology, and Biochemistry.2025; 89(10): 1464. CrossRef
Gemigliptin Alleviates Succinate Induced Endoplasmic Reticulum Stress and Activation of Hepatic Stellate Cells
Dinh-Vinh Do, Giang Nguyen, So Young Park, Eun-Hee Cho
Journal of Korean Medical Science.2025;[Epub] CrossRef
Injured Endothelial Cell: A Risk Factor for Pulmonary Fibrosis
Weiming Zhao, Lan Wang, Yaxuan Wang, Hongmei Yuan, Mengxia Zhao, Hui Lian, Shuaichen Ma, Kai Xu, Zhongzheng Li, Guoying Yu
International Journal of Molecular Sciences.2023; 24(10): 8749. CrossRef
Tissue fibrosis induced by radiotherapy: current understanding of the molecular mechanisms, diagnosis and therapeutic advances
Zuxiang Yu, Chaoyu Xu, Bin Song, Shihao Zhang, Chong Chen, Changlong Li, Shuyu Zhang
Journal of Translational Medicine.2023;[Epub] CrossRef
MiRNAs in Systemic Sclerosis Patients with Pulmonary Arterial Hypertension: Markers and Effectors
Mor Zaaroor Levy, Noa Rabinowicz, Maia Yamila Kohon, Avshalom Shalom, Ariel Berl, Tzipi Hornik-Lurie, Liat Drucker, Shelly Tartakover Matalon, Yair Levy
Biomedicines.2022; 10(3): 629. CrossRef
Recent advance in treatment of atherosclerosis: Key targets and plaque-positioned delivery strategies
Li Li, Sainan Liu, Jianying Tan, Lai Wei, Dimeng Wu, Shuai Gao, Yajun Weng, Junying Chen
Journal of Tissue Engineering.2022;[Epub] CrossRef
Vascular Calcification: New Insights Into BMP Type I Receptor A
Zhixing Niu, Guanyue Su, Tiantian Li, Hongchi Yu, Yang Shen, Demao Zhang, Xiaoheng Liu
Frontiers in Pharmacology.2022;[Epub] CrossRef
Yi-Shen-Hua-Shi Granule Alleviates Adriamycin-Induced Glomerular Fibrosis by Suppressing the BMP2/Smad Signaling Pathway
Zhuojing Tan, Yachen Si, Yan Yu, Jiarong Ding, Linxi Huang, Ying Xu, Hongxia Zhang, Yihan Lu, Chao Wang, Bing Yu, Li Yuan
Frontiers in Pharmacology.2022;[Epub] CrossRef
Panax notoginseng Suppresses Bone Morphogenetic Protein-2 Expression in EA.hy926 Endothelial Cells by Inhibiting the Noncanonical NF-κB and Wnt/β-Catenin Signaling Pathways
Tsu-Ni Ping, Shu-Ling Hsieh, Jyh-Jye Wang, Jin-Bor Chen, Chih-Chung Wu
Plants.2022; 11(23): 3265. CrossRef
Vascular calcification: New insights into endothelial cells
Cheng Yuan, Lihua Ni, Changjiang Zhang, Xiaorong Hu, Xiaoyan Wu
Microvascular Research.2021; 134: 104105. CrossRef
Concentrated small extracellular vesicles from menstrual blood-derived stromal cells improve intrauterine adhesion, a pre-clinical study in a rat model
Siwen Zhang, Qiyuan Chang, Pingping Li, Xiaoyu Tong, Yi Feng, Xinyao Hao, Xudong Zhang, Zhengwei Yuan, Jichun Tan
Nanoscale.2021; 13(15): 7334. CrossRef

Clinical Study
Low Predictive Value of FRAX Adjusted by Trabecular Bone Score for Osteoporotic Fractures in Korean Women: A Community-Based Cohort Study: Hana Kim, Jung Hee Kim, Min Joo Kim, A Ram Hong, HyungJin Choi, EuJeong Ku, Ji Hyun Lee, Chan Soo Shin, Nam H. Cho; Endocrinol Metab. 2020;35(2):359-366. Published online June 24, 2020; DOI: https://doi.org/10.3803/EnM.2020.35.2.359

11,465 View
156 Download
12 Web of Science
15 Crossref

Abstract PDF PubReader ePub

Background
The value of the Fracture Risk Assessment Tool (FRAX) and the trabecular bone score (TBS) for assessing osteoporotic fracture risk has not been fully elucidated in Koreans. We conducted this study to clarify the predictive value of FRAX adjusted by TBS for osteoporotic fractures in Korean women.
Methods
After screening 7,192 eligible subjects from the Ansung cohort, 1,165 women aged 45 to 76 years with available bone mineral density (BMD) and TBS data were enrolled in this study. We assessed their clinical risk factors for osteoporotic fractures and evaluated the predictive value of FRAX with or without BMD and TBS.
Results
During the mean follow-up period of 7.5 years, 99 (8.5%) women suffered major osteoporotic fractures (MOFs) and 28 (2.4%) experienced hip fractures. FRAX without BMD, BMD-adjusted FRAX, and TBS-adjusted FRAX were significantly associated with the risk of MOFs (hazard ratio [HR] per percent increase, 1.08; 95% confidence interval [CI], 1.03 to 1.14; HR, 1.09; 95% CI, 1.03 to 1.15; and HR, 1.07; 95% CI, 1.02 to 1.13, respectively). However, BMD-adjusted FRAX and TBS-adjusted FRAX did not predict MOFs better than FRAX without BMD based on the Harrell’s C statistic. FRAX probabilities showed limited value for predicting hip fractures. The cut-off values of FRAX without BMD, FRAX with BMD, and FRAX with BMD adjusted by TBS for predicting MOFs were 7.2%, 5.0%, and 6.7%, respectively.
Conclusion
FRAX with BMD and TBS adjustment did not show better predictive value for osteoporotic fractures in this study than FRAX without adjustment. Moreover, the cut-off values of FRAX probabilities for treatment might be lower in Korean women than in other countries.

Citations

Citations to this article as recorded by

Artificial Intelligence for Fracture Risk Prediction: A Bibliometric Analysis of Research Hotspots and Evolutionary Trends
Bo Wang, Yin Lian, Lina Gao
Applied Artificial Intelligence Research.2026;[Epub] CrossRef
Prevalence and Clinical Implications of BMD–TBS Discordance in Postmenopausal Women: A Real-World DXA Study
Robert Bot, Carmen Delia Nistor-Cseppento, Adrian Tirla, Simona Daniela Cavalu
Balneo and PRM Research Journal.2026;[Epub] CrossRef
Trabecular Bone Score in Type 2 Diabetes Mellitus: An Updated Systematic Review and Meta-Analysis
A.B.M. Kamrul-Hasan, Saptarshi Bhattacharya, Vanishri Ganakumar, Lakshmi Nagendra, Deep Dutta, Fatema Tuz Zahura Aalpona, Joseph M. Pappachan
Journal of Clinical Densitometry.2025; 28(4): 101602. CrossRef
Update on the utility of trabecular bone score (TBS) in clinical practice for the management of osteoporosis: a systematic review by the Egyptian Academy of Bone and Muscle Health
Yasser El Miedany, Walaa Elwakil, Mohammed Hassan Abu-Zaid, Safaa Mahran
Egyptian Rheumatology and Rehabilitation.2024;[Epub] CrossRef
Enhancing Osteoporosis Management: A Thorough Examination of Surgical Techniques and Their Effects on Patient Outcomes
Mihnea Popa, Adrian Cursaru, Bogdan Cretu, Sergiu Iordache, Georgian L Iacobescu, Razvan Spiridonica, Bogdan Serban, Catalin Cirstoiu
Cureus.2024;[Epub] CrossRef
Imaging bone turnover assessment through volumetric density-adjusted standardized uptake value using quantitative bone SPECT/CT in osteoporosis
Dong Yun Lee, Jungsu S. Oh, Ji Wan Kim, Seung Hun Lee, Beom-Jun Kim, Jung-Min Koh, Jae Seung Kim, Jin-Sook Ryu
EJNMMI Research.2024;[Epub] CrossRef
Comparison of predictive value of FRAX, trabecular bone score, and bone mineral density for vertebral fractures in systemic sclerosis: A cross-sectional study
Kyung-Ann Lee, Hyun-Joo Kim, Hyun-Sook Kim
Medicine.2023; 102(2): e32580. CrossRef
Screening for the primary prevention of fragility fractures among adults aged 40 years and older in primary care: systematic reviews of the effects and acceptability of screening and treatment, and the accuracy of risk prediction tools
Michelle Gates, Jennifer Pillay, Megan Nuspl, Aireen Wingert, Ben Vandermeer, Lisa Hartling
Systematic Reviews.2023;[Epub] CrossRef
Chronic airway disease as a major risk factor for fractures in osteopenic women: Nationwide cohort study
Sung Hye Kong, Ae Jeong Jo, Chan Mi Park, Kyun Ik Park, Ji Eun Yun, Jung Hee Kim
Frontiers in Endocrinology.2023;[Epub] CrossRef
Update on the clinical use of trabecular bone score (TBS) in the management of osteoporosis: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Disease
Enisa Shevroja, Jean-Yves Reginster, Olivier Lamy, Nasser Al-Daghri, Manju Chandran, Anne-Laurence Demoux-Baiada, Lynn Kohlmeier, Marie-Paule Lecart, Daniel Messina, Bruno Muzzi Camargos, Juraj Payer, Sansin Tuzun, Nicola Veronese, Cyrus Cooper, Eugene V.
Osteoporosis International.2023; 34(9): 1501. CrossRef
Comparison of HU histogram analysis and BMD for proximal femoral fragility fracture assessment: a retrospective single-center case–control study
Sun-Young Park, Hong Il Ha, Injae Lee, Hyun Kyung Lim
European Radiology.2022; 32(3): 1448. CrossRef
Association of Trabecular Bone Score-Adjusted Fracture Risk Assessment Tool with Coronary Artery Calcification in Women
Tzyy-Ling Chuang, Yuh-Feng Wang, Malcolm Koo, Mei-Hua Chuang
Diagnostics.2022; 12(1): 178. CrossRef
Risk of osteoporotic fracture in women using the FRAX tool with and without bone mineral density score in patients followed at a tertiary outpatient clinic ‒ An observational study
Maria Helena Sampaio Favarato, Maria Flora de Almeida, Arnaldo Lichtenstein, Milton de Arruda Martins, Mario Ferreira Junior
Clinics.2022; 77: 100015. CrossRef
Comparison of Trabecular Bone Score–Adjusted Fracture Risk Assessment (TBS-FRAX) and FRAX Tools for Identification of High Fracture Risk among Taiwanese Adults Aged 50 to 90 Years with or without Prediabetes and Diabetes
Tzyy-Ling Chuang, Mei-Hua Chuang, Yuh-Feng Wang, Malcolm Koo
Medicina.2022; 58(12): 1766. CrossRef
Application of the Trabecular Bone Score in Clinical Practice
Sung Hye Kong, Namki Hong, Jin-Woo Kim, Deog Yoon Kim, Jung Hee Kim
Journal of Bone Metabolism.2021; 28(2): 101. CrossRef

Review Article

Mineral, Bone & Muscle
Potential Biomarkers to Improve the Prediction of Osteoporotic Fractures: Beom-Jun Kim, Seung Hun Lee, Jung-Min Koh; Endocrinol Metab. 2020;35(1):55-63. Published online March 19, 2020; DOI: https://doi.org/10.3803/EnM.2020.35.1.55

14,447 View
173 Download
32 Web of Science
30 Crossref

Abstract PDF PubReader ePub

Osteoporotic fracture (OF) is associated with high disability and morbidity rates. The burden of OF may be reduced by early identification of subjects who are vulnerable to fracture. Although the current fracture risk assessment model includes clinical risk factors (CRFs) and bone mineral density (BMD), its overall ability to identify individuals at high risk for fracture remains suboptimal. Efforts have therefore been made to identify potential biomarkers that can predict the risk of OF, independent of or combined with CRFs and BMD. This review highlights the emerging biomarkers of bone metabolism, including sphongosine-1-phosphate, leucine-rich repeat-containing 17, macrophage migration inhibitory factor, sclerostin, receptor activator of nuclear factor-κB ligand, and periostin, and the importance of biomarker risk score, generated by combining these markers, in enhancing the accuracy of fracture prediction.

Citations

Citations to this article as recorded by

Advanced lung cancer inflammation index as a diagnostic indicator of bone turnover in osteoporotic fracture patients: a non-linear analysis
Jiahao Wang, Mengcheng Zhu, Weihong Wang, Chong Li, Ke Lu, Yanming Hao
Frontiers in Endocrinology.2026;[Epub] CrossRef
Prognostic value of serum estradiol and sclerostin for predicting fracture healing in postmenopausal women with osteoporotic vertebral compression fractures
Xulei Wu, Baixue Zhang, Chengliang Wang, Dan Liu, Shan Hu
European Spine Journal.2026; 35(7): 4485. CrossRef
Hormonal Shifts and Structural Strain: A Literature Review of Menopause and Perimenopause in Relation to Overuse Injuries and Stress Fractures
Mustafa Ansari, Faisal Hussain, Mutasem Shopon, Hanfa Ajmal, Mueez Asif, Sharon David
Annals of Rehabilitation Medicine.2026; 50(3): 139. CrossRef
Proteomic profile of bone in patients with acromegaly: new insights from a pilot exploratory study
Luigi Demarchis, Sabrina Chiloiro, Pier Paolo Mattogno, Michela Cicchinelli, Penelope Giambò, Federico Valeri, Elena Panizzi, Flavia Angelini, Antonella Giampietro, Emanuele Vodola, Domenico Milardi, Giorgio Quintino D’Alessandris, Laura De Marinis, Liver
Journal of Endocrinological Investigation.2026;[Epub] CrossRef
Bone mineral density in French adults with early-treated phenylketonuria
Elisa Dybal, François Maillot, François Feillet, Alain Fouilhoux, Leonardo Astudillo, Christian Lavigne, Jean-Baptiste Arnoux, Sylvie Odent, Claire Gay, Manuel Schiff, Karin Mazodier, Alice Kuster, Vincent Rigalleau, Christel Thauvin-Robinet, Vanessa Legu
Molecular Genetics and Metabolism.2025; 144(3): 109044. CrossRef
The Impact of Traditional Chinese Medicines on Osteoclastogenesis through NF-κB Signaling Pathway: A Review
Jiajun Huang, Diyou Wu, Yu Zhao, Yun Xue, Junqing Huang, Bin Yang
Pharmacognosy Magazine.2025; 21(4): 1153. CrossRef
Global knowledge mapping of receptor activator of nuclear factor kappa-B ligand in osteoporotic fractures: a bibliometric analysis (2001–2024)
Shuai Lu, Huaishuang Shen, Minjuan Li, Yiming Luo, Hao Sun, Xian Zhao, Jianming Chen, Ruifeng Bai, Pengli Han, Yejun Zha, Xieyuan Jiang
Frontiers in Molecular Biosciences.2025;[Epub] CrossRef
Bone biomarkers in post-polio clinic patients
Seyed Pezhman Madani, Richard Kremer, Ami Grunbaum, Shaddam Bagmar, Andrea Benedetti, Daria A. Trojan
Frontiers in Endocrinology.2025;[Epub] CrossRef
Identification and Validation of Novel Lipids Linked to Bone Mineral Density Change and Fracture Risk
Canchen Ma, Ziyuan Shen, Jing Tian, Yvette L. Schooneveldt, Corey Giles, Flavia Cicuttini, Graeme Jones, Peter J. Meikle, Feng Pan
Calcified Tissue International.2025;[Epub] CrossRef
Isorhamnetin ameliorates ovariectomy-induced osteoporosis in female rats by regulating the receptor activator of nuclear factor kappa B ligand, osteoprotegerin, bone morphogenetic protein 2 and runt-related transcription factor 2 signaling pathway
Haibin JIAO, Kun ZHENG
Journal of Veterinary Medical Science.2025; 87(7): 826. CrossRef
Systematic Review and Meta-Analysis of Clinical Efficacy of Herbal Medicine on Osteoporosis
Su Min Hong, Hyun Ju Ha, Sohyeon Park, Chang-Gue Son, Min-Seok Oh, Eun-Jung Lee
Journal of Korean Medicine Rehabilitation.2025; 35(3): 13. CrossRef
The Association of Bone-related Biomarkers With Incident Hip Fracture: A Nested Case-control Study
Sara J Cromer, Elaine W Yu, Elisabetta Patorno, Gary C Curhan, Julie M Paik
Journal of the Endocrine Society.2025;[Epub] CrossRef
Evaluation of osteoporosis in adult patients with beta-thalassemia major and its relation to serum sclerostin level
Ahmed Abd El Fattah El Bamby, Tamer Abd El Hamid El bedawi, Mohammed Adel Eltomi, Sara Mamdouh Shoeeb, Enji Abd El Wahab Ibrahim
Clinics and Research in Hepatology and Gastroenterology.2025; 49(9): 102709. CrossRef
Novel aspects of biochemical assessment of bone remodeling and mineralization
Dorota Leszczyńska, Alicja Szatko, Agata Toboła, Katarzyna Karoń, Waldemar Misiorowski, Piotr Glinicki, Wojciech Zgliczyński
Frontiers in Endocrinology.2025;[Epub] CrossRef
Application of artificial intelligence in osteoporosis: a review
Shu-Ting Fan, Min Lu, Jin-Lu Dong, Yi-Lin Li, Li-Na Hao, Ren-Chao Dong, Ming-Dong Hou
Frontiers in Medicine.2025;[Epub] CrossRef
Ångstrom-scale gold particles loaded with alendronate via alpha-lipoic acid alleviate bone loss in osteoporotic mice
Weihang Gao, Jiao Jiao Li, Jingyu Shi, Hongbing Lan, Yuanyuan Guo, Dehao Fu
Journal of Nanobiotechnology.2024;[Epub] CrossRef
Changes in bone turnover markers 6–12 months after bariatric surgery
Per G. Farup
Scientific Reports.2024;[Epub] CrossRef
Imaging bone turnover assessment through volumetric density-adjusted standardized uptake value using quantitative bone SPECT/CT in osteoporosis
Dong Yun Lee, Jungsu S. Oh, Ji Wan Kim, Seung Hun Lee, Beom-Jun Kim, Jung-Min Koh, Jae Seung Kim, Jin-Sook Ryu
EJNMMI Research.2024;[Epub] CrossRef
The administration of bovine hydroxyapatite-alendronate implant accelerates bone defect healing in an osteoporotic rat
Toetik Aryani, Aniek Setiya Budiatin, Samirah, Aulia Maulidina, Aulia Intan Firdaus, Maria Apriliani Gani, Khoirotin Nisak, Junaidi Khotib, Alvi Jauharotus Syukriya
Technology and Health Care.2023; 31(5): 1747. CrossRef
Impact of Intravenous Iron Substitution on Serum Phosphate Levels and Bone Turnover Markers—An Open-Label Pilot Study
Alexandra Struppe, Jakob E. Schanda, Andreas Baierl, Paul Watzl, Christian Muschitz
Nutrients.2023; 15(12): 2693. CrossRef
Dynamics of Bone Disease Biomarkers Dickkopf-1 and Sclerostin in Patients with Multiple Myeloma
Vladimir Gerov, Daniela Gerova, Ilina Micheva, Miglena Nikolova, Galya Mihaylova, Bistra Galunska
Journal of Clinical Medicine.2023; 12(13): 4440. CrossRef
Impact of vitamin D supplementation on markers of bone turnover: Systematic review and meta‐analysis of randomised controlled trials
Mohammad Hassan Sohouli, Sicong Wang, Faisal Almuqayyid, Mariana Papini Gabiatti, Fateme Mozaffari, Zahra Mohamadian, Nazanin Koushki, Kamar Allayl Alras, Abdullah M. AlHossan, Saud K. Albatati, Aya Alfardous Alazm, Saeed Baradwan, Mihnea‐Alexandru Găman,
European Journal of Clinical Investigation.2023;[Epub] CrossRef
Night shift work and serum markers of bone turnover in male shift workers
Margherita Martelli, Gianmaria Salvio, Raffaella Lazzarini, Marijana Milinkovic, Alessandro Ciarloni, Giancarlo Balercia, Lory Santarelli, Massimo Bracci
Chronobiology International.2023; 40(9): 1270. CrossRef
Circulating sRANKL, Periostin, and Osteopontin as Biomarkers for the Assessment of Activated Osteoclastogenesis in Myeloma Related Bone Disease
Vladimir Gerov, Daniela Gerova, Ilina Micheva, Miglena Nikolova, Milena Pasheva, Neshe Nazifova, Bistra Galunska
Cancers.2023; 15(23): 5562. CrossRef
Oral Administration of Isovitexin, a Naturally Occurring Apigenin Derivative Showed Osteoanabolic Effect in Ovariectomized Mice: A Comparative Study with Teriparatide
Subhashis Pal, Shivani Sharma, Konica Porwal, Mohammed Riyazuddin, Chirag Kulkarni, Sourav Chattopadhyay, Sabyasachi Sanyal, Jiaur R. Gayen, Naibedya Chattopadhyay
Calcified Tissue International.2022; 111(2): 196. CrossRef
Serum sclerostin levels in osteoporotic fracture patients
Erwin A. Gorter, Casper R. Reinders, Pieta Krijnen, Natasha M. Appelman-Dijkstra, Inger B. Schipper
European Journal of Trauma and Emergency Surgery.2022; 48(6): 4857. CrossRef
Elevated gamma-glutamyl transpeptidase level is associated with an increased risk of hip fracture in postmenopausal women
Kyoung Jin Kim, Namki Hong, Min Heui Yu, Seunghyun Lee, Sungjae Shin, Sin Gon Kim, Yumie Rhee
Scientific Reports.2022;[Epub] CrossRef
Effect of androgen deprivation therapy on serum levels of sclerostin, Dickkopf-1, and osteoprotegerin: a cross-sectional and longitudinal analysis
Alice Wang, Nishi Karunasinghe, Lindsay D. Plank, Shuotun Zhu, Sue Osborne, Charis Brown, Karen Bishop, Tiffany Schwass, Sofian Tijono, Michael Holmes, Jonathan Masters, Roger Huang, Christine Keven, Lynnette R. Ferguson, Ross Lawrenson
Scientific Reports.2021;[Epub] CrossRef
Update on Glucocorticoid Induced Osteoporosis
Soo-Kyung Cho, Yoon-Kyoung Sung
Endocrinology and Metabolism.2021; 36(3): 536. CrossRef
Nobiletin promotes osteogenic differentiation of human osteoblastic cell line (MG-63) through activating the BMP-2/RUNX-2 signaling pathway
Ying Pang, Lili Liu, Hong Mu, Vishnu Priya Veeraraghavan
Saudi Journal of Biological Sciences.2021; 28(9): 4916. CrossRef

Original Article

Effects of Interleukin-6 on mRNA Expression of Alkaline Phosphatase, Osteopontin, Decorin and a1(1)-collagen in Human Bone Marrow Stromal Cells.: Chul Hee Kim, Dong Kwan Kim, Seung Il Park, Kwang Hyun Sohn, Ghi Su Kim; J Korean Endocr Soc. 1996;11(2):156-162. Published online November 7, 2019

1,860 View
25 Download

Abstract PDF: Background
Inter1eukin-6(IL-6) is known to be produced by osteoblastic cells and to have impartant role in regulation of bone remodelling, Most previous studies indicated that IL-6 bas a major role in stimulating osteoclastic resorption by increasing recruitment and proliferation of preosteoclasts. But its autocrine effect on osteoblastic cells has not been well established yet. Therefore, we studied the effects of IL-6 on messenger RNA (mRNA) expression of proteins that are characteristic of osteoblastic cells in human bone marrow stromal (osteoprogenitor) cells (hRMSC). Methods: The expression of mRNAs for alkaline phosphatase, al(1)-collagen, osteopontin and decorin were studied by northern blot analysis after 3 7 days' treatrnent with IL-6 in the concenttation range of 101,000 U/ml. Results: The mRNA levels for any of the osteoblastic proteins studied did not change significantly by IL-6 treatment up to the concentration of 1,000 U/ml. Conclusion: These results suggest that IL-6 does not have a significant role in differentiatian or activities of human bone rnarrow stromal.

Case Reports

A Case of Adult Fanconi Syndrome with Hypophosphatemic Osteomalacia.: Ji Hyun Lee, Young Sup Byun, Bong Soo Cha, Moon Suk Nam, Young Duk Song, Sung Kil Lim, Kyung Rae Kim, Hyun Chul Lee, Kap Bum Huh, Jin Kim, Jong In Yook; J Korean Endocr Soc. 1996;11(1):93-101. Published online November 7, 2019

4,201 View
127 Download

Abstract PDF: The Fanconi syndrome is characterized by generalized disturbance of tubular function. It leads to excessive losses of amino acids, glucose, phosphate, bicarbonate, and other organic and inorganic substrates handled by the proximal tubules. The metabolic consequences are acidosis, hypophosphatemia, hypocalemia, dehydration, rickets, osteomalacia, osteoporosis, and growth retardation. This syndrome may either be congenital or acquired, primary or secondary. Acquired Fanconi syndrome may result from multiple myeloma, Wilsons disease, primary amyloidosis, light chain nephropathy, and heavy metal poisoning such as lead, mercury, and cadmium. A 33-year-old female presented with multiple bone pain, and progressive proximal muscle weakness for 15 months. The blood urea nitrogen, creatinine, calcium, phosphate, and uric acid were 12.1 mg/dL, 1.5 mg/dL, 8.4 mg/dL, 1.8 mg/dL, and 1.7 mg/dL, respectively. The urine volume, protein, calcium, phosphate, and creatinine clearance were 2,330 ml, 343.7 mg, 146 mg, 424 mg, and 44.6 ml/min, respectively in 24 hour collection urine study. The tubular reabsorption rate of phosphate was decreased. In arterial blood gas analysis study, pH was 7.348, bicarbonate was 17.6 mmol/L, which means metabolic acidosis. In chest X-ray, fracture was seen in eighth and ninth left ribs. The whole body bone scan revealed hot uptake at both first and second ribs, right third rib, both eighth and ninth ribs, left sacroiliac joint and right hip joint. Bone densitometry showed moderate osteopenia in spine and femur neck. After NE4Cl loading, the urine pH was decreased below 5.0 at two and third hour, which means proximal renal tubular acidosis. Amino acid such as, hydroxyproline, threonine, serine, asparagine, glutamine excreted much more than normal in 24 hour urine. Bone biopsy showed the presence of increased osteoid volume and osteoid seam width and marked decreased mineral appositional rate as evidence for osteomalacia. The patients symptoms, including bone pain and proximal muscle weakness, were relieved after supplement of calcitonin, Vitamin D and calcium carbonate. We report a case of Fanconi syndrome with hypophosphatemic osteomalacia with brief review of literature.

A Korean Pedigree of Paget Bone Disease.: Young Kee Shong, Joong Yeol Park, Ki Up Lee, Ghi Su Kim, Suhn Hee Kim, Jae Kun Cho, You Sook Cho, Hong Ja Kim, Myung Jin Shin; J Korean Endocr Soc. 1995;10(4):451-455. Published online November 7, 2019

1,946 View
22 Download

Abstract PDF: Paget bone disease(PBD) is usually focal, but can be wide spread disorder of the skeletal remodeling characterized by greatly increased osteoclast size and activity. It has extremely variable prevalence worldwide, being common in England and northern European countries and areas populated by their descendants, but strikingly uncommon in Asia, the middle east, Africa and Scandinavia. It's occurrence also shows familial clustering, some postulates autosomal dominant inheritance. Many studies have shown that paramyxoviruses may play a critical role in the etiology of this disorder. However, the precise etiology of PBD remains unknown.We describe a kindred with PBD in 3 successive generations. The propositus, a 55-year-old man, has panostotic PBD and giant cell reparative granuloma of pagets disease involving his head, mandible, abdomen and ileum, rare tumorous complication of Paget's disease. Bowed limbs were first noticed at age 25 years, and progressed for 20 years. Giant cell reparative granuloma began manifesting at age 45 years, and responded dramatically to high-dose dexamethasone therapy. His pretreatment biochemical finding were remarkable for elevated serum ALP, 765(normal 66-220 u/L) and osteocalcin, 154(normal 6.3-30.7 mg/ml), but normal serum calcium, phosphorous, 250HD and PTH. A nondecalcified iliac crest specimen demonstrated classic histopathologic 25OHD and PTH. A nondecalcified iliac crest specimen demonstrated classic histopathologic changes of PBD on light microscopy. His decreased father had a similar degree of bony deformities beginning at age 20 years, but had not been examined. His two asymptomatic daughters, 20 and 24-year-old, were both found to be affected with widespread PBD by bone scan, radiographic study, and their serum ALP levels, 939 and 435U/L, respectively. This is the first report of familial occurance of PBD and a case of giant cell reparative granuloma of Paget's disease in Korea, where PBD is very rare.

Original Article

Estrogen Replacement Therapy Continuously Combined with Progesterone; Effect on Bone Mineral Density and Lipid Metabolism.: Keun Yong Park; J Korean Endocr Soc. 1995;10(4):411-417. Published online November 7, 2019

1,771 View
17 Download

Abstract PDF: A study in 51 healthy postmenopausal women was performed to assess the effect of estrogen replacement therapy continuously combined with progesterone for 6 months on bone mineral density and lipid metabolism.Seventeen hysterectomized women were treated with conjugated estrogen(0.625mg/D), 33 nonhysterectomized women with conjugated estrogen(0.625mg/D) and medroxyprogesterone(2.5mg/D), and 1500mg/day calcium supplementation was given to all patients.After 6 month-treatment, serum total cholesterol and LDL-cholesterol levels were reduced significantly (p<0.01) between the two groups. But lumber BMD and other lipid profiles were not changed significantly between the two groups. Our data suggest that continuously applied progesterone in combined hormone replacement therapy dose not annihilate the beneficial effects on bone mineral density and lipid metabolism induced by estrogen.

Case Report

A Case of Primary Hyperparathyroidism Associated with Proximal Renal Tubular Acidosis and Postoperative Hungry Bone Syndrome.: Je Ho Han, Kun Ho Yoon, Bong Yun Cha, Ho Young Son, Kwang Woo Lee, Hae Ok Jung, Chang Sup Kim, Moo Il Kang, Chul Soo Cho, Ho Yun Kim, Sung Koo Kang; J Korean Endocr Soc. 1994;9(2):141-149. Published online November 6, 2019

2,768 View
52 Download

Abstract PDF: Primary hyperparathyroidism is a generalezed disorder of calcium, phosphorus and bone metabolism due to an increased secretion of parathyroid hormone. Single parathyroid adenoma is the most common cause of primary hyperparathyroidism. Because parathyroid hormone has been proposed as an important inhibitor of renal bicarbonate reabsorption of proximal tubule, proximal renal tubular acidosis is not rare in primary hyperparaphyroidism. After parathyroid resection, significant hypocalcemia and hypophosphatemia requiring prolonged medical management may develop, termed hungery bone syndrome. We experienced a case of primary hyperparathyroidism associated with proximal renal tubular acidosis, and severe hungry bone syndrome after resection of the adenoma of parathyroid gland.

Original Articles

Changes in Bone Mineral Density in Patients with Sheehan's Syndrome.: Jae Myung Yoo, Sang Jin Kim, Kyung Mook Choi, Sei Hyun Baik, Dong Seop Choi, Eun Jong Lee, Yong Hyun Kim; J Korean Endocr Soc. 1994;9(1):10-17. Published online November 6, 2019

2,528 View
42 Download

Abstract PDF: Osteoporosis is a common clinical problem with high risk of fractures in old age, especially postmenopausal women.Secondary causes of osteoporosis can be identified in 20% of women and 40% of men with vertebral fractures. One of the causes of secondary osteoporosis is endocrine disease such as hypogonadism, ovarian agenesis, hyperadrenocorticism, hyperthyroidism, hyperparathyroidism and diabetes mellitus. Patients with Sheehan's syndrome have deficiency of multiple hormones which may cause bone loss.To determine changes in the bone mineral density in women with Sheehan's syndrome and to compare clinical and biochemical characteristics between the patients with osteoporosis and the patients without osteoporosis, we measured the bone mineral density(BMD) of the lumber spine and midradius by dual energy X-ray absortiometry(DEXA) and the serum levels of estrogen and osteocalcin in 11 patients of Sheehan's syndrome.The results were as follows;1) The BMDs of the lumbar spine were significantly decreased in patients with Sheehan's syndrome when compared with those of age-matched control.2) The prevalence of osteoporosis in patients with Sheehan's syndromes was 55%. Between the patients with osteoporosis and the patients without osteoporosis, there were no difference in the onset age of amenorrhea, the duration of amenorrhea, and the serum levels of osteocalcin and alkaline phosphatase.3) Serum estradiol levels were decreased uniformly in the patients with Sheehan's syndrome except three patients with estrogen replacement, but the concentration of estradiol was not correlated with the degree of the decrease in bone mass.In conclusion, the patients with Sheehan's syndrome have an increased prevalence of osteoporosis. But the effect of each anterior pituitary hormone deficiency on bone loss should be clarified in the futher prospective study.

Changes of Bone Turnover Markers after Treatment with Growth Hormone Therapy in Children with Growth Retardation.: In Myung Yang, Jeong Taek Woo, Sung Woon Kim, Jin Woo Kim, Young Seol Kim, Young Kil Choi, Ki Oak han, Duk Yoon Kim, Hyung In Yang; J Korean Endocr Soc. 1994;9(4):344-349. Published online November 6, 2019

2,033 View
26 Download

Abstract PDF: The effects of growth hormone(GH) deficiency and recombinant human GH replacement(0.5IU/kg per week) on bone mineral metabolism in 21GH-deficiency children were studied. All children had significantly reduction of bone density(Z score;-1.4+-0.71). After 1 month of therapy, the levels of serum insulin-like growth factor 1(IGF-1), osteocalcin(OC) and carboxyterminal propeptede of type 1 procollagen(PICP) were significantly elevated. But IGFBP-3 were not shown to change significantly. The changes in serum levels of PICP during the first month of recombinant human GH treatment were positively related to growth velocity, whereas the changes in IGF-1 and OC during the first month of therapy were not. We conclude that the recombinant human GH treatment caused significant modifications of mineral metablism and that the measurement of the changes of biochemical markers of bone metablism espacially PICP may be a useful tool in prediction improved growth velocity during long term GH replacement therpy.

Study on Restriction Fragment Length Polymorphisms of Vitamin - D Receptor Gene in relation to Bone Mineral Density and Bone Markers in Pre - and Postmenopausal Korean Women.: Myung Hee Yoo, Dong Won Byun, Kyo Il Suh, Guk Bae Kim, Sang Woo Kim, Ihn Gul Moon, In Kwon Han; J Korean Endocr Soc. 1994;10(3):249-261. Published online November 6, 2019

1,961 View
33 Download

Abstract PDF: Osteoporosis is now a major health problem because of the increasing elderly population and related osteoporosis fractures. Recently, it has been suggested that lower bone mass with/and high bone turnover rate is considered to be important in the developing of osteoporosis, and so there has been many efforts to identify the risk factors which is considered to cause lower bone mass and high bone turnover.Osteocalcin, the most abundant noncollagenous protein in bone, is a marker of bone turnover and its synthesis is induced by calcitriol(the active form of vitamine-D) through the vitamine-D receptor(VDR) and a specific vitamine D-responsive element in the osteocalcin gene promoter. Serum concentrations of osteocalcin are under the strong genetic influences and may reflect allelic variation in VDR gene. Therefore, the present study were designed to find the relationships among the polymorphisms of Vitamine-D receptor gene, bone mineral density and bone markers. We analysed the restriction fragment length polymorphisms of VDR gene with Bsm I endonuclease enzyme in relation to bone mineral density by using DEXA(dual energy X-ray absorptiometry, QDR-2000) and bone markers, especially serum osteocalcin concentrations in 356 pre- and postmenopausal Korean women.The frequence of RFLPs of VDR gene is 3.3% in BB type, 10.1% in Bb type, 86.6% in bb type. The concentrations of osteocalcin, alkaline phosphatase, procollagen-C and urinary deoxypyridinoline/creatinine were found to be higher in postmenopausal than premenopausal women and the levels of BMD were lower in postmenopausal than premenopausal women. The BB type, which is known to have a strong genetic determinant, is less frequently encountered in Korean women and does not correlate with levels of bone markers and bone mineral density. Even though the number of women with BB type is small, we noted the mean serum level of each bone marker was greater in postmenopausal women with BB type than in premenopausal women with the same genotype.In conclusion, this may suggest a partial agreement of our data with that of Australlian group and that we have to try to find out another genotype specifically related with lower bone density in Korean women.

Review Article

Mineral, Bone & Muscle
Effects of Resistance Exercise on Bone Health: A Ram Hong, Sang Wan Kim; Endocrinol Metab. 2018;33(4):435-444. Published online November 30, 2018; DOI: https://doi.org/10.3803/EnM.2018.33.4.435

94,801 View
974 Download
208 Web of Science
216 Crossref

Abstract PDF PubReader ePub

The prevalence of chronic diseases including osteoporosis and sarcopenia increases as the population ages. Osteoporosis and sarcopenia are commonly associated with genetics, mechanical factors, and hormonal factors and primarily associated with aging. Many older populations, particularly those with frailty, are likely to have concurrent osteoporosis and sarcopenia, further increasing their risk of disease-related complications. Because bones and muscles are closely interconnected by anatomy, metabolic profile, and chemical components, a diagnosis should be considered for both sarcopenia and osteoporosis, which may be treated with optimal therapeutic interventions eliciting pleiotropic effects on both bones and muscles. Exercise training has been recommended as a promising therapeutic strategy to encounter the loss of bone and muscle mass due to osteosarcopenia. To stimulate the osteogenic effects for bone mass accretion, bone tissues must be exposed to mechanical load exceeding those experienced during daily living activities. Of the several exercise training programs, resistance exercise (RE) is known to be highly beneficial for the preservation of bone and muscle mass. This review summarizes the mechanisms of RE for the preservation of bone and muscle mass and supports the clinical evidences for the use of RE as a therapeutic option in osteosarcopenia.

Citations

Citations to this article as recorded by

Acute effect of impact and resistance exercise on Wnt signaling modulators, bone and cartilage metabolism
Benjamin Boxer, Zhuoyue Zhang, Jonathan P Folland, Richard Eastell, Fatma Gossiel, Ogulcan Caliskan, Katherine Brooke-Wavell
Journal of Bone and Mineral Research.2026; 41(3): 282. CrossRef
Feasibility of testing the effect of individualised home-based exercises on function, quality of life and BMD in patients with and without HIV managed for femoral shaft fractures
Hellen Myezwa, Sam Ibeneme, Eustasius Musenge, Sebastian Magobotha, Adedayo Tunde Ajidahun
AIDS Care.2026; 38(2): 371. CrossRef
High prevalence of low bone mineral density in wheelchair users regardless of sports participation: a cross-sectional analysis of the bonewheel study
Linn C. Risvang, Jan-Willem van Dijk, Julia K. Baumgart, Hannah M. Rice, Anja M. F. Liljegren, Vegard Strøm, Truls Raastad, Kristin L. Jonvik
European Journal of Applied Physiology.2026; 126(5): 2879. CrossRef
Association between knee osteoarthritis and volumetric bone mineral density
Duy K. Hoang, An T. Truong, Linh N. Luu, Tan D. Nguyen, Nhan M. Le, Huy G. Nguyen, Lan T. Ho-Pham, David J. Hunter, Tuan V. Nguyen
Osteoarthritis and Cartilage Open.2026; 8(1): 100740. CrossRef
Optimizing recovery after a hip fracture: Protocol of a randomized controlled trial to study the effects, costs, and cost-effectiveness of a combined protein and exercise intervention in older adults after a hip fracture (ProBUS study)
Emma Treijtel, Hugo H. Wijnen, Nienke M.S. Golüke, Marian A.E. de van der Schueren, Lisette C.P.G.M. de Groot, Inge Groenendijk
Experimental Gerontology.2026; 213: 112999. CrossRef
Physical activity patterns and all-cause mortality in U.S. adults with osteopenia or osteoporosis: A prospective cohort study
Jun Xu, Pincheng Luo, Yanxue Lian
Medicine.2026; 105(3): e47293. CrossRef
How women engage in muscle-strengthening exercises: a qualitative study from the WISH project
Nur Dania Rosaini, Stuart R. Gray, Esther Oyebola, Gemma C. Ryde
BMC Public Health.2026;[Epub] CrossRef
Effects of different types of exercise over 24 weeks on bone mineral density in postmenopausal women: A systematic review with pairwise and network meta-analysis of randomized controlled trials
Zhining Zhou, Xiaoyu Wei, Xinwen Zhang, Barbara E. Ainsworth, Jiaojiao Lü, Yu Liu
Journal of Sport and Health Science.2026; 15: 101127. CrossRef
Pediatric weight training fractures due to improper use: a review of national injury data, 2014–2023
Charu Jain, Uma Balachandran, Luca M. Valdivia, Camila Vicioso, Niklas H. Koehne, Auston R. Locke, Avanish Yendluri, Nikan K. Namiri, Sheena C. Ranade
The Physician and Sportsmedicine.2026; 54(3): 236. CrossRef
The metabolites for muscle and osteoclast activity are indicators of femoral neck osteoporosis
Masahiro Kameda, Mitsuhiro Yanagida, Hiroshi Kondoh
Scientific Reports.2026;[Epub] CrossRef
Diverse exercise modalities in alleviating osteoporosis: A narrative review
Wanlin Zou, Renhui Liu
Endocrine.2026;[Epub] CrossRef
High-intensity interval training (HIIT) and creatine supplementation reduce endurance strength and mineralization of bone tissue
Robson Chacon Castoldi, Paulo Henrique Aleixo, Evelyn de Andrade Salomão, Alex Yuiti Ogura, Richard Nicolas Marques Caputi, Giuliano Moreto Onaka, Mateus Dassie Maximino, Carlos José Leopoldo Constantino, Paula Felippe Martinez, Sílvio Assis de Oliveira-J
Sport Sciences for Health.2026;[Epub] CrossRef
What is the connection between screen time and lifestyle factors important for bone health? Findings from the Hertfordshire Intergenerational Study
Leo Westbury, Gregorio Bevilacqua, Faidra Laskou, Fiona Kirkham-Wilson, Nicholas Fuggle, Elaine Dennison
Archives of Osteoporosis.2026;[Epub] CrossRef
It's never too late: The impact of resistance training on strength and body composition in females across the lifespan – A systematic review and meta-analysis
Eduard Isenmann, Stephan Geisler, Tim Havers, Florian Siegert, Felix Hemke, Steffen Held
Journal of Science and Medicine in Sport.2026; 29(10): 1174. CrossRef
Disturbances in bone mineral metabolism in soldiers of the Armed Forces of Ukraine with pulmonary tuberculosis who were returned from Russian captivity
M.I. Lynnyk, Ye.A. Nastenko, G.L. Gumeniuk, V.I. Ignatieva, A.I. Alforov, V.A. Svyatnenko
Infusion & Chemotherapy.2026; 9(1): 17. CrossRef
Syndrome Differentiation and Treatment of Senile Osteoporotic Distal Radius Fractures: Insights from the “Bone and Muscle Are Not Closely Related” Theory
学成马
Advances in Clinical Medicine.2026; 16(04): 164. CrossRef
Strength unseen: confronting prejudice in women’s resistance and weight training
Jinpyo Hong, Shubhangi Singh, Vasu Gupta, Baltej Singh, Rohit Jain
Annals of Medicine.2026;[Epub] CrossRef
Effects of lean beef on resistance training-induced strength and body composition adaptations: a randomized controlled trial protocol.
Morgan Lewis, Conor C. Carey, Kevin D. Cashman, Alice Lucey, Elaine K. McCarthy
HRB Open Research.2026; 9: 52. CrossRef
The Effects of Exercise on Fluorosis: A Comprehensive Multisystem Review
Fengge Han, Xiaohui Li, Sheraz Ahmad, Qi Lei, Zilong Sun
Veterinary Sciences.2026; 13(5): 446. CrossRef
The effects of exercise interventions on bone mineral density in middle-aged and older men: a systematic review and meta-analysis
Chengqian Feng, Jie Shu, Yang Li, Zhicheng Lin
Frontiers in Physiology.2026;[Epub] CrossRef
High-Intensity Training Increases Osteocalcin Levels: A Meta-Analysis of Effects of Exercise on Bone Remodeling biomarkers
Viktória Barna, Amir Makolli, Zsuzsanna Pásztorné Benyó, Marie Anne Engh, Ádám Zolcsák, Brigitta Teutsch, Vivienne Seymour, Péter Hegyi, Renáta Papp, Nora Sydo, Péter Ferdinandy
Sports Medicine - Open.2026;[Epub] CrossRef
A network meta-analysis of the effects of different aerobic exercise prescriptions on bone density in osteoporosis patients
Xiaobin Zhou, Ningning Yang, Chenlong Xi, Jing Ji, Tao Xu
Frontiers in Endocrinology.2026;[Epub] CrossRef
Effect of New Zealand Blackcurrant Supplementation on Sports Performance: A Systematic Review
Samira Gholamian, Sina Ebrahimi, Arezoo Razmdideh, Mohammad Shariatzadeh, Ehsan Rezaee Moeini
Current Developments in Nutrition.2026; 10(7): 109388. CrossRef
The Association Between Self‐Perceptions of Ageing and Foot and Lower‐Limb Health in Community‐Dwelling Older Adults
Prue Molyneux, Ella Bloomfield, Miles Broderick, Sarah Stewart
Journal of Foot and Ankle Research.2026;[Epub] CrossRef
Irisin acts as an exercise mimetic to alleviate sedentary-induced osteoporosis by reprogramming macrophage-mediated inflammation via the HSP90–MAPK signaling axis
Xiuting Xiang, Yunjun Ruan, Shiyu Feng, Wenyin Bin, Biyun Lan, D. Maryama Awang Daud, Rahmawati Pare, Praneetha Palasuberniam, Jie Huang, Huan Liu, Weizhou jiang, Ling He
Free Radical Biology and Medicine.2026; 254: 496. CrossRef
Exercise for myeloma patients with bone disease: a scoping review
Joanne Land, Orla McCourt, Charalampia Kyriakou, Abigail Fisher, Kwee Yong
Supportive Care in Cancer.2026;[Epub] CrossRef
Effects of progressive multimodal resistance training with varied muscle actions and range of motion on bone mineral density in osteopenic older women: a pilot study
Albeiro Dávila-Grisalez, Yovanny A. Tascón-Martínez, Jhony A. Rodríguez-Gómez, Juan C. Calderón-González, Diana M. Bedoya-Salazar, Diego A. Bonilla, César A. Mazuera-Quiceno
Frontiers in Physiology.2026;[Epub] CrossRef
Evaluating the Feasibility and Acceptability of a Culturally Adapted Intervention to Promote Resistance Exercise in Young Black Women: A Randomized Controlled Trial
Chloe S. Jones, Katherine E. Spring, Danielle D. Wadsworth
International Journal of Environmental Research and Public Health.2026; 23(7): 867. CrossRef
The Components of Physical Fitness: A Roundtable Statement by the American College of Sports Medicine
DEBORAH RIEBE, MEIR MAGAL, LEONARD A. KAMINSKY, ROBERT ROSS, STUART M. PHILLIPS, SOFIYA ALHASSAN, ROSS ARENA, DAVID G. BEHM, SARAH M. CAMHI, TIMOTHY S. CHURCH, ELLEN M. EVANS, YURI FEITO, AVERY D. FAIGENBAUM, STEVEN B. HEYMSFIELD, CHARLES H. HILLMAN, CATH
Medicine & Science in Sports & Exercise.2026; 58(8): 1827. CrossRef
CT-based body composition enhances prognostic performance of PASO score for surgical outcome in primary aldosteronism
Seunghyun Lee, Sung Joon Cho, Jin Ah Park, Seungjin Baek, Yumie Rhee, Namki Hong
Hypertension Research.2026; 49(10): 2854. CrossRef
Impacted Bones: Can Extant Primates Help Identify Tool Use in Early Hominins?
Rachel M. Hurwitz, Katarina Almeida‐Warren, Susana Carvalho, Thomas A. Püschel
Evolutionary Anthropology: Issues, News, and Reviews.2026;[Epub] CrossRef
Genetic Perspective on the Relationship between Female Reproductive Traits, Exercise, and Bone Health Outcomes: Evidence from a National Database
Bo-Kai Chen, Jansen Marcos Cambia, Chien-An Shih, Meng-Che Tsai
Lifestyle Genomics.2026; 19(1): 116. CrossRef
Effects of Mind–Body Exercise on Bone Health in Perimenopausal Women: A Systematic Review and Three-Level Meta-Analysis
Zhuo Zeng, Chengyu Zhou, Lin Luo, Shuaihao Zhao, Xusong Dong, Wenhui Yin, Wenyan Yin, Dongxu Huang, Haoqiang Shi, Haoran Li, Yongmin Xie, Aiguo Zhou, Chengyi Zhang
Life.2026; 16(9): 1389. CrossRef
Greater D3-creatine muscle mass and MRI thigh muscle volume are associated with higher bone strength in older adults: exploratory findings in The Study of Muscle, Mobility and Aging (SOMMA)
Nina Z Heilmann, Kerri S Freeland, Lauren S Roe, Nicole M Sekel, Kristen J Koltun, Katelyn I Guerriere Aaron, Julie M Hughes, Bradley C Nindl, Kristine M Ruppert, Ashley A Weaver, Paolo Caserotti, Megan Hetherington-Rauth, Peggy M Cawthon, Anne B Newman,
JBMR Plus.2026;[Epub] CrossRef
Epidemiology of sports- and recreation-related shoulder and elbow injuries in older adults presenting to emergency departments in the United States between 2010 and 2024
Akin A. Adio, Peter Boufadel, Muhammad Hamza Ilyas, Eric M. Black, Brian W. Hill, Hafiz F. Kassam, Adam Z. Khan, John G. Horneff, Joseph A. Abboud
Injury.2026; 57(11): 113636. CrossRef
Therapeutic aspect of Yoga therapy for musculoskeletal health of elderly: A mechanistic review
Shringarika Mishra, Mamta Tiwari
Journal of Research in Ayurvedic Sciences.2026; 10(Suppl 2): S219. CrossRef
Effects of lean beef on resistance training-induced strength and body composition adaptations: a randomized controlled trial protocol.
Morgan Lewis, Conor C. Carey, Kevin D. Cashman, Alice Lucey, Elaine K. McCarthy
HRB Open Research.2026; 9: 52. CrossRef
Milk consumption following acute high-intensity exercise supports bone status indices in young, healthy adults: a randomized crossover study
Nicholas Cheng, Emily C. Fraschetti, Monika Nguyen, Sara Gagnon, Joel L. Prowting, Panagiota Klentrou, Andrea R. Josse
Applied Physiology, Nutrition, and Metabolism.2026; 51: 1. CrossRef
Decoding osteoporosis: Understanding the disease, exploring current and new therapies and emerging targets
Dhruvee Patel, Bhagawati Saxena
Journal of Orthopaedic Reports.2025; 4(4): 100472. CrossRef
Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR)
Mikel Izquierdo, Philipe de Souto Barreto, Hidenori Arai, Heike A. Bischoff-Ferrari, Eduardo L. Cadore, Matteo Cesari, Liang-Kung Chen, Paul M. Coen, Kerry S. Courneya, Gustavo Duque, Luigi Ferrucci, Roger A. Fielding, Antonio García-Hermoso, Luis Miguel
The Journal of nutrition, health and aging.2025; 29(1): 100401. CrossRef
Physiotherapy and occupational therapy in rheumatoid arthritis: Bridging functional and comorbidity gaps
Nur Azizah Allameen, Yi Wye Lai, Guojie Lian, Tyrik Zhen-Yuan Lee, Saranya Selvakumaran, Rachel Yuet Teng Tan, Chuanhui Xu
Best Practice & Research Clinical Rheumatology.2025; 39(1): 102032. CrossRef
Exploring the application of dietary antioxidant index for disease risk assessment: a comprehensive review
Hossein Pourmontaseri, Sina Bazmi, Matin Sepehrinia, Ayda Mostafavi, Reza Arefnezhad, Reza Homayounfar, Farhad Vahid
Frontiers in Nutrition.2025;[Epub] CrossRef
Heavy resistance training provides short-term benefits on bone formation in well-functioning older adults
Mads Bloch-Ibenfeldt, Anne Theil Gates, Niklas Rye Jørgensen, Allan Linneberg, Mette Aadahl, Michael Kjær, Carl-Johan Boraxbekk
Bone.2025; 193: 117393. CrossRef
Muscle, Fat, Bone, and Lungs: Unlocking the Fitness and Health Equation of Firefighters in Porto, Portugal
Giorjines Boppre, João Pedro Rocha Nunes, David Gomes Fernandes, Bruno João de Castro Sousa e Ribeiro Carlos, João Miguel Neves Barros, Aline Teixeira Maia de Freitas, José Augusto Rodrigues dos Santos, Rodrigo Zacca
Life.2025; 15(3): 334. CrossRef
The Impact of Fermented Dairy Products and Probiotics on Bone Health Improvement
Hafiza Hira Bashir, Muhammad Adeel Hasnain, Aoun Abbas, Jae-Hyuk Lee, Gi-Seong Moon
Food Science of Animal Resources.2025; 45(2): 449. CrossRef
Multidimensional Differences Between Athletes of Endurance, Strength, and Intermittent Sports: Body Composition, Diet, Resting Metabolic Rate, Physical Activity, Sleep Quality, and Subjective Well-Being
Marcos Rueda-Cordoba, Juan J. Martin-Olmedo, Sergio Espinar, Jonatan R. Ruiz, Lucas Jurado-Fasoli
Nutrients.2025; 17(7): 1172. CrossRef
Strategies for preventing bone loss in populations with insufficient calcium and vitamin D intake
Kyung-Jin Yeum, Seyoung Ju, Uyory Choe
Nutrition Research and Practice.2025; 19(2): 155. CrossRef
Relationship between Muscle Mass and Muscle Strength with Bone Density in Older Adults: A Systematic Review
Nur Riviati, Surya Darma, Muhammad Reagan, Muhammad Baharul Iman, Fara Syafira, Bima Indra
Annals of Geriatric Medicine and Research.2025; 29(1): 1. CrossRef
Assessing the Effects of Sports Disciplines on Body Composition and Bone Health: A Focus on Yoga, Weightlifting, and Long-Distance Running
Naseer Ud Din Waza, Nishan Singh Deol
Physical Education Theory and Methodology.2025; 25(2): 254. CrossRef
Effects of resistance training on microcirculation of bone tissue and bone turnover markers in postmenopausal women with osteopenia or osteoporosis: A systematic review
Fatemeh Sangtarash, Azadeh Shadmehr, Haniyeh Choobsaz, Sara Fereydounnia, Alireza Sadeghi, Friedrich Jung, Muhammad Sarfraz
Clinical Hemorheology and Microcirculation.2025; 89(2): 171. CrossRef
Treatment Considerations for Severe Osteoporosis in Older Adults
Heidi See, Emma Gowling, Evie Boswell, Pritti Aggarwal, Katherine King, Nicola Smith, Stephen Lim, Mark Baxter, Harnish P. Patel
Drugs & Aging.2025; 42(5): 395. CrossRef
[18F]NaF PET/CT Imaging of Iliac Bones to Assess Bone Turnover
Shashi B. Singh, Om H. Gandhi, Bimash B. Shrestha, Patrick Glennan, Anuradha Rosario Bahadur, Niloofaralsadat Motamedi, Kishor Khanal, Sagar Wagle, Poul Flemming Høilund-Carlsen, Thomas J. Werner, Mona-Elisabeth Revheim, Abass Alavi
Molecular Imaging and Biology.2025; 27(3): 295. CrossRef
Myokines and interorgan crosstalk: bridging exercise to health promotion and disease prevention
Junseo Ha, Suchan Sung, Hyeonwoo Kim
Annals of Pediatric Endocrinology & Metabolism.2025; 30(2): 59. CrossRef
Investigating the Effects of a High-Load Resistance Training Program on Bone Health in Wheelchair Users (the BoneWheel Study): Protocol for a Randomized Controlled Trial
Linn Christin Risvang, Vegard Strøm, Jan-Willem van Dijk, Hannah Rice, Øyvind Sandbakk, Lars Peder Bovim, Julia Kathrin Baumgart, Marte Bentzen, Truls Raastad, Kristin L Jonvik
JMIR Research Protocols.2025; 14: e70125. CrossRef
Optimizing Performance and Health: Nutrition Considerations for Female Athletes in Strength and Conditioning
Hannah E. Cabre
Strength & Conditioning Journal.2025; 47(6): 619. CrossRef
Optimal resistance training parameters for improving bone mineral density in postmenopausal women: a systematic review and meta-analysis
Fang Zhao, Wenbo Su, Yaowei Sun, Jing Wang, Bin Lu, Hezhang Yun
Journal of Orthopaedic Surgery and Research.2025;[Epub] CrossRef
Optimization of high-intensity resistance exercise protocols for improving bone mineral density in the elderly without chronic diseases: a systematic review and network meta-analysis
Yang Cheng, Yue Yi, Shumin Bo, Jun Mao, Jing Ma
Frontiers in Physiology.2025;[Epub] CrossRef
Bone Health Status and its Association with Body Composition, Physical Activity, and Calcium Intake Among Malaysian University Students in Bangi, Selangor, Malaysia
Fatin Norhasny Leman, Noor Fairuzi Suhana Yahya, Fiona Zi Yi Leong , Norlida Mat Daud
Malaysian Applied Biology.2025; 54(2): 28. CrossRef
Resistance and Aerobic Preconditioning Delays Unloading‐Induced Multisystemic Physiological Changes: The NEBULA Project
Théo Fovet, Margot Issertine, Pauline Jacob, Stephanie Ghislin, Norbert Laroche, Sandrine Roffino, Claire Camy, Julian Theuil, Christelle Bertrand‐Gaday, Pierre Delobel, Béatrice Chabi, Vincent Ollendorff, Guillaume Py, Jean‐Pol Frippiat, Jean‐Luc Morel,
The FASEB Journal.2025;[Epub] CrossRef
Mechanically active biomaterials for tissue repair and regeneration
Wenzhen Gao, Lian Wang, Qing Zhao, Chenchen Zhou, Bo Huang, Guiting Liu
Journal of Materials Chemistry B.2025; 13(29): 8598. CrossRef
Diagnosis of vertebral mineral metabolism disorders in patients with drug-resistant pulmonary tuberculosis using computed tomography data
М.І. Lynnyk, V.І. Іgnatieva, G.L. Gumeniuk, V.А. Svyatnenko, N.M. Bobok
Infusion & Chemotherapy.2025; 8(2): 15. CrossRef
Diagnosis of vertebral mineral metabolism disorders in patients with drug-resistant pulmonary tuberculosis using computed tomography data
М.І. Lynnyk, V.І. Іgnatieva, G.L. Gumeniuk, V.А. Svyatnenko, N.M. Bobok
Infusion & Chemotherapy.2025; 8(2): 15. CrossRef
Chronic effects of resistance training in women with low bone mineral density associated with medication use: a systematic review
Thayane Sarmento de Souza, Ravini de Souza Sodré, Giullio César Pereira Salustiano Mallen da Silva, Alex Santos Meireles, Lenifran de Matos Santos, Diego Gama Linhares, Rodrigo Gomes de Souza Vale
Journal of Gerontology and Geriatrics.2025; 73(2): 46. CrossRef
Experiences and outcomes of older adults with obesity transitioning from gym- to home-based resistance training due to COVID-19 lockdowns: a mixed-methods analysis of a RCT
Costas Glavas, Jakub Mesinovic, Anoohya Gandham, Mavil May Cervo, Carrie-Anne Ng, Peter R. Ebeling, Elena S. George, Robin M. Daly, Belinda R. Beck, Paul Jansons, David Scott
BMC Geriatrics.2025;[Epub] CrossRef
Physical Activity, Exerkines, and Their Role in Cancer Cachexia
Jan Bilski, Aleksandra Szlachcic, Agata Ptak-Belowska, Tomasz Brzozowski
International Journal of Molecular Sciences.2025; 26(16): 8011. CrossRef
High-intensity training and irisin response: A possible molecular cross-talk for irisin response
Ping Li, Ligang Tong, Xuecui Bi
Current Research in Physiology.2025; 8: 100163. CrossRef
Associations between muscle mass and strength and bone microarchitecture in Caucasian postmenopausal women
Anoohya Gandham, Liesbeth Vandenput, Alisa Turbic, Marion MacRae, Hadeel Nassar, Orville G. Kolterman, Adam Perlman, Marin E. Thompson, Leonidas G. Karagounis, Mattias Lorentzon
Osteoporosis International.2025; 36(10): 2031. CrossRef
Effects of Resistance Training With or Without Blood Flow Restriction on Bone Metabolism in Osteopenic Women: A Randomized Controlled Trial
Clodoaldo Antônio De Sá, Wan Cley Rabuske, Aline Mânica, Felipe Corbellini, Fátima Kremer Ferretti, Sedinei Lopes Copatti, Vanessa da Silva Corralo, Irfan Ahmad
International Journal of Clinical Practice.2025;[Epub] CrossRef
Determinants of forearm bone mineral density in male athletes with different osteogenic index of training
Jakub Bałdyka, Anna Kopiczko
Scientific Reports.2025;[Epub] CrossRef
Synergistic Effects of an Eight-Week Resistance Training and Probiotic Supplementation on Bone Metabolism in Ovariectomized Rats
Sogand Nasabeh asl, Farhad Daryanoosh, Seyyed Shahram Shekarforoush, Nader Tanideh, Omid Koohi-Hosseinabadi, Arash Khorshidian, Amir Hossein Zarifkar
Preventive Nutrition and Food Science.2025; 30(4): 323. CrossRef
Polyphenols and exercise in autophagy regulation: potential benefits for cancer management and healthspan
Wei Liu, MengDi Hu, Feng Cao, Shen Jin
Frontiers in Nutrition.2025;[Epub] CrossRef
“Silent Bone-loss”: Estimating Osteoporosis Risk among Postmenopausal Indian Women using a Self-assessment Tool
Goutami Katage, Payal Vasant Dhawale, Aishwarya Kamble
Journal of Mid-life Health.2025; 16(3): 295. CrossRef
Load-bearing aerobic exercise prior to injury moderates systemic immunosuppression response to fracture
Lia K. Strait, Dayne Dewan, Kylie E. Williams, Tyler Guyer, Nick J. Willett, Robert E. Guldberg
Frontiers in Physiology.2025;[Epub] CrossRef
Association between weekend warrior physical activity patterns, physical activity intensity, and osteoporosis in adults over 50 years old: a cross-sectional study based on the NHANES 2017–2020
Jia Xu, Changmao Dai, Xiaolan Sun, Feier Chen, Maojun Cheng, Liyang Li, Xueping Li
BMC Public Health.2025;[Epub] CrossRef
Sex differences in upper-body strength, lean mass, and bone density across the adult lifespan: insights into musculoskeletal aging and strength preservation
William J. Kraemer, Noor F. Chaudhry, Jillian H. Graham, Matthew J. Stauder, James A. Onate, Maren S. Fragala, Jeff S. Volek, Scott M. Hayes
Journal of Applied Physiology.2025; 139(4): 1000. CrossRef
Investigation of bone toxicity in drug development: review of current and emerging technologies
Anik Tuladhar, Magali Guffroy, Sjoerd J Finnema, Romy Christmann, Terry R Van Vleet, Shuaib Ali Khan Mayana, Stacey Fossey
Toxicological Sciences.2025; 208(2): 207. CrossRef
Sleep quality and body composition in active and inactive young adults
Krystian Maruszczak, Wojciech Kasperek, Konrad Kustra, Grzegorz Przysada, Maciej Kochman
Scientific Reports.2025;[Epub] CrossRef
Relationship between Locomotive Syndrome and Cortical Bone Thickness and Trabecular Bone Density in a Community-dwelling Postmenopausal Population
Satoko NAKANO, Etsuko OZAKI, Wataru NAKANO, Michitaka KATO, Yasunari KURITA, Daisuke TAKAGI, Daisuke MATSUI, Naoyuki TAKASHIMA
Physical Therapy Research.2025; 28(3): 198. CrossRef
Discovery Begets Discovery: Special Edition on Melatonin and the Musculoskeletal System
Paula A. Witt‐Enderby
Journal of Pineal Research.2025;[Epub] CrossRef
Weight loss induced bone loss: mechanism of action and clinical implications
Hanghang Liu, Bolun Li, Linyi Liu, Wangyang Ying, Clifford J. Rosen
Bone Research.2025;[Epub] CrossRef
Effects of Combined Exercise and Calcium/Vitamin D Supplementation on Bone Mineral Density in Postmenopausal Women: A Systematic Review and Meta-Analysis
Jie Bai, Wenrui Huang, Ruixiang Yan, Xuelian Du
Nutrients.2025; 17(24): 3866. CrossRef
Weight-Bearing Ladder Climbing Exercise Improves Bone Loss and Bone Microstructural Damage While Promoting Bone Injury Healing in OVX Rats
Yiting Kang, Nan Li, Yanan Yu, Dingkang Wang, Tingting Zhao, Lijun Sun, Changjiang Liu, Liang Tang
Biology.2025; 15(1): 55. CrossRef
Effect of COVID‐19 pandemic on lifestyle and bone mineral density in young adults
Darina Falbová, Viktória Kovalčíková, Radoslav Beňuš, Simona Sulis, Lenka Vorobeľová
American Journal of Human Biology.2024;[Epub] CrossRef
Obesity, diabetes and risk of bone fragility: How BMAT behavior is affected by metabolic disturbances and its influence on bone health
Gregório Corrêa Guimarães, João Bosco Costa Coelho, João Gabriel Oliveira Silva, Ana Carolina Chalfun de Sant’Ana, Cássia Alves Carrilho de Sá, Júlia Marques Moreno, Lívia Marçal Reis, Camila Souza de Oliveira Guimarães
Osteoporosis International.2024; 35(4): 575. CrossRef
Bone mineral density after exercise training in patients with chronic kidney disease stages 3 to 5: a sub-study of RENEXC—a randomized controlled trial
Vaida Petrauskiene, Matthias Hellberg, Philippa Svensson, Yunan Zhou, Naomi Clyne
Clinical Kidney Journal.2024;[Epub] CrossRef
Atp6v1h Deficiency Blocks Bone Loss in Simulated Microgravity Mice through the Fos-Jun-Src-Integrin Pathway
Zanyan Zhao, Xiangpu Wang, Yu Ma, Xiaohong Duan
International Journal of Molecular Sciences.2024; 25(1): 637. CrossRef
Exercise and Musculoskeletal Health in Men With Low Bone Mineral Density: A Systematic Review
Katherine Hu, Maree Cassimatis, Christian Girgis
Archives of Rehabilitation Research and Clinical Translation.2024; 6(1): 100313. CrossRef
Influence of 8-weeks of supervised static stretching or resistance training of pectoral major muscles on maximal strength, muscle thickness and range of motion
Tim Wohlann, Konstantin Warneke, Vincent Kalder, David G. Behm, Tobias Schmidt, Stephan Schiemann
European Journal of Applied Physiology.2024; 124(6): 1885. CrossRef
High-Protein Diets during either Resistance or Concurrent Training Have No Detrimental Effect on Bone Parameters in Resistance-Trained Males
Reza Bagheri, Zohreh Karimi, Zeynabalsadat Mousavi, Mahdi Ziaee Bashirzad, Donny M. Camera, Ramin Sadeghi, Vahid Reza Dabbagh, Mehdi Kargarfard, Frederic Dutheil
Nutrients.2024; 16(2): 325. CrossRef
Cafeteria Diet Can Affect Bone Microarchitecture in Sedentary and Trained Male Rats
Marcio Koiti Saito, Beatriz Kawano de Oliveira, Ana Paula Macedo, Caio Sorrentino dos Santos, Ricardo Tadeu Lopes, Jéssica Suzuki Yamanaka, Antonio Carlos Shimano
Journal of Clinical Densitometry.2024; 27(2): 101467. CrossRef
The Relationship Among Probable SARCopenia, Osteoporosis and SuprasPinatus Tendon Tears in Postmenopausal Women: The SARCOSP Study
Murat Kara, Özgür Kara, Mahmut Esad Durmuş, Pelin Analay, Fatıma Edibe Şener, Beyza Nur Çıtır, Gizem Olgu Korkmaz, Zeliha Ünlü, Tülay Tiftik, Eda Gürçay, Cevriye Mülkoğlu, Berkay Yalçınkaya, Fatih Bağcıer, Mahmud Fazıl Aksakal, Kübra Erdoğan, Ahmet Sertçe
Calcified Tissue International.2024; 114(4): 340. CrossRef
Low Bone Mass in Ambulatory Spinal Muscular Atrophy: A Proactive Approach for an Often-Overlooked Impairment
Caitlin Trancho, Bailey Stickney, Stacy Kinirons, David Uher, Cara H. Kanner, Ashwini K. Rao, Michael P. McDermott, Carol Ewing Garber, Darryl C. De Vivo, Jacqueline Montes
Journal of Clinical Medicine.2024; 13(5): 1336. CrossRef
DXA-based appendicular composition measures in healthy aging Caucasian Greek women: a cross-sectional study
Stavroula J. Theodorou, Daphne J. Theodorou, Vassiliki Kigka, Ioannis Gkiatas, Andreas Fotopoulos
Rheumatology International.2024; 44(9): 1715. CrossRef
Predictors of Hand Grip Strength in Adults Without Sarcopenia: Data From the NHANES, 2013–2014
Mansour M Alotaibi
Current Developments in Nutrition.2024; 8(5): 102149. CrossRef
Why don't women engage in muscle strength exercise? An integrative review
A. M. Stimson, C. Anderson, A.‐M. Holt, A. J. Henderson
Health Promotion Journal of Australia.2024; 35(4): 911. CrossRef
Plant-Based Diets versus the Mediterranean Dietary Pattern and Their Socio-Demographic Determinants in the Spanish Population: Influence on Health and Lifestyle Habits
Elena Sandri, Marco Sguanci, Eva Cantín Larumbe, Germán Cerdá Olmedo, Lisa Ursula Werner, Michela Piredda, Stefano Mancin
Nutrients.2024; 16(9): 1278. CrossRef
Exercise-Induced Alterations in Irisin and Osteocalcin Levels: A Comparative Analysis Across Different Training Modalities
P. Adilakshmi, V. Suganthi, K. Balu Mahendran, K. Satyanarayana Rao, B. Savithri
Cureus.2024;[Epub] CrossRef
A comprehensive review on glucocorticoids induced osteoporosis: A medication caused disease
Asim Rahman, Md Faheem Haider
Steroids.2024; 207: 109440. CrossRef
Unilateral avascular necrosis of the right hip in an HIV patient with tearing of the rectus femoris and adductor longus muscles
Syed Raza, Nazia Khan
BMJ Case Reports.2024; 17(5): e258709. CrossRef
Knowledge, attitude, and practice toward osteoporosis among patients with chronic kidney disease in Zhejiang
Pengjie Xu, Nadan Zhao, Jiangdong Wang
Medicine.2024; 103(20): e38153. CrossRef
The role of exercise in aromatase inhibitor‐induced arthralgia
Kerstin Yu, Pauline Portes, G. Stephen Morris, Laura Huang, Elizabeth R. Felix, Gary J. Farkas, Diana Molinares, Eduard Tiozzo
PM&R.2024; 16(12): 1406. CrossRef
Effectiveness of interventions to prevent or reverse pre-frailty and frailty in middle-aged community dwelling adults: A systematic review
Tom H. Brennan, Lucy K. Lewis, Susan J. Gordon, Ivanka Prichard
Preventive Medicine.2024; 185: 108008. CrossRef
What is the force required to treat trismus in patients undergoing oral cavity free flap reconstruction?
Emma Charters, Jamie Loy, Kai Cheng, Masako Dunn, Timothy Manzie, Boyang Wan, Vinay Tumuluri, Jonathan R. Clark
Head & Neck.2024; 46(12): 2935. CrossRef
Bone remodeling in survivors of pediatric hematopoietic stem cell transplantation: Impact of heavy resistance training
Lise Marie Krogh, Anne Nissen, Sarah Weischendorff, Bolette Hartmann, Jesper Løvind Andersen, Jens Juul Holst, Kaspar Sørensen, Martin Kaj Fridh, Abigail Louise Mackey, Klaus Müller
Pediatric Blood & Cancer.2024;[Epub] CrossRef
The Interplay of Nutrition, Exercise, and Dietary Intervention for Enhanced Performance of Athletes and General Well-Being of Non-Athletes: A Review
Oghenerume Lucky Emakpor, Great Iruoghene Edo, Emad Yousif, Princess Oghenekeno Samuel, Agatha Ngukuran Jikah, Khalid Zainulabdeen, Athraa Abdulameer Mohammed, Winifred Ndudi, Susan Chinedu Nwachukwu, Ufuoma Ugbune, Joy Johnson Agbo, Irene Ebosereme Ainya
OBM Integrative and Complementary Medicine.2024; 09(02): 1. CrossRef
Dietary content and combined training, but not daily physical activity, are associated with 6-month bone mineral changes in adolescents with obesity: A Secondary analysis of the PAC-MAnO trial
Antonio Videira-Silva, Inês Santos, Dalise Freaza, Mariana Gameiro, Luis B. Sardinha, Helena Fonseca
European Journal of Pediatrics.2024; 183(9): 3969. CrossRef
Prevalence and risk factors of osteopenia and osteoporosis among postmenopausal women: A cross‐sectional study from Jordan
Manar H. Abu Khurmah, Mohammad J. Alkhatatbeh, Osama Y. Alshogran, Hamza M. Alarda
Public Health Nursing.2024; 41(5): 996. CrossRef
Optimizing serum electrolyte levels in stroke patients: a multimodal approach with soymilk supplementation
Babak Esmealy, Leyla Esmealy, Leila Gholizadeh, Saeid Nikookheslat, Vahid Sari-Sarraf
Annals of Medicine & Surgery.2024; 86(9): 5230. CrossRef
An In Vitro Orbital Flow Model to Study Mechanical Loading Effects on Osteoblasts
Subburaman Mohan, Ritika Surisetty, Chandrasekhar Kesavan
Biology.2024; 13(9): 646. CrossRef
Dairy and Exercise for Bone Health: Evidence from Randomized Controlled Trials and Recommendations for Future Research
Nicholas Cheng, Andrea R. Josse
Current Osteoporosis Reports.2024; 22(6): 502. CrossRef
Yaşlılarda Sarkopeni ve Toplumsal Katılım
Merve Arı, Gülfidan Başer, Nursen İlçin
Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi.2024; 11(3): 494. CrossRef
Exercise for improving bone health in patients with AIRDs: Understanding underlying biology and physiology
Ilke Coskun Benlidayi, Latika Gupta, Jasmine Parihar, Aviya Lanis Levy, Helene Alexanderson
International Journal of Rheumatic Diseases.2024;[Epub] CrossRef
The WE-RISE™ multi-domain intervention: a feasibility study for the potential reversal of cognitive frailty in Malaysian older persons of lower socioeconomic status
Resshaya Roobini Murukesu, Suzana Shahar, Ponnusamy Subramaniam, Hanif Farhan Mohd Rasdi, Amrizal Muhammad Nur, Devinder Kaur Ajit Singh
BMC Geriatrics.2024;[Epub] CrossRef
Strength Training Among Male Master Cyclists—Practices, Challenges, and Rationales
Vidar Vikestad, Terje Dalen
Journal of Functional Morphology and Kinesiology.2024; 9(4): 232. CrossRef
A Comparison of Physical Activity and Exercise Recommendations for Public Health: Inconsistent Activity Messages Are Being Conveyed to the General Public
Vincent J. Dalbo, Michael A. Carron
Sports.2024; 12(12): 335. CrossRef
Egzersize Katılım Motivasyonu Ölçeği’nin Geliştirilmesi (EKMÖ): Geçerlik ve Güvenirlik Çalışması
Sevinç Namlı, Gönül Tekkurşun Demir
Research in Sport Education and Sciences.2024; 26(4): 177. CrossRef
Male osteoporosis: the impact of lifestyle, from nutrition to physical activity
Giuseppe Defeudis, Ludovica Cardinali, Samaneh Eftekhariranjbar, Maria Chiara Massari, Silvia Migliaccio
Journal of Endocrinological Investigation.2024; 48(5): 1075. CrossRef
The Positive Effect of Physical Exercise Activities on Physical Fitness Improvement Under the National Fitness Policy Environment
Yumei Liao
American Journal of Health Behavior.2024; 48(6): 1480. CrossRef
Combined effect of core stability and dynamic resistance exercises on bone mineral density in postmenopausal women
Nermeen Shaaban Abd El Azeem, Hala Mohamed Emara, Mohamed Ahmed Awad, Sameh Hussien Samir
Advances in Rehabilitation.2024; 38(2): 21. CrossRef
From Cells to Environment: Exploring the Interplay between Factors Shaping Bone Health and Disease
Samradhi Singh, Devojit Kumar Sarma, Vinod Verma, Ravinder Nagpal, Manoj Kumar
Medicina.2023; 59(9): 1546. CrossRef
Effect of resistance exercise on bone health of old aged individuals: Review
A. Khanna
Science & Sports.2023; 38(4): 323. CrossRef
Relationship between physical exercise and COVID-19 (SARS-CoV-2): systematic review
Robson Chacon Castoldi, Juliana Cristina de Ângelo, Thiago Teixeira Pereira, Rodrigo Martins Dias, Fábio Juliano Negrão
Sport Sciences for Health.2023; 19(1): 55. CrossRef
Impact of Physical Rehabilitation on Bone Biomarkers in Non-Metastatic Breast Cancer Women: A Systematic Review and Meta-Analysis
Alessandro de Sire, Lorenzo Lippi, Nicola Marotta, Arianna Folli, Dario Calafiore, Stefano Moalli, Alessio Turco, Antonio Ammendolia, Nicola Fusco, Marco Invernizzi
International Journal of Molecular Sciences.2023; 24(2): 921. CrossRef
Does wing use and disuse cause behavioural and musculoskeletal changes in domestic fowl ( Gallus gallus domesticus )?
Renée C. Garant, Bret W. Tobalske, Neila Ben Sassi, Nienke van Staaveren, Dan Tulpan, Tina Widowski, Donald R. Powers, Alexandra Harlander-Matauschek
Royal Society Open Science.2023;[Epub] CrossRef
Increased fat mass negatively influences femoral neck bone mineral density in men but not women
Nipith Charoenngam, Caroline M. Apovian, Chatlert Pongchaiyakul
Frontiers in Endocrinology.2023;[Epub] CrossRef
Influence of Strength Training Variables on Neuromuscular and Morphological Adaptations in Prepubertal Children: A Systematic Review
Alberto Sánchez Pastor, Carlos García-Sánchez, Moisés Marquina Nieto, Alfonso de la Rubia
International Journal of Environmental Research and Public Health.2023; 20(6): 4833. CrossRef
The Role of Oxidative Stress in Multiple Exercise-Regulated Bone Homeostasis
Haoyang Gao, Yilong Zhao, Linlin Zhao, Zhikun Wang, Kai Yan, Bo Gao, Lingli Zhang
Aging and disease.2023; 14(5): 1555. CrossRef
Kadınlarda Fiziksel Aktivite ve Egzersizin Osteoporozu Önleme ve Tedavi Edici Rolü
Sümena HAREKET, İlknur NAZ GÜRŞAN
Cumhuriyet Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi.2023; 8(1): 73. CrossRef
Osteosarcopenia as a satellite of aging
B. I. Isaeva, K. M. Alieva-Kharkharova
Meditsinskiy sovet = Medical Council.2023; 17(9): 130. CrossRef
Examining Physical Wellness as the Fundamental Element for Achieving Holistic Well-Being in Older Persons: Review of Literature and Practical Application in Daily Life
Sheng-Te Hung, Yi-Chen Cheng, Chieh-Chen Wu, Chun-Hsien Su
Journal of Multidisciplinary Healthcare.2023; Volume 16: 1889. CrossRef
Effects of Exercise, Rehabilitation, and Nutritional Approaches on Body Composition and Bone Density in People with Multiple Sclerosis: A Systematic Review and Meta-Analysis
Natascia Rinaldo, Alba Pasini, Sofia Straudi, Giovanni Piva, Anna Crepaldi, Andrea Baroni, Lorenzo Caruso, Fabio Manfredini, Nicola Lamberti
Journal of Functional Morphology and Kinesiology.2023; 8(3): 132. CrossRef
Changes in Desk-Based Workers’ Sitting, Standing, and Stepping Time: Short- and Longer-Term Effects on Musculoskeletal Pain
FRANCIS Q. S. DZAKPASU, NEVILLE OWEN, ALISON CARVER, CHRISTIAN J. BRAKENRIDGE, ELIZABETH G. EAKIN, GENEVIEVE N. HEALY, ANTHONY D. LAMONTAGNE, MARJ MOODIE, PIETER COENEN, LEON STRAKER, DAVID W. DUNSTAN
Medicine & Science in Sports & Exercise.2023; 55(12): 2241. CrossRef
Shared decision making in sarcopenia treatment
Kang An, Zengxiang Wu, Yu Qiu, Mengjia Pan, Lin Zhang, Zhenmei An, Shuangqing Li
Frontiers in Public Health.2023;[Epub] CrossRef
Effects of combined traditional Chinese medicine therapy in patients of lower limbs injuries with osteoporosis: A retrospective paired cohort study
Yu-Hua Lu, Chi-Hsiang Chung, Chien-Jung Lin, Li-Jen Tsai, Kuang-Chung Shih, Chieh-Hua Lu, Wu-Chien Chien
Medicine.2023; 102(49): e36489. CrossRef
ASSESSMENT OF LUMBAR VERTEBRAE IN DIFFERENT GROUPS AS HYPOTHYROIDISM, EUTHYROIDISM AND HYPERTHYROIDISM PATIENTS
Zeenath S Sheikh, Manmohini Sharma
ShodhKosh: Journal of Visual and Performing Arts.2023;[Epub] CrossRef
The theory of planned behavior and strength training in college-aged women
Diana Cuy Castellanos, Corinne M. Daprano, Clarissa Blevins, Anne Crecelius
Journal of American College Health.2022; 70(3): 837. CrossRef
The effect of exercise for improving bone health in cancer survivors — A systematic review and meta-analysis
Benjamin Singh, Kellie Toohey
Journal of Science and Medicine in Sport.2022; 25(1): 31. CrossRef
The role of estrogens in osteosarcopenia: from biology to potential dual therapeutic effects
A. Mandelli, E. Tacconi, I. Levinger, G. Duque, A. Hayes
Climacteric.2022; 25(1): 81. CrossRef
Changes in blood bone markers after the first and second bouts of whole‐body eccentric exercises
Tsang‐Hai Huang, Kazunori Nosaka, Trevor C. Chen
Scandinavian Journal of Medicine & Science in Sports.2022; 32(3): 521. CrossRef
Questions Individuals with Cardiac Conditions Engaging in Exercise often Ask Health Fitness Professionals: Research-Based Responses
Kirk D. Hendrickson, Cindy Haskin-Popp, Barry A. Franklin
ACSM'S Health & Fitness Journal.2022; 26(2): 29. CrossRef
Effects of Different Types of Exercise on Kidney Diseases
Hamid Arazi, Majid Mohabbat, Payam Saidie, Akram Falahati, Katsuhiko Suzuki
Sports.2022; 10(3): 42. CrossRef
Sport Activity Load and Skeletomuscular Robustness in Elite Youth Athletes
Irina Kalabiska, Annamaria Zsakai, Dorina Annar, Robert M. Malina, Tamas Szabo
International Journal of Environmental Research and Public Health.2022; 19(9): 5083. CrossRef
A pas de deux of osteoporosis and sarcopenia: osteosarcopenia
O. V. Yakushevskaya, S. V. Yureneva, V. I. Komedina
Meditsinskiy sovet = Medical Council.2022; (6): 116. CrossRef
The Effect of Endurance and Endurance-Strength Training on Bone Health and Body Composition in Centrally Obese Women—A Randomised Pilot Trial
Małgorzata Jamka, Sylwia E. Piotrowska-Brudnicka, Joanna Karolkiewicz, Damian Skrypnik, Paweł Bogdański, Judyta Cielecka-Piontek, Gulnara Sultanova, Jarosław Walkowiak, Edyta Mądry
Healthcare.2022; 10(5): 821. CrossRef
Kinematic and Kinetic Characteristics of Repetitive Countermovement Jumps with Accentuated Eccentric Loading
Micah Gross, Jan Seiler, Bastien Grédy, Fabian Lüthy
Sports.2022; 10(5): 74. CrossRef
Osteosarcopenia: A Narrative Review on Clinical Studies
Angela Polito, Lorenzo Barnaba, Donatella Ciarapica, Elena Azzini
International Journal of Molecular Sciences.2022; 23(10): 5591. CrossRef
Efficacy of Bracing on Thoracic Kyphotic Angle and Functionality in Women with Osteoporosis: A Systematic Review
Beatriz Sánchez-Pinto-Pinto, Carlos Romero-Morales, Daniel López-López, Carmen de-Labra, Guillermo García-Pérez-de-Sevilla
Medicina.2022; 58(6): 693. CrossRef
Are There Any Differences Between the Effect of Resistance and Aerobic Training on Spatial Learning and Memory in the Rat Model of AD?
Khadijeh Ebrahimi, Behrouz Baghaiee
Journal of Clinical Research in Paramedical Sciences.2022;[Epub] CrossRef
Effects of Whole-Body Vibration on Breast Cancer Bone Metastasis and Vascularization in Mice
Takeshi Matsumoto, Akihiro Mukohara
Calcified Tissue International.2022; 111(5): 535. CrossRef
Current Status of the Diagnosis and Management of Osteoporosis
Agustín Aibar-Almazán, Ana Voltes-Martínez, Yolanda Castellote-Caballero, Diego Fernando Afanador-Restrepo, María del Carmen Carcelén-Fraile, Elena López-Ruiz
International Journal of Molecular Sciences.2022; 23(16): 9465. CrossRef
Methodological Proposal for Strength and Power Training in Older Athletes: A Narrative Review
Emilio Jofré-Saldía, Álvaro Villalobos-Gorigoitía, Gemma Gea-García
Current Aging Science.2022; 15(2): 135. CrossRef
Robotic Walking to Mitigate Bone Mineral Density Decline and Adverse Body Composition in Individuals With Incomplete Spinal Cord Injury
Claire Shackleton, Robert Evans, Sacha West, Wayne Derman, Yumna Albertus
American Journal of Physical Medicine & Rehabilitation.2022; 101(10): 931. CrossRef
Exploration of Aging-Care Parameters to Predict Mortality of Patients Aged 80-Years and Above with Community-Acquired Pneumonia
Chunxin Lv, Wen Shi, Teng Pan, Houshen Li, Weixiong Peng, Jiayi Xu, Jinhai Deng
Clinical Interventions in Aging.2022; Volume 17: 1379. CrossRef
Pharmacological, Nutritional, and Rehabilitative Interventions to Improve the Complex Management of Osteoporosis in Patients with Chronic Obstructive Pulmonary Disease: A Narrative Review
Alessandro de Sire, Lorenzo Lippi, Vittorio Aprile, Dario Calafiore, Arianna Folli, Francesco D’Abrosca, Stefano Moalli, Marco Lucchi, Antonio Ammendolia, Marco Invernizzi
Journal of Personalized Medicine.2022; 12(10): 1626. CrossRef
Resistance circuit training combined with hypoxia stimulates bone system of older adults: A randomized trial
Alba Camacho-Cardenosa, Marta Camacho-Cardenosa, Ismael Martínez-Guardado, Alejo Leal, José María Villa Andrada, Rafael Timón
Experimental Gerontology.2022; 169: 111983. CrossRef
Effects of Strength Training on BDNF in Healthy Young Adults
Miroslaw Babiarz, Radoslaw Laskowski, Tomasz Grzywacz
International Journal of Environmental Research and Public Health.2022; 19(21): 13795. CrossRef
Celecoxib impairs primary human myoblast proliferation and differentiation independent of cyclooxygenase 2 inhibition
Ronald W. Matheny, Alexander L. Kolb, Alyssa V. Geddis, Brandon M. Roberts
Physiological Reports.2022;[Epub] CrossRef
The effects on type 2 diabetes mellitus mouse femoral bone achieved by anti-osteoporosis exercise interventions
Miao Zhang, Yuexuan Li, Lifei Liu, Mei Huang, Miao Wang, Jun Zou
Frontiers in Endocrinology.2022;[Epub] CrossRef
Physical Activity and Post-Transcriptional Regulation of Aging Decay: Modulation of Pathways in Postmenopausal Osteoporosis
Federica Vita, Sebastiano Gangemi, Giovanni Pioggia, Fabio Trimarchi, Debora Di Mauro
Medicina.2022; 58(6): 767. CrossRef
Sclerostin as a biomarker of physical exercise in osteoporosis: A narrative review
Anna Oniszczuk, Agnieszka Kaczmarek, Mateusz Kaczmarek, Maria Ciałowicz, Ersan Arslan, Ana Filipa Silva, Filipe Manuel Clemente, Eugenia Murawska-Ciałowicz
Frontiers in Endocrinology.2022;[Epub] CrossRef
Exercise and Bone Health in Cancer: Enemy or Ally?
Alice Avancini, Giulia Benato, Anita Borsati, Luca Oliviero, Lorenzo Belluomini, Marco Sposito, Daniela Tregnago, Ilaria Trestini, Jessica Insolda, Francesca Zacchi, Elena Fiorio, Federico Schena, Michele Milella, Sara Pilotto
Cancers.2022; 14(24): 6078. CrossRef
Asupan Makanan dan Intensitas Latihan Kaitannya dengan Fungsi Ginjal dan Komposisi Tubuh pada Komunitas Gym
Deny Yudi Fitranti, Khusana Aniq, Rachma Purwanti, Dewi Marfu'ah Kurniawati, Hartanti Sandi Wijayanti, Rani Ridowahyu Saphira
Amerta Nutrition.2022; 6(1): 63. CrossRef
State of Knowledge on Molecular Adaptations to Exercise in Humans: Historical Perspectives and Future Directions
Kaleen M. Lavin, Paul M. Coen, Liliana C. Baptista, Margaret B. Bell, Devin Drummer, Sara A. Harper, Manoel E. Lixandrão, Jeremy S. McAdam, Samia M. O'Bryan, Sofhia Ramos, Lisa M. Roberts, Rick B. Vega, Bret H. Goodpaster, Marcas M. Bamman, Thomas W. Bufo
Comprehensive Physiology.2022; 12(2): 3193. CrossRef
Composite Indices of Femoral Neck Strength in Middle-Aged Inactive Subjects Vs Former Football Players
Boutros Finianos, Gautier Zunquin, Rawad El Hage
Journal of Clinical Densitometry.2021; 24(2): 214. CrossRef
Relationship between bone strength index of the hemiparetic tibial diaphysis and muscle strength in people with chronic stroke: influence of muscle contraction type and speed
Z. Yang, T. Miller, M. Y. C. Pang
Osteoporosis International.2021; 32(5): 951. CrossRef
Effect of 12 months of creatine supplementation and whole-body resistance training on measures of bone, muscle and strength in older males
Darren G Candow, Philip D Chilibeck, Julianne Gordon, Emelie Vogt, Tim Landeryou, Mojtaba Kaviani, Lisa Paus-Jensen
Nutrition and Health.2021; 27(2): 151. CrossRef
Effects of 6-Month Multimodal Physical Exercise Program on Bone Mineral Density, Fall Risk, Balance, and Gait in Patients with Alzheimer’s Disease: A Controlled Clinical Trial
A. Silvia Puente-González, M. Carmen Sánchez-Sánchez, Eduardo J. Fernández-Rodríguez, J. Elicio Hernández-Xumet, Fausto J. Barbero-Iglesias, Roberto Méndez-Sánchez
Brain Sciences.2021; 11(1): 63. CrossRef
Resistance Training Modulates the Matrix Metalloproteinase-2 Activity in Different Trabecular Bones in Aged Rats
Ivo Vieira de Sousa Neto, João Luiz Quaglioti Durigan, Gonçalo Carreiro de Farias Junior, Fabio Henrique Bogni, Amanda Lima Ruivo, Juliana Oliveira de Araújo, Keico Okino Nonaka, Heloísa Selistre-de-Araújo, Rita de Cássia Marqueti
Clinical Interventions in Aging.2021; Volume 16: 71. CrossRef
Resistance Exercise in Prostate Cancer Patients: a Short Review
Andrej Zdravkovic, Timothy Hasenoehrl, Richard Crevenna
Current Physical Medicine and Rehabilitation Reports.2021; 9(1): 32. CrossRef
Sturz, Sarkopenie und Osteoporose
Marcus Köller
Journal für Mineralstoffwechsel & Muskuloskelettale Erkrankungen.2021; 28(1): 19. CrossRef
Effects of marathon race on selected myokines and sclerostin in middle-aged male amateur runners
Ewa Śliwicka, Tomasz Cisoń, Łucja Pilaczyńska-Szcześniak, Andrzej Ziemba, Anna Straburzyńska-Lupa
Scientific Reports.2021;[Epub] CrossRef
Lower extremity joint loading during Bounce rope skip in comparison to run and walk
Rajani Mullerpatan, Triveni Shetty, Yuvraj Singh, Bela Agarwal
Journal of Bodywork and Movement Therapies.2021; 26: 1. CrossRef
Powerlifting exercise performance and muscle mass indices and their relationship with bone mineral density
Daniel A. Hackett, Angelo Sabag
Sport Sciences for Health.2021; 17(3): 735. CrossRef
Physical Activity and Bone Health in Men: A Systematic Review and Meta-Analysis
Maureen C. Ashe, Isis Kelly dos Santos, Nicola Y. Edward, Laura A. Burnett, Rosanne Barnes, Lena Fleig, Joseph H. Puyat, Joanna E. M. Sale, Heather A. McKay, Lora M Giangregorio
Journal of Bone Metabolism.2021; 28(1): 27. CrossRef
Pathophysiology and treatment of osteoporosis: challenges for clinical practice in older people
J. Barnsley, G. Buckland, P. E. Chan, A. Ong, A. S. Ramos, M. Baxter, F. Laskou, E. M. Dennison, C. Cooper, Harnish P. Patel
Aging Clinical and Experimental Research.2021; 33(4): 759. CrossRef
Sarcopenia and Bone Mass Loss as Risks during Aging on Female Elderly with Light Activity
Yoni Astuti, Zulkhah Noor, Rahmah Rahmah
Open Access Macedonian Journal of Medical Sciences.2021; 9(T4): 168. CrossRef
Effect of intradialytic exercise on bone profile in hemodialysis patients
Howaida Abdelhameed Elshinnawy, Ahmed Mohamed Bakr Bakr Mohamed, Dina Abou Bakr Farrag, Moustafa Abd Elnassier AbdElgawad
Egyptian Rheumatology and Rehabilitation.2021;[Epub] CrossRef
Osteoporosis guidelines from a rehabilitation perspective: systematic analysis and quality appraisal using AGREE II
Giovanni IOLASCON, Alessandro de SIRE, Claudio CURCI, Marco PAOLETTA, Sara LIGUORI, Dario CALAFIORE, Francesca GIMIGLIANO, Antimo MORETTI
European Journal of Physical and Rehabilitation Medicine.2021;[Epub] CrossRef
A Case Study of an 87-Year-Old Male Bodybuilder with Complex Health Conditions
Daniel A. Hackett, Lachlan Mitchell, Guy C. Wilson, Trinidad Valenzuela, Matthew Hollings, Maria Fiatarone Singh
Medicina.2021; 57(7): 664. CrossRef
Frailty Pathogenesis, Assessment, and Management in Older Adults With COVID-19
Quan She, Bo Chen, Wen Liu, Min Li, Weihong Zhao, Jianqing Wu
Frontiers in Medicine.2021;[Epub] CrossRef
Optimization of transdisciplinary management of elderly with femur proximal extremity fracture: A patient-tailored plan from orthopaedics to rehabilitation
Alessandro de Sire, Marco Invernizzi, Alessio Baricich, Lorenzo Lippi, Antonio Ammendolia, Federico Alberto Grassi, Massimiliano Leigheb
World Journal of Orthopedics.2021; 12(7): 456. CrossRef
International Exercise Recommendations in Older Adults (ICFSR): Expert Consensus Guidelines
Mikel Izquierdo, R.A. Merchant, J.E. Morley, S.D. Anker, I. Aprahamian, H. Arai, M. Aubertin-Leheudre, R. Bernabei, E.L. Cadore, M. Cesari, L.-K. Chen, P. de Souto Barreto, G. Duque, L. Ferrucci, R.A. Fielding, A. García-Hermoso, L.M. Gutiérrez-Robledo, S
The Journal of nutrition, health and aging.2021; 25(7): 824. CrossRef
Intra-bone nuclear DNA variability and STR typing success in Second World War first ribs
Laura Božič, Tajda Benedik Bevc, Eva Podovšovnik, Tomaž Zupanc, Irena Zupanič Pajnič
International Journal of Legal Medicine.2021; 135(6): 2199. CrossRef
Can Resistance Exercise Be a Tool for Healthy Aging in Post-Menopausal Women with Type 1 Diabetes?
Zeinab Momeni, Jessica E. Logan, Ronald J. Sigal, Jane E. Yardley
International Journal of Environmental Research and Public Health.2021; 18(16): 8716. CrossRef
Role of the Myokine Irisin on Bone Homeostasis: Review of the Current Evidence
Amanda Kornel, Danja J. Den Hartogh, Panagiota Klentrou, Evangelia Tsiani
International Journal of Molecular Sciences.2021; 22(17): 9136. CrossRef
Prevalence and Correlates of Muscle-Strengthening Activity Participation in Croatia: A Cross-Sectional Study in a National Representative Sample of 4561 Adults
Hrvoje Radašević, Jelena Čvrljak, Željko Pedišić, Danijel Jurakić
International Journal of Environmental Research and Public Health.2021; 18(17): 8905. CrossRef
Intra-bone nuclear DNA variability and STR typing success in Second World War 12th thoracic vertebrae
Tajda Benedik Bevc, Laura Božič, Eva Podovšovnik, Tomaž Zupanc, Irena Zupanič Pajnič
Forensic Science International: Genetics.2021; 55: 102587. CrossRef
Vascular Ageing and Aerobic Exercise
Michaela Kozakova, Carlo Palombo
International Journal of Environmental Research and Public Health.2021; 18(20): 10666. CrossRef
Efficacy of Creatine Supplementation and Resistance Training on Area and Density of Bone and Muscle in Older Adults
DARREN G. CANDOW, PHILIP D. CHILIBECK, JULIANNE J. GORDON, SAIJA KONTULAINEN
Medicine & Science in Sports & Exercise.2021; 53(11): 2388. CrossRef
Perspectives of personalized approach to prevention and treatment of anticonvulsant-induced osteoporosis via action on vitamin D exchange and VDR expression
E. A. Dontseva, V. V. Trefilova, T. E. Popova, M. M. Petrova, M. Al-Zamil
Personalized Psychiatry and Neurology.2021; 1(2): 46. CrossRef
Bone health in adolescence
Maria R. AMBROSIO, Ludovica ALIBERTI, Irene GAGLIARDI, Paola FRANCESCHETTI, Maria C. ZATELLI
Minerva Obstetrics and Gynecology.2021;[Epub] CrossRef
To Evaluate the Awareness and Prevention of Osteoporosis in Patients Attending Orthopaedics Outdoor Clinics in a Tertiary Level Hospital
Annie Sandhu, Dharminder Singh, Akashdeep Singh, Kuldip Singh Sand
Trends in Medical Research.2021; 16(2): 73. CrossRef
Novel Insights into the Pathogenesis of Spinal Sarcopenia and Related Therapeutic Approaches: A Narrative Review
Yu-Kai Kuo, Yu-Ching Lin, Ching-Yu Lee, Chih-Yu Chen, Jowy Tani, Tsung-Jen Huang, Hsi Chang, Meng-Huang Wu
International Journal of Molecular Sciences.2020; 21(8): 3010. CrossRef
Multifactorial effects of hyperglycaemia, hyperinsulinemia and inflammation on bone remodelling in type 2 diabetes mellitus
V.A. Shahen, M. Gerbaix, S. Koeppenkastrop, S.F. Lim, K.E. McFarlane, Amanda N.L. Nguyen, X.Y. Peng, N.B. Weiss, T.C. Brennan-Speranza
Cytokine & Growth Factor Reviews.2020; 55: 109. CrossRef
Effect of pre-treatment of strength training and raloxifene in periestropause on bone healing
Melise Jacon Peres-Ueno, Fernanda Fernandes, Victor Gustavo Balera Brito, Ângela Cristina Nicola, Camila Tami Stringhetta-Garcia, Robson Chacon Castoldi, Amanda Pinatti Menezes, Paulo Cézar Ciarlini, Mário Jeferson Quirino Louzada, Sandra Helena Penha Oli
Bone.2020; 134: 115285. CrossRef
Physical rehabilitation of patients with osteoporosis
E.D. Yehudina, O.S. Kalashnikova
Voprosy kurortologii, fizioterapii i lechebnoi fizicheskoi kul'tury.2020; 97(2): 78. CrossRef
RANKL/RANK/OPG Pathway: A Mechanism Involved in Exercise‐Induced Bone Remodeling
Mohammad Tobeiha, Mohammed H. Moghadasian, Negin Amin, Sadegh Jafarnejad, Despina Deligianni
BioMed Research International.2020;[Epub] CrossRef
Effects of muscular strength training and growth hormone (GH) supplementation on femoral bone tissue: analysis by Raman spectroscopy, dual-energy X-ray absorptiometry, and mechanical resistance
Robson Chacon Castoldi, Guilherme Akio Tamura Ozaki, Thiago Alves Garcia, Ines Cristina Giometti, Tatiana Emy Koike, Regina Celi Trindade Camargo, João Domingos Augusto dos Santos Pereira, Carlos José Leopoldo Constantino, Mário Jefferson Quirino Louzada,
Lasers in Medical Science.2020; 35(2): 345. CrossRef
Approaches to the diagnosis and prevention of frailty
S. J. Woolford, O. Sohan, E. M. Dennison, C. Cooper, H. P. Patel
Aging Clinical and Experimental Research.2020; 32(9): 1629. CrossRef
The Impact of Exercise on Bone Health in Type 2 Diabetes Mellitus—a Systematic Review
R. Viggers, Z. Al-Mashhadi, R. Fuglsang-Nielsen, S. Gregersen, J. Starup-Linde
Current Osteoporosis Reports.2020; 18(4): 357. CrossRef
Transformation of Mature Osteoblasts into Bone Lining Cells and RNA Sequencing-Based Transcriptome Profiling of Mouse Bone during Mechanical Unloading
A Ram Hong, Kwangsoo Kim, Ji Yeon Lee, Jae-Yeon Yang, Jung Hee Kim, Chan Soo Shin, Sang Wan Kim
Endocrinology and Metabolism.2020; 35(2): 456. CrossRef
Physical Exercise Potentials Against Viral Diseases Like COVID-19 in the Elderly
Sandra Amatriain-Fernández, Thomas Gronwald, Eric Murillo-Rodríguez, Claudio Imperatori, Alexandre Francisco Solano, Alexandra Latini, Henning Budde
Frontiers in Medicine.2020;[Epub] CrossRef
Osteosarcopenia: beyond age-related muscle and bone loss
Gabriela Fagundes Belchior, Ben Kirk, Evela Aparecida Pereira da Silva, Gustavo Duque
European Geriatric Medicine.2020; 11(5): 715. CrossRef
Mediating role of physical fitness and fat mass on the associations between physical activity and bone health in youth
Duarte Henriques-Neto, João Pedro Magalhães, Pedro Júdice, Megan Hetherington-Rauth, Miguel Peralta, Adilson Marques, Luís B. Sardinha
Journal of Sports Sciences.2020; 38(24): 2811. CrossRef
Impact of physical activity and exercise on bone health in patients with chronic kidney disease: a systematic review of observational and experimental studies
Daniela F. Cardoso, Elisa A. Marques, Diogo V. Leal, Aníbal Ferreira, Luke A. Baker, Alice C. Smith, João L. Viana
BMC Nephrology.2020;[Epub] CrossRef
Short and medium-term effects of a multicomponent physical exercise program with a Mediterranean diet on bone mineral density, gait, balance, and fall risk for patients with Alzheimer disease
Ana Silvia Puente-González, Felipe Sánchez-González, Juan Elicio Hernández-Xumet, María Carmen Sánchez-Sánchez, Fausto José Barbero-Iglesias, Roberto Méndez-Sánchez
Medicine.2020; 99(38): e22385. CrossRef
Sarcopenia during COVID-19 lockdown restrictions: long-term health effects of short-term muscle loss
Richard Kirwan, Deaglan McCullough, Tom Butler, Fatima Perez de Heredia, Ian G. Davies, Claire Stewart
GeroScience.2020; 42(6): 1547. CrossRef
Acute Effects of Two Types of Dumbbell Exercise on Oxygenated Hemodynamic Concentration of Cerebral Activation in Healthy Young Male Adults: A Functional Near-Infrared Spectroscopy Study
Yana Wang, Jiaojiao Lü, Jifeng Rong, Linjie Song, Wei Wang, Yifan Jiang, Yu Liu, Lingyan Huang
Frontiers in Human Neuroscience.2020;[Epub] CrossRef
Muscle-Derived Lumican Stimulates Bone Formation via Integrin α2β1 and the Downstream ERK Signal
Jin Young Lee, So Jeong Park, Da Ae Kim, Seung Hun Lee, Jung-Min Koh, Beom-Jun Kim
Frontiers in Cell and Developmental Biology.2020;[Epub] CrossRef
Analysis of Age-Based Bone Mineral Density in the Korean Adult Population Using Dual-Energy X-ray Absorptiometry
Jung Chul Lee, Chong Hoon Lee, Dong Wha Chung, Hee Joo Lee, Jae Yong Park
Applied Sciences.2020; 10(23): 8469. CrossRef
Preventive Moderate Continuous Running-Exercise Conditioning Improves the Healing of Non-Critical Size Bone Defects in Male Wistar Rats: A Pilot Study Using µCT
Céline Bourzac, Morad Bensidhoum, Mathieu Manassero, Christine Chappard, Nicolas Michoux, Stéphane Pallu, Hugues Portier
Life.2020; 10(12): 308. CrossRef
BONE MINERAL DENSITY: AN ANALYSIS OF WEIGHT BEARING, RESISTANCE AND IMPACT PHYSICAL ACTIVITIES
Arvind Malik, Sonia Malik, Vishal Dahiya
PARIPEX INDIAN JOURNAL OF RESEARCH.2020; : 1. CrossRef
Effects of ursolic acid on muscle mass and bone microstructure in rats with casting-induced muscle atrophy
Yun Seok Kang, Eun Bi Noh, Sang Hyun Kim
Journal of Exercise Nutrition & Biochemistry.2019; 23(3): 45. CrossRef
Osteoporosis and Sarcopenia Increase Frailty Syndrome in the Elderly
Emanuela A. Greco, Peter Pietschmann, Silvia Migliaccio
Frontiers in Endocrinology.2019;[Epub] CrossRef
Associations of Health-Related Quality of Life, Fear of Falling and Objective Measures of Physical Function with Bone Health in Postmenopausal Women with Low Bone Mass
Anoohya Gandham, Lachlan B. McMillan, Carrie-Anne Ng, Ludovic Humbert, Maxine P. Bonham, Ayse Zengin, Peter R. Ebeling, David Scott
Journal of Clinical Medicine.2019; 8(9): 1370. CrossRef
Osteoblasts are “educated” by crosstalk with metastatic breast cancer cells in the bone tumor microenvironment
Alexus D. Kolb, Alison B. Shupp, Dimpi Mukhopadhyay, Frank C. Marini, Karen M. Bussard
Breast Cancer Research.2019;[Epub] CrossRef

First
Prev
Page of 3
Next
Last

Search